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ABSTRACT
This thesis investigates the mechanisms which underlie the blood oxygenation 
level dependent (BOLD) functional magnetic resonance imaging (fMRI) signal. 
Detailed understanding of the BOLD signal will allow fMRI to make the 
transition from a qualitative to quantitative neuroimaging technique, increasing its 
clinical potential. It is possible to further investigate the vascular, neuronal and 
physical processes which combine to give a resulting BOLD signal by using 
respiratory challenges to alter blood levels of carbon dioxide and oxygen. 
Isocapnic hyperoxia was found to have no significant effect on vascular responses 
at 7 Tesla (T). No significant change was found in resting-state cerebral blood 
flow (CBF), resting-state cerebral blood volume (CBV) and task evoked CBF. 
This suggests that the convention that oxygen has a vasoconstrictive effect on 
blood vessels reported in prior studies was based on an effect associated with a 
drop in carbon dioxide accompanying the increase in oxygenation. The effect of 
isocapnic hyperoxia on neuronal oscillations was assessed with 
magnetoencephalography (MEG). Whilst a significant reduction in oscillatory 
power is reported in the occipital lobe in response to hyperoxia, the change is 
significantly smaller than the global reduction in oscillatory power that has been 
previously measured with hypercapnia. Together these findings suggest that 
hyperoxia is an ideal tool for calibrated BOLD fMRI, although further research is 
required to quantify the association between neuronal oscillations and the cerebral 
metabolic rate of oxygen (CMRO2).
With no significant effect on vasculature, isocapnic hyperoxia is a useful tool for 
investigating the relationship between the change in blood oxygenation and the 
FKDQJHLQWUDQVYHUVHVLJQDOƅ52*). This relationship plays a key role in calibrated 
BOLD fMRI and has previously been determined by numerical and analytical 
simulations or experimental measures which have been confounded by a change 
in cerebral blood volume. The relationship between the fractional change in 
blood oxygenation and ƅ52*was found to be sub-linear across 1.5, 3 and 7 T, 
although a linear dependence was found to be a reasonable approximation. 
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Differences between these results and previous results which suggest a supralinear 
relationship at 1.5 and 3 T and a linear relationship at 7 T, are attributed to the 
relative contribution of intravascular and extravascular signals and their 
dependence on both field strength, blood oxygenation and choice of echo times. 
Hypercapnia is a potent vasodilator and is a popular and useful research tool 
when investigating cerebral metabolism and cerebrovascular reactivity. Due to the 
effect of hypercapnia on transit time, it is likely that arterial spin labelling (ASL) 
measures of CBF made at a single post-label label delay time (TI) will be prone to 
errors. A comparison of single and multiphase ASL is made at 7 T, with a 
modified Look-locker EPI sequence presented. The modified sequence allows 
simultaneous measurement of CBF and transit time, whilst increasing the 
available BOLD signal. Whilst the hypercapnia-induced change in CBF was found 
to be significantly higher with multiphase ASL, the change in BOLD signal was 
equivalent between single and multi-phase ASL. This could have important 
implications for hypercapnia calibrated BOLD fMRI, where the choice of ASL 
sequence may affect the estimated change in CMRO2. Furthermore, by increasing 
the sensitivity to perfusion and BOLD, this provides a framework for future 
cerebral haemodynamic studies in health and disease where simultaneous 
measurements are required.  
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1 Introduction 
 
Functional MRI (fMRI) images the physiological response of the brain in 
response to activation. It arose from the discovery that the magnetic properties of 
blood are dependent on its oxygenation level [1-5]. Over the past twenty years, 
this blood oxygenation level dependent (BOLD) response has been an area of 
active research, providing an invaluable tool in the fields of psychology and 
neuroscience. The use of the BOLD response within a clinical setting is currently 
limited by the fact it is an indirect measure of neural activity which is dependent 
on baseline physiology (such as cerebral blood flow (CBF), cerebral blood volume 
(CBV) [6] and blood oxygenation (Y)) which varies between subjects, particularly 
on ageing and patient groups. The work presented in this thesis investigates the 
physiological processes that give rise to the BOLD response, with the aim of 
increasing the validity of future fMRI research.  
Calibration of the BOLD response using functional MRI (fMRI) can provide a 
fractional change in the cerebral metabolic rate of oxygen consumption (CMRO2) 
[7, 8]. CMRO2, as measured with calibrated BOLD fMRI, minimises the vascular 
contribution to the BOLD signal and is therefore more closely linked to neuronal 
activity than the BOLD response. The two main methods of calibration rely on 
respiratory challenges. The original method used hypercapnia to modulate CBF [7] 
and this was adapted for a hyperoxic stimulus which directly modulated 
oxygenation [8]. Both techniques assume these stimuli do not modulate neuronal 
activity. More recently combined methods have been proposed where both CBF 
and oxygenation are modulated using hyperoxia and hypercapnia to estimate 
absolute CMRO2 [9, 10]. This thesis aims to improve the quantitative nature of 
calibrated BOLD by assessing the assumptions made in the calibrated BOLD 
model. The experimental data provide a novel insight into the most appropriate 
stimulus choice, parameter estimation and imaging acquisition for calibrated 
BOLD.   
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1.1 Thesis Outline 
 
This thesis describes how the modulation of oxygen (O2) and carbon dioxide 
(CO2) can be used to investigate the cerebral haemodynamics which underlie the 
blood oxygenation level dependent (BOLD) response. The experimental findings 
presented in Chapters 4-6 are from work carried out in The Sir Peter Mansfield 
Magnetic Resonance Centre, Department of Physics and Astronomy at The 
University of Nottingham between September 2010 and February 2014.  
Chapter 2 introduces the basic principles which underlie NMR and how they are 
applied in MRI to enable image acquisition. The imaging sequences are introduced 
along with the MRI hardware required to implement them. Only healthy 
volunteers were scanned for the work presented in this thesis, however there are 
still ethical and safety considerations to be made and these are discussed.  
Chapter 3 provides an overview of neuro-anatomy and physiology. The BOLD 
contrast is introduced along with current limitations of interpreting BOLD fMRI 
data. BOLD fMRI, arterial spin labelling (ASL), Phase-Contrast Magnetic 
Resonance Angiography (PC-MRA) and magnetoencephalography (MEG) are 
used in this thesis to assess the different physiological components of the BOLD 
response. Chapter 3 introduces these techniques, describing the background 
theory and their implementation. 
Chapter 4 describes how modulation of blood gas levels of O2 can be used to 
calibrate the BOLD response to estimate the rate of cerebral O 2 metabolism 
(CMRO2). The effect of isocapnic hyperoxia on resting state physiology is 
measured in order to assess the assumptions currently made in hyperoxia 
calibrated BOLD fMRI. Chapter 4 then presents findings on the effect of 
isocapnic hyperoxia on evoked responses to functional activation, assessing the 
role of O2 in functional hyperaemia.  
Chapter 5 presents the experimental findings from a cross-field study at 1.5, 3 and 
7 Tesla. A novel method for assessing the relationship between transverse 
relaxation rate (R2
*) and fractional oxygenation (1-Yv) is introduced. It is proposed 
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that when intravascular and extravascular signal contributions are accounted for, 
this relationship is sub-linear. This finding is contrary to prior belief that the 
relationship is supralinear at 1.5 and 3 T and tends towards a linear relationship at 
7 T. The implications of this finding for calibrated BOLD fMRI are discussed.  
Chapter 6 introduces a modified pulse sequence termed Look-Locker Double 
Acquisition with Background Suppression (LL_DABS) to allow more accurate 
measurements of simultaneous BOLD and cerebral blood flow (CBF) under 
situations of increased flow, such as hypercapnia, where transit time changes must 
be considered. The current challenges faced when measuring the effects of 
hypercapnia on cerebral physiology are assessed and direct comparison made 
between two alternative arterial spin labelling (ASL) readout schemes with a view 
to improving the validity of future research. 
Chapter 7 summarises the experimental work and introduces future research 
directions.   
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2 Magnetic Resonance Theory 
 
2.1 Outline 
 
This chapter introduces the basic principles which underlie nuclear magnetic 
resonance (NMR). The behaviour of a single proton in the presence of a static 
magnetic field is discussed and then expanded to an ensemble of protons. These 
principles are used in magnetic resonance imaging (MRI), and a brief introduction 
of how the MR signal is spatially encoded to produce an image is provided, 
including an overview of scanner hardware and relevant pulse sequences.  
2.2 Nuclear Magnetic Resonance 
 
2.2.1 Quantum mechanical description 
 
Spin angular momentum is a quantum mechanical property of a nucleus, taking 
the vector quantity J with cartesian components [ĥ,x ĥ,y ĥ,z]. The magnitude of J is 
described by Equation 2-1: 
)1(  II!J ,        2-1 
where ĥ LV 3ODQN·V FRQVWDQW GLYLGHG E\ ư DQG I represents the spin quantum 
number. I can take either integer, half-integer values, or zero (a non-zero value is 
required for a nucleus to exhibit MR properties). A particle with quantum spin 
number I, can take 2I+1 states when placed in an external magnetic field, B, as 
determined by mI, where mI = -I, (-I+1), ... I.  The quantum number mI determines 
the discrete orientation of the spin angular momentum, such that if the magnetic 
field is parallel to the z-axis, Jz can be described by: 
!Iz mJ  .         2-2 
The primary nucleus of interest in magnetic resonance imaging (which will be the 
focus of this thesis) is hydrogen (1H), due to its high natural abundance in the 
human body. For 1H, the single proton in the nucleus deems that I = ½, thus 
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there are two distinct spin states of mI ; + 1/2  (spin up) and - 1/2 (spin down) 
and spin angular momentum Jz= ±½ĥ. These discrete values describe two distinct 
spin states; for spins parallel to B0 (mI = + ½), and anti-parallel to B0 (mI = - ½), 
where B0 is the magnitude of the magnetic field in the z-direction, 
zB 0B          2-3 
Classically, each individual hydrogen nucleus can be viewed as a rotating charged 
VSKHUHKHQFHIRUWKUHIHUUHGWRDVD´VSLQµWKXVLWSRVVHVVHVDPDJQHWLFPRPHQW
(Ƭ) in addition to spin angular momentum 7KH J\URPDJQHWLF UDWLR ƣ 
MHz/T for 1H) [11] is a nucleus-specific proportionality constant relating the two 
properties such that 
Jȝ J                           2-4 
Using Equation 2-2, the z-component of Ƭ can be written as 
Iz m!JP           2-5 
The nucleus will acquire energy (E) in the presence of an external magnetic field, 
B0, given by E = -ƬzB0.  Substituting for Ƭz gives E = -ƣĥPIB0. It can be seen that 
each spin state will have a different energy level, with the parallel spin-state (spin 
up or +½) orientation having the lowest energy. 
The energy associated with a spin state is proportional to the applied magnetic 
field, B0. Therefore, in the absence of an external magnetic field, there is no 
splitting of energy levels. The separation of energy levels in a magnetic field is 
known as Zeeman splitting [11] (Figure 2-1), where for the 1H nucleus energy 
difference it is defined as: 
BE !J ' .         2-6 
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Figure 2-1) Schematic of Zeeman splitting for 1H. The difference in energy 
OHYHOƅ(LVWKHSURGXFWRIWKHJ\URPDJQHWLFUDWLRƣĥ3ODQFN·VFRQVWDQW
GLYLGHG E\ư DQG WKH H[WHUQDOPDgnetic field (B0). In the absence of a 
magnetic field, the energy levels of both states are equal.  
In NMR, by applying an oscillating magnetic field B1 in the xy-plane, a transition 
can be made between spin states (i.e. low-energy parallel state to high energy anti-
parallel state). The required oscillatory frequency (v0) is determined by  
S
J
2
0
0
B
v           2-7 
ZKLFKLVW\SLFDOO\ZULWWHQLQWHUPVRIDQJXODUIUHTXHQF\ƹ0ZKHUHƹ0 ưY0 and 
00 BJZ   .         2-8 
This is termed the Larmor frequency which for hydrogen is 63.8 MHz at 1.5 T, 
127.6 MHz at 3 T and 297.7 MHz at 7 T.  
Thus far, only a single proton has been considered. In a sample of 2 x 2 x 3 mm (a 
typical MRI voxel), there will be on the order of 8.0 x 1020 protons per voxel 
(where a single volume of spins can be called a spin isochromat). The Boltzmann 
distribution, as described by Equation 2-9, determines how populated each energy 
state is at thermal equilibrium. Assuming each spin is non-interacting,  N+ and N- 
denote the number of nuclei in the parallel spin state (mI=+½ ) and anti-parallel 
spin state (mI=-½ ) respectively, k LV %ROW]PDQQ·V FRQVWDQW  [ -23 
Joules/Kelvin) and T is the temperature in Kelvin [12]. 
7 
 
kTEe
N
N /'


                     2-9 
In the high temperature limit ƅ(kT, Equation 2-9 can be expanded using the 
first two terms of the Taylor series and substituting Equation 2-7 gives 
kT
B
N
N 01 !J|

.        2-10 
The total number of spins (N) can be taken as the sum of N+ and N-, (where the 
difference between states is so small such that N+ §1-) so that the population 
difference, n, can be written as 
kT
BN
kT
BN
n
2
00 !! JJ   

.       2-11 
It can be seen from Equation 2-11 that the energy difference between states and 
the population difference is dependent on B0, therefore the signal to noise ratio is 
improved with increasing field strength. Similarly, using Equation 2-11 to derive 
the magnitude of the net magnetisation (M) indicates the signal dependence on 
field strength. 
 Pn M                     2-12 
where,  
2
!JP  , such that  
 
 
kT
BN o
4
2!J M         2-13 
In the absence of an external magnetic field, the spins will be randomly oriented 
and therefore M0 will be zero (Figure 2-2A). However, in the presence of an 
external magnetic field, spins are aligned either parallel or anti-parallel to B0. 
Slightly more spins occupy the low-energy parallel state, so that M0 is non-zero 
(Figure 2-2B). 
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Figure 2-2) A) In the absence of an external magnetic field (B0), spins are 
randomly oriented such that the net magnetisation (M) is zero. B) In the 
presence of B0, spins are positioned either parallel or anti-parallel to the 
field. Slightly more spins are in the parallel state such that M0 >0. 
2.2.2 Classical description 
 
A magnetic moment placed in a magnetic field, B0 will experience a torque and so 
the spin angular momentum vector J will begin to precess about B0 at a constant 
angle with respect to B0, as given by Equation 2-14. 
BȝJ x 
dt
d
,         2-14 
where zB 0B         2-15 
This can be written in terms of magnetic moment (Equation 2-4) and assuming 
that the magnetic field is parallel to the z-axis (Equation 2-15), the precession can 
be described along the x, y and z components (Equations 2-17-2-19, Figure 2-3). 
Bȝȝ xJ 
dt
d
                               2-16 
0zd
dt
P   ,                                                                                                 2-17 
x
y z
d B
dt
P JP  ,        2-18 
y
x z
d
B
dt
P JP           2-19 
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The frequency of this precession is kQRZQ DV WKH /DUPRU IUHTXHQF\ ƹ0) 
(Equation 2-20), corresponding to the resonance frequency defined by quantum 
theory (Equation 2-8).   
0 0.BZ J                                 2-20 
 
Figure 2-3) Precession of a magnetic dipole when placed in an external 
magnetic field (B0). The torque exerted by B0 in combination with the 
angular momentum of the magnetic dipole, causes it to precess around B0 
with angular IUHTXHQF\ƹ0. 
2.2.3 Rotating Frame of Reference and the application of a 
radiofrequency pulse (B1) 
 
Before considering how magnetisation is detected, it is useful to simplify the 
mathematics by introducing the rotating frame of reference. In the rotating frame 
of reference (with co-RUGLQDWHV [· \· DQG ]· LW LV DVVXPHG WKDW WKH ZRUOG LV
URWDWLQJDERXW]LH] ]·DWIUHTXHQF\ƹr relative to the laboratory frame.   For 
the FRQGLWLRQƹr = ƹ0 spins at the Larmor frequency no longer appear to precess 
but appear stationary.  
With the effective removal of precession, the application of an oscillating 
magnetic field at the Larmor frequency, B1 DORQJWKH[·-axis causes the protons to 
precess about B1. This is generally in the radiofrequency range and so this field 
perturbation is also called a radiofrequency (RF) pulse and is generated by an 
oscillating current through a transmit coil.  The application of B1 for time t causes 
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WKHQHWPDJQHWLVDWLRQWRPRYHIURPWKH]·-SODQHLQWRWKH[·\·-plane by flip angle 
(FA) ƨDVGHILQHGE\ 
1BtT J .         2-21 
RF pulse types that are regularly used in MR pulse-sequences are an excitation 
SXOVHƨ °DQGDQLQYHUVLRQSXOVHƨ °).  Following an RF SXOVHRIƨ 
90°WKHQHWPDJQHWLVDWLRQYHFWRULV]HURLQWKH]·-plane and M0 LQWKH[·\·-plane. 
)ROORZLQJ DQ 5) SXOVH RI ƨ   °, the net magnetisation vector is inverted 
WKURXJKWKH[·\·-SODQHVRWKDWLWLVQRZDORQJWKHQHJDWLYH]·-axis (Figure 2-4). The 
WLSSLQJ RI WKH QHW PDJQHWLVDWLRQ DZD\ IURP WKH ]· RU ] D[LV LQ WR WKH [·\·
(transverse) plane is essential for NMR signal detection.  
 
Figure 2-4) After B1 is aSSOLHG IRU WLPH W DORQJ WKH [·-axis, the net 
PDJQHWLVDWLRQ WLSV LQWR WKH[·\·-plane with ƨ ƣ%1W)RU ƨ °, the net 
magnetisation is tipped fully into the x-\·-SODQH&)RU ƨ  °, the net 
magnetisation is inverted to be along the ²]·D[LV 
2.3 Relaxation 
 
At equilibrium, the z-component of magnetisation vector is equal to the 
equilibrium magnetisation vector (Mz = M0) and Mxy = 0. During an RF pulse, the 
longitudinal magnetisation is perturbed due to the transition of spin states, and 
transverse magnetisation (Mxy) is induced via phase coherence. After an RF pulse, 
the longitudinal and transverse signal components relax back to their equilibrium 
state, each with different rate constants. 
11 
 
2.3.4 Longitudinal Relaxation 
 
Longitudinal relaxation arises from spins experiencing fluctuating magnetic fields. 
Each spin has its own magnetic dipole moment and so when an individual spin is 
precessing at the Larmor frequency, a magnetic field is generated. This generated 
magnetic field will cause neighbouring nuclei to change spin-state and so gradually 
restore the equilibrium state where slightly more spins exist in the lower energy 
spin-state than the higher energy spin-state. The interaction between spins and the 
VXUURXQGLQJODWWLFHLVDIIHFWHGERWKE\WKHPROHFXOH·VDELOLW\WRPRYHWKURXJKWKH
lattice, described by the FRUUHODWLRQWLPHƴc) which itself is temperature dependent.  
Following an RF pulse, the spin system returns energy to the lattice (surrounding 
environment) in order to re-establish the Boltzmann distribution of spin states. 
The time taken for Mz to recover back to the equilibrium value of M0 is 
characterised by the time constant T1 (Figure 2-5). In general, longitudinal 
recovery can be described as an exponential process, as described by the 
simplified Bloch Equation:  
0
1
zz
M MdM
dt T
                                        2-22 
The solution following a 180° inversion pulse such that Mz = -M0 at time t = 0 is 
given by: 
1/
0(1 2 )t TzM M e                                2-23 
T1 varies according to sample properties such as water binding, water content and 
concentration of macromolecules and so can provide a useful contrast mechanism 
to distinguish between different tissue types (Table 2-1). T1 is most commonly 
measured by an inversion recovery (IR) sequence. After the initial inversion pulse 
(Figure 2-6) there is a delay oU ´LQYHUVLRQ WLPHµ 7, DOORZLQJ VRPH VLJQDO WR
recover, before a 90° RF pulse knocks the magnetisation at time TI into the 
transverse plane. This is then repeated for differing values of TI and the resulting 
data are fitted to Equation 2-23.  
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Figure 2-5) Relaxation of the longitudinal magnetisation component Mz 
back to equilibrium state M0 following a 180° inversion RF pulse. Recovery 
is governed by the time constant T1 (Equation 2-22). 
 T
1
 (ms)  
Field Strength 
(T)  
Grey Matter  White Matter  Venous 
Blood  
1.5  1197 [13] 646 [13] 1429 [14] 
3.0  1607 [13] 838 [13] 1667[14] 
7.0  1939 [13]
 
1126[13] 1905[14]  
Table 2-1) Example longitudinal relaxation times (T1) in milliseconds, for 
tissue and blood at 1.5, 3 and 7 T.   
 
Figure 2-6) Basic pulse diagram for an inversion recovery (IR) sequence. 
The delay between the 180° RF pulse and 90° RF pulse is characterised by 
the inversion time (TI).  
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2.3.5 Transverse Relaxation  
 
Following an RF excitation pulse, all spins are initially in phase, precessing at 
approximately the same frHTXHQF\ƹ0. However, the transverse signal component 
decays as the spin system loses phase coherence. If all spins were to precess at the 
Larmor frequency, then Mxy would precess coherently about the z-axis, appearing 
to be static in the rotating frame. However, each spin experiences a slightly 
different magnetic field causing a range of precession frequencies. In the rotating 
frame, spins which rotate at a frequency above or below the Larmor frequency  
will cause the spin isochromats to fan out, until they are normally distributed and 
Mxy = 0 (Figure 2-7). 
 
Figure 2-7) $7UDQVYHUVHPDJQHWLVDWLRQLQWKH[·\·-plane (rotating frame of 
reference) immediately following a 90° RF pulse. B) Mxy reduces over time 
via T2 or T2
* relaxation, caused by loss of phase coherence due to individual 
VSLQVSUHFHVVLQJDWIUHTXHQFLHVRWKHUWKDQWKH/DUPRUIUHTXHQF\ƹL).  
During the recovery of Mxy to equilibrium state (where Mxy = 0), energy is 
transferred between spins but does not exchange with the energy of the lattice. 
The exponential decay of the transverse component of magnetisation is governed 
by the time constant T2  (or T2
*) (Figure 2-8). The transition of spin states which 
induce T1 effects will contribute to the loss of phase coherence and thus T1 
contributes to T2 relaxation. Transverse relaxation can be described by the 
following simplified Bloch Equation as given by:  
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   ,                 2-24 
Equation 2-25 gives the solution: 
2/
0
t T
xyM M e
 .                 2-25 
 
Figure 2-8) Relaxation of the transverse magnetisation component Mxy to 
equilibrium following an RF pulse. Recovery is governed by the relaxation 
time constant T2 (Equation 2-24). 
As well as the irreversible time variant processes (T2), transverse decay can also be 
caused by invariant changes (T2· LQ WKH ORFDO PDJQHWLF ILHOG ZKLFK FDXVH
irreversible and reversible transverse decay. The combination of these effects is 
described by the rate constant, T2
*, where 
* '
2 2 2
1 1 1
T T T
                           2-26 
In order to measure T2, it is necessary to rephase the static T2·HIIHFWV72·HIIHFWV
can be refocused using a spin-echo sequence [15] which uses a 180° refocusing 
pulse (applied at time TE/2 after the initial RF pulse) to refocus the magnetisation 
vector (Figure 2-9). Phase accumulation is now reversed so that spins precessing 
at a frequency greater than the Larmor frequency now have a negative net phase. 
Assuming that they continue to precess at the same frequency, dephased spins are 
rephased by an equal amount, such that at time TE an echo of the original signal 
can be measured. By repeating a SE sequence across a range of TE values, T2 can 
be measured.  
15 
 
 
Figure 2-9 7UDQVYHUVH PDJQHWLVDWLRQ LQ WKH [·\·-plane immediately 
following a 180° RF pulse B) Mxy reduces over time via T2 relaxation, 
caused by loss of phase coherence over time due to individual spins 
SUHFHVVLQJDWIUHTXHQFLHVRWKHUWKDQWKH/DUPRUIUHTXHQF\ƹL). C) At time 
TE/2, a 180° UHIRFXVLQJ SXOVH LV DSSOLHG DORQJ WKH \·-axis so that phase 
accumulation is reversed. D) At time TE, an echo of the original signal is 
IRUPHGRQ WKH \·-axis.  E) Basic pulse sequence diagram for a spin echo 
sequence; a 180° RF pulse is applied at time TE/2. 
Diffusion effects become more problematic at high field strengths as T2 decreases 
and so the relative contribution of diffusion effects increases, meaning a spin echo 
repeated at different echo times is not the optimal method to measure T2. An 
alternative approach to a spin-echo sequence is a Carr-Purcell-Meiboom-Gill 
(CPMG) sequence [16, 17]. By applying a series of 180° refocusing pulses (with 
TE defined as the time between each refocusing pulse and increasing 
incrementally), the available time for diffusion effects to accumulate is minimised. 
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This results in a more accurate T2 value, which can be made in a single experiment, 
provided the pulses are short. 
The separate effects of these three relaxation time constants and their role in 
signal contrast will be discussed in more detail in Chapter 5. Literature values of 
T2 and T2
* across field strength are shown in Table 2-2. The measurement of T2
* is 
introduced in section 2.4.12 and the quantification and modelling of T2
* 
considered further in Chapter 5. 
Field 
Strength 
(T)  
Grey Matter  White Matter  Venous Blood  
 T
2 
(ms)  T
2
*
(ms)
 
 
T
2
(ms)
 
 T
2
* 
(ms)
 
 
T
2
(ms)
 
 T
2
* 
(ms)
 
 
1.5  83.5 
[18] 
84.0 [14]   80.0 [18] 66.2 [14]  128.0 [19]  40.0 [20]  
3.0 72.0 
[18] 
66.0 [14]   71.0 [18] 53.2 [14] 31.1  [21] 14.3 [20]   
7.0  46.5 
[18] 
33.2 [14] 47.0 [18] 26.8 [14] 13.1 [22]
 
  
 4.3  [20] 
 
 
Table 2-2) Example T2 and T2
* relaxation times in milliseconds, across 
different field strengths.  
2.3.6 Free Induction Decay 
 
$IWHUDQ5)SXOVHLVDSSOLHGZLWKFDUULHUIUHTXHQF\ƹ0, the resulting signal in the 
transverse plane wiOO LQGXFH D FXUUHQW LQ WKH UHFHLYHU FRLO )DUDGD\·V
electromagnetic induction law) which oscillates at the Larmor frequency. This 
signal decays with a transverse time constant back to equilibrium, according to the 
Bloch Equations (Equation 2-24). The signal difference between the Larmor and 
carrier frequencies is known as the free induction decay (FID) and is the basic 
form of all MR signals arising from a single RF pulse (Figure 2-10). The 
magnitude of the FID depends on the flip angle and the magnitude of M0 which is 
dependent on the strength of the applied magnetic field, B0 and the proton density.  
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Figure 2-10) Schematic of the free induction decay of magnetisation 
following an RF pulse. The signal decays exponentially as described by 
time constant T2
*, taking ~ 5T2
* to decay to zero. 
2.4 Magnetic Resonance Imaging 
 
This section extends the basic principles of NMR to the field of MRI and will 
outline the theory behind the imaging techniques used in this thesis. So far, the 
theory of using an RF excitation pulse to generate a signal has been introduced. 
Here this is extended to explain how the signal is spatially encoded to produce an 
image. 
2.4.7 Magnetic Field Gradients 
 
Magnetic field gradients (G) are used to produce linearly varying fields along the 
axis in which they are applied (Equation 2-27, where i refers to either the x, y or z 
axis).  
di
dBG zi                      2-27 
Applying a gradient G will lead to a spatial variation in the Larmor frequency such 
that frequency is described as a function of position r by  
0( ) ( )r B GrZ J                      2-28 
In the absence of a gradient, all spins will precess with the same frequency and 
phase and so it is not generally possible to determine if/how the signal varies 
across image voxels. By applying magnetic field gradients along the x, y and z axes, 
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it is possible to gain 3D spatial information in order to reconstruct an image from 
the MR signal [23]. Arrangement of surface coils can be used to encode additional 
spatial information; however such parallel acquisition techniques are beyond the 
scope of this thesis. 
MR signals can be represented as either a function of frequency or time. Signal 
oscillations are recorded over time, which represent many different frequencies, 
each different frequency corresponding to a different spatial location.  Frequency 
and time hold a reciprocal relationship, such that a Fourier transform (FT) can 
translate MR signal from the frequency domain to the time domain.    
2.4.8 Slice Selection 
 
To excite an image slice, rather than the entire sample, a magnetic field gradient is 
applied along the z-axis (Gz) so that the Larmor frequency now varies with z. The 
RF pulse used has a narrow frequency bandwidth so that only a limited range of 
IUHTXHQFLHVƅƹDUHH[FLWHG)URPFigure 2-11 it can be seen that an RF pulse of 
EDQGZLGWKƅƹVHOHFWVDVOLFHRIZLGWKƅ]SHUSHQGLFXODUWRWKH]-axis, where  
G zZ J'  '                                                       2-29 
 
Figure 2-11) Applying an RF pulse of finite duration along the z-axis 
H[FLWHVDQDUURZUDQJHRIIUHTXHQFLHVƅƹFRUUHVSRQGLQJWRDVOLFHZLGWKƅ] 
An RF pulse of a single carrier frequency is convolved with a sinc function 
(sin(x)/x), such that the FT of the product is a boxcar (Figure 2-12) with non-zero 
values across a baQGZLGWKƅƹ+RZHYHUWKH5)SXOVHLVRIDILQLWHOHQJWKDQGVR
the sinc function must be truncated, meaning the boxcar is less well-defined but 
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remains a sufficient approximation. Slice thickness is defined by the amplitude of 
the gradient, G or, the RF baQGZLGWKƅƹ0. Multi-slice acquisition is achieved by 
DSSO\LQJVHTXHQWLDO5)SXOVHVRIEDQGZLGWKƅƹZLWKGLIIHUHQWFDUULHUIUHTXHQFLHV
ƹ0. 
 
Figure 2-12) Convolution of the Fourier Transformed (FT) RF pulse with a 
WUXQFDWHG VLQF IXQFWLRQ ZLWK GHILQHG FDUULHU IUHTXHQF\ ƹ0 to excite a 
QDUURZZLGWKRI IUHTXHQFLHVƅƹZLOOSURGXFHDER[FDURIQRQ-zero values 
and when in the presence of a linear gradient will produce a square slice 
profile. 
2.4.9 k-space 
 
k-space is a two or three dimensional array of spatial frequencies. The frequency 
array arises from the combined effects of magnetic field gradients (along their 
respective axis) which have accumulated between the initial excitation pulse and 
the readout pulse. If the rHDGRXWRFFXUV DW WLPH W· N-space coordinates from a 
two-dimensional array can be defined as: 
 
'
0
( ') ( )
t
x xk t G t dtJ ³ .                             2-30
                 
From Equation 2-30 it can be seen that the location of a data point within k-space 
is determined by the gradient strength and duration. By applying a combination of 
gradients along the x axes, k-space can be traversed and a series of data points 
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sampled. An object at a particular position in a gradient will produce a signal 
which varies sinusoidally in k space at a frequency which depends on its position. 
The kx coordinates represent spatial frequencies (typically measured in mm
-1) i.e. 
the rate at which signal phase will change as a function of position. A similar 
approach can be taken in the other two spatial dimensions.  
The centre of k-space stores low spatial-frequency information such as overall 
shape and image contrast. High frequency information is stored on the edge of k-
space, encoding information such as edges. This highlights the need for an image 
to be reconstructed from as much of k-space as possible in order to increase the 
image spatial resolution. In the simplest of image acquisitions, one line of k-space 
is acquired following an RF pulse in each repetition time (TR), however there are 
many different methods to fill k-space. The main pulse sequence used in this 
thesis is Echo-Planar Imaging (EPI) technique, more details of this method are 
provided in section 2.4.12.  
The matrix size and sampling of k-space will determine the field of view (FOV) 
DQGVSDWLDOUHVROXWLRQRIWKHLPDJH)29LVWKHLQYHUVHRIƅNLQERWK[IUHTXHQF\
encoding) and y (phase encoding) directions. The spatial resolution is the inverse 
of the maximum spatial frequency, such that for a standard symmetric array, 
spatial resolution = FOV/matrix size. 
2.4.10 Frequency encoding 
 
To gain spatial specificity beyond the slice/volume of spins which have been 
excited, it is necessary to use frequency encoding (FE) gradients. These are 
applied after the slice-select gradient. Applying the gradient along the x-axis (Gx), 
so that Gx varies with x, further spatial localisation is gained by separating out the 
signal frequencies.  
2.4.11 Phase encoding 
 
With a third magnetic field gradient, applied along the y-axis, spatial localisation 
can be extended across 3 dimensions. After the application of Gy, the phase varies 
linearly along the y-axis. By applying Gy for a short period of time after slice 
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selection but prior to the readout gradient each line of k-space has a different 
phase/frequency combination.   Whilst the work in this thesis uses 2D MRI 
techniques, it is worth noting that in 3D imaging, phase encoding is applied along 
a third dimension in relation to the frequency and phase encoding directions  used 
in 2D imaging.  
SENSE 
Parallel imaging uses array receive coils to allow the acquisition of fewer lines of 
k-space in order to reduce acquisition time, which in the case of echo planar 
imaging (EPI, see Section 2.4.12) reduces image artefacts. If the distance between 
each line of k-space is increased but the maximum value held constant (resolution 
unaltered). Reducing the number of acquired lines decreases k y resulting in 
reduced FOV and image aliasing (see section 2.4.13), where the image is folded 
over such that signal is no longer encoded to spatially distinct k-space coordinates. 
 Sensitivity Encoding (SENSE) is a common method of parallel imaging [24] 
which is implemented on Philips platforms. By using a receive coil with multiple 
receive elements (8/32/32 channels at 1.5/3/7 T respectively), the ambiguous 
spatial encoding can be resolved using the unique signal sensitivity profile of each 
coil. A reference scan is acquired prior to the main imaging sequence, so that the 
sensitivity for each separate receive element can be mapped. The amount that k-
space has been reduced by is defined as the SENSE factor and this is limited by 
the number of receive elements and their geometry. 
2.4.12 Imaging Sequences 
 
Gradient Echo 
In a basic gradient echo (GE) sequence, only one line of k-space is acquired from 
each RF pulse. Each repeat has a different ky encoding and so in this way k-space 
can gradually be acquired (Figure 2-13). The transverse magnetisation must 
recover between each RF excitation and so the basic GE sequence is time-
consuming.  
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k-space is acquired by initial application of a negative frequency encoding gradient 
(Gx) and phase encoding gradient (Gy) for time T, which dephases spins (Figure 
2-14). Subsequently, a positive Gx is applied for time 2T, which acts to first re-
SKDVHWKHVSLQVFUHDWLQJDQ´HFKRµ$VWKHVZLWFKLQJUDGLHQWSRODULW\GRHVQRW
move the spins into another plane, the same static (T2) and time-variant (T2´) field 
changes are experienced and so GE is sensitive to both effects and so T2
*.  
 
Figure 2-13) Pulse sequence diagram and k-space trajectory for standard 
2D gradient echo (GE). In each TR a single line of k-space is acquired.  
 
 
Figure 2-14) Schematic of net magnetisation in basic Gradient Echo (GE) 
sequences. A) Net magnetisation is moved into the transverse plane by the 
excitation pulse. B) Net magnetisation in the transverse plane decreases as 
spins dephase. Reversing the polarity of the frequency encoding gradient 
rephases the spins magnetisation in the transverse plane is restored at the 
centre of the second frequency encoding gradient.  And net 
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Echo Planar imaging 
Echo Planar Imaging (EPI) is a technique developed at The University of 
Nottingham by Mansfield et al [25]. By acquiring multiple lines of k-space in a 
single TR, EPI rapidly reduces the acquisition time of an image. With increased 
temporal resolution it is possible to image dynamic processes such as the cerebral 
haemodynamic response function (HRF) in functional MRI (fMRI) which is on 
the order of seconds (See Chapter 3). 
 
Figure 2-15) Pulse sequence diagram and k-space trajectory for 2D echo 
planar imaging (EPI). 
Figure 2-15 shows the basic pulse sequence and k-space trajectory in 2D-EPI. By 
rapidly switching the frequency encoding gradient (Gx), each alternating line of k-
space is traversed in an opposing direction. The read-out moves between lines by 
a small step in ky after each line is acquired. Alternate lines of k-space must be 
time-reversed prior to Fourier transformation to correct for opposing acquisition 
directions. EPI can be either single shot (full acquisition of k-space in a single TR), 
or segmented, where a sub-set of lines of k-space are acquired in each shot. 
Double echo (DE) EPI can be implemented whereby a second set of gradients 
are applied after the first EPI train, at a later TE (Figure 2-16A). This allows k-
space to be sampled a second time without the need for  a second excitation pulse 
[26]. Multi-echo EPI can be achieved by increasing the number of gradient repeats 
even further.  This can only be done if there is sufficient signal, but T 2
* is the 
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limiting factor. As this scheme acquires k-space at subsequently later echo times, it 
can be used to map T2
* [27]. 
 
Figure 2-16) A) Pulse sequence and k-space trajectory for double echo EPI. 
By applying a second set of refocusing gradients at a later TE, k-space can 
be sampled a second time within the same TE. B) Example Double Echo 
2D-EPI images at 7 T (TE1/ TE2/TR = 16/46.9/3000 ms, 2x2x3 mm
3, FOV 
= 192x192x15 mm, SENSE 2.5) 
MPRAGE 
Magnetisation Prepared Rapid Gradient Echo (MPRAGE) is a T1-weighted pulse 
sequence commonly used for anatomical images in neuroscience. This pulse 
sequence usually has a short TR and so an initial 180° inversion pulse is applied to 
control T1-weighting prior to the excitation RF pulse (Figure 2-17), with contrast 
dependent on the time between the inversion, the centre of k-space and the 
readout pulses. MPRAGE is a rapid acquisition method, developed from Turbo 
Fast Low Angle Shot (TurboFLASH) and so has a short TR which may not allow 
sufficient time for all transverse magnetisation to decay. To overcome this 
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problem, RF or gradient spoilers (or both) can be applied before each subsequent 
excitation pulse. The longitudinal magnetisation is preserved by using small flip 
angles of typically less than 8°. 
 
Figure 2-17) Pulse sequence diagram for anatomical imaging sequence 
Magnetisation Prepared Rapid Gradient Echo (MPRAGE). During the 
preparation step, an inversion pulse is applied to control T1-weighting. In 
the spoiling step, remaining transverse magnetisation is dephased prior to 
the next RF pulse. Multiple imaging and spoiling steps can be performed 
for a single preparation step.  
2.4.13 Image Artefacts 
 
Image artefacts can be a regular occurrence attributable to many different factors 
such as operator error, parameter choice or the presence of metallic objects. This 
section will focus on the main types of artefacts which are common in MRI.   
The Nyquist ghost (or N/2) is a common artefact in EPI, whereby a ghost image 
is overlaid on top of the actual image, but shifted in the phase encoding direction 
by half of the FOV (N/2). It is caused because the alternating direction of k-space 
trajectory may have systematic errors in the centre of k-space. If k-space lines are 
acquired slightly off centre, they cannot be perfectly reversed prior to the Fourier 
Transform.  
Aliasing or signal wrap-around is caused when regions outside of the FOV are 
excited so that the receive coil also detects these unencoded signals. If any 
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detected frequencies exceed the maximum frequency (fmax, determined by the 
1\TXLVWWKHRUHPE\ƅIWKHQWKHVLJQDOZLOOEHHQFRGHGLQN-space at a location 
fmax ² ƅI7KLVUHVXOWVLQWKHVLJQDOEHLQJZUDSSHGWRWKHRSSRVLWHVLGHRIWKHLPDJH
To minimise the occurrence of aliasing, the FOV can be increased to cover a 
larger region, however this can reduce the achievable spatial resolution and 
increase scan time. Depending on the region of interest, surface coils (with higher 
SNR) help to minimise aliasing as the signal outside the FOV is much lower than 
with a volume coil. Finally, the signal outside the FOV can be saturated using 
outer volume suppression techniques in which RF pulses such as rest-slabs are 
used to suppress signal.   
The bandwidth (BW) per pixel relates to the range of frequencies encoded and 
detected and the frequency of k-space sampling. It is directly related to SNR, 
which increases as BW decreases. A small bandwidth increases image distortion, 
described by Equation 2-31 ZKHUHƅx is the spatial shift in signal encoding and x 
is the voxel size. This is most problematic in EPI, where the bandwidth is small, 
particularly in the phase encoding direction.  
pixel perBW
x
Z' '                   2-31 
An artefact is often seen at boundaries between air and tissue due to the different 
PDJQHWLFVXVFHSWLELOLWLHVƷ0DJQHWLFVXVFHSWLELOLW\LVDFRQVWDQWZKLFKGHVFULEHV
how magnetised a material will become in the presence of an external magnetic 
field. At a susceptibility boundary, there will be a change in local magnetic field 
which will cause image distortion due to phase changes (and so incorrect sampling 
of k-space). The presence of a metallic object will create an extreme susceptibility 
boundary and create a more extreme distortion, albeit far less common due to 
safety precautions in place.  
An image can be distorted at fat-water boundaries due to their different resonant 
frequencies [28]. The change of frequency is incorrectly attributed to a change in 
spatial location and so the fat signal is shifted in the frequency encoding direction. 
In brain imaging, the fat in the scalp can be problematic unless the signal from the 
fat is suppressed. Suppression is achieved by an inversion or suppression pulse 
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prior to image acquisition. Commonly employed techniques rely on the selective 
excitation of fat spins and/or different T1 times. At higher field strength, SPIR 
(Spectral Presaturation with Inversion Recovery) is a popular technique which 
uses a 90° RF pulse to selectively excite fat-bound protons which have a different 
resonant peak to water protons. As the signal from fat recovers through the null 
point, the standard MR sequence is collected. Whilst SPIR is advantageous 
because it does not cause inherent T1-weighting, it requires good B0 homogeneity 
so that the frequency ranges of fat and water are distinct and so a smaller FOV is 
preferable. SPAIR (Spectral Adiabatic Inversion Recovery) is an adaptation of 
SPIR which uses a 180° adiabatic to selectively excite the fat-bound protons 
which reduces the sensitivity to B1 inhomogeneities. STIR (Short Inversion-time 
Inversion Recovery) is based on different T1 times, using a 180° inversion pulse to 
invert the spins of both fat-bound and water protons. The acquisition sequence is 
started as the fat signal crosses the null point. Whilst subsequent tissue contrast 
will be altered, it does not depend on chemical shifts and so is insensitive to B0 
inhomogeneities, therefore it is suitable for lower field strengths and/or larger 
)29·V For spin-echo based sequences, slice-selective gradient reversal (SSGR) 
can be used [29], where the polarity of the 180° refocusing pulse is reversed so 
that no echo is formed from the fat signal (where displacement of the fat signal 
relative to water is proportional to bandwidth). It is better suited to high field, 
where the chemical shift between fat and water are increased and can be 
combined with SPIR for improved results [30]. 
2.4.14 Hardware 
 
The majority of MRI scanners use superconducting magnets as they generate 
larger magnetic fields than permanent magnets. Large currents are sent through 
magnet coils, and since they are maintained superconductive by liquid helium, the 
current flows indefinitely. A cryostat and cryocoolers maintain the required low 
temperature and also prevent boil-off. This thesis presents data collected on 1.5, 
3.0 and 7.0 Tesla Philips Achieva whole body MR scanners (Best, Netherlands). 
Each of these scanners utilises a horizontal bore magnet (schematic shown in 
Figure 2-18) , which is shielded by an iron box to minimise the extent of the 
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fringe field and prevent passers-by from experiencing increased magnetic fields 
and the associated safety risks (see section 2.4.15). A bed can be moved in/out of 
the cylindrical bore so that the volume of interest can be placed in the magnet iso-
centre. 
 
Figure 2-18) A schematic outline of an MRI system.  
Gradient coils are used to induce a linear variation in the magnetic field along the 
x, y and/or z-axis (as described in section 2.4.7). To allow rapid data collection for 
EPI, the gradient must be able to switch at a high rate. Gradient coils are defined 
by their maximum amplitude (induced field strength) and slew rate (maximum 
switching rate). The rapid switching can increase the temperature by resistive 
heating, and so gradient coils are typically water-cooled. 
In order to image over a large volume, the magnetic field (static B0) must be 
spatially homogenous. The method of detecting and correcting any 
inhomogeneities is called shimming. Both passive and active shimming techniques 
are used.  Passive shimming is done using ferromagnetic blocks which are inserted 
into the magnet bore after installation and aim to minimise the residual between 
expected and observed magnetic field [31]. Active shimming passes current 
through shim coils (Figure 2-18) to correct for any field inhomogeneities. For first 
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order shimming, pencil beam excitations are made at 2 echo times along the x, y 
and z axes. The phase difference between the two echo times is proportional to B 0 
inhomogeneity and ƅ7(7KXV WKH ILHOGRIIVHW FDQEHFDOFXODWHGDQGGLVWRUWLRQV
corrected for. For second order shimming, excitations are also made along the z2, 
zx, zy, xy and x2, y2 axes). FASTMAP [32] is an active technique which can be 
automatically implemented by the scanner. The magnetic field is sampled and 
corrected, in around 3-4 iterations, taking approximately 20 seconds. Although 
FASTMAP offers a rapid robust shimming technique, image-based shimming 
methods have been shown to be preferable at 7 T [33] and have been employed in 
the ultra-high field work presented in this thesis. At the start of each scan session, 
a B0 map is taken prior to the main scan which is used to strip the skull and create 
a brain mask. Shim coils are used to eliminate field inhomogeneities from inside 
the mask [33]. 
A radiofrequency (RF) transmit coil generates the field perturbation (B1) required 
to excite spins and tip the longitudinal magnetisation into the transverse plane 
(Section 2.2.3). In the 1.5 and 3.0 T Philips Achieva systems, a body transmit coil 
is situated at the innermost layer of the scanner bore. In the 7.0 T system, a head 
volume transmit coil is used. Whilst surface coils exist, volume coils transmit and 
receive homogenous signal over a relatively large volume and so only volume coils 
are used in the scope of this thesis. 
For MRI of the brain, RF receive coils (which detect MR signal) are usually 
VLWXDWHGFORVHWRWKHVXEMHFW·VKHDGDVFRLOVHQVLWLYLW\UHGXFHVZLWKGLVWDQFH7KH
receive coil generally has multiple receive elements which reduces scan acquisition 
time if they can be used with acceleration methods such as SENSE (Section 
2.4.12 ). The receive coil is gated off during RF transmission as the excitation 
pulse from the transmit coil is on the order of kilovolts, whilst the received signal 
is on the order of millivolts.  
Since the detected signal does not provide information on whether the change in 
phase is positive or negative (i.e. whether precession is clockwise or anticlockwise) 
relative to the rotating frame, a quadrature detection coil solves this problem by 
detecting two signals 90° out of phase (one real, one imaginary). 
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The scanner console is used to set up the scan sequence parameters and enter 
subject identification details etc. The console calculates the required waveforms 
and RF pulses and sends these to the waveform generator as a digital signal 
(Figure 2-18). The digital signal is converted to analogue, amplified and sent to the 
relevant coil. After being received, the signal is converted back to digital and 
reconstructed to an image by the image processor. The console is also responsible 
for monitoring safety aspects such as the gradient temperature and specific 
absorption rate (SAR) see section 2.4.15.  
2.4.15 Safety Considerations 
 
Static magnetic fields can pose a number of safety risks. Firstly, magnetic objects 
will be attracted towards the scanner bore with significant force. Projectiles pose a 
serious risk of both injuring people and damaging the scanner and care should be 
taken not to take any magnetic objects within the magnet hall, this includes chairs, 
the patient trolley and standard fire extinguishers (extinguishers in the near 
vicinity of the scanner are non-magnetic). Subjects must fill in a safety screening 
questionnaire prior to entering the scanner control room and those who have 
contraindications such as pacemakers (which may malfunction in the presence of 
magnetic fields), aneurysm clips or dental implants will not be allowed beyond the 
5 gauss line (0.5 mT). All persons who are to be in close vicinity to the scanner 
must remove any magnetic items from themselves (e.g. coins or bank cards in a 
pocket). Safety screening also minimises any potential risk of thermal burns, by 
identifying any metallic objects which may interact with the RF field (see below). 
RF radiation has the potential to cause thermal burns. Tissue which is not well 
perfused is of greater risk as increased heat is dissipated via blood flow. This 
deposition of power is known as the specific absorption rate (SAR), measured in 
watts/kilogram and is dependent on such things as pulse sequences, body mass 
and coil configuration. This rate is monitored so that core body temperature does 
not increase by more than 1°C (International Commission on Non-ionising 
Radiation Protection guidelines, 2004). 
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RF radiation can also cause thermal burns via the heating of electrical conductors, 
which absorb heat until they are dangerously hot. This risk is minimised by 
ensuring that the subject does not have any metallic objects on their person and a 
full screening to ensure they have no metallic implants. This risk extends to 
tattoos, where the metallic dye in older tattoos may lead to heating effects and risk 
burning. When objects which pose a potential risk are present in the magnet bore, 
e.g. the vector cardiogram (VCG) box and leads, insulating padding is used to 
minimise direct contact with skin. Thermal burns may also be induced by 
circulating currents through body parts such as crossed arms and feet, so patients 
are instructed not to do this. 
Subjects may suffer temporary discomfort whilst moving through the static field, 
including dizziness, sickness, headaches and a metallic taste in the mouth. Care is 
taken to move the scanner bed in/out of the magnet at a slow rate to minimise 
these effects induced by crossing a number of magnetic fields in quick succession. 
Similarly, staff should take care when changing coils or other such maintenance to 
avoid these effects. 
In case of emergency, a scanner can be quenched, whereby the helium is dispersed, 
resulting in a loss of superconductivity. A build-up of heat induces resistance in 
the magnet coil and the magnetic field is ramped down. This presents a safety risk 
to anybody in the vicinity as if the helium is inadvertently allowed to enter the 
room, oxygen levels may be reduced and so an oxygen depletion alarm is installed 
in the scanner control room. It is likely that a scanner will be damaged if 
quenched, and it will take significant time to ramp back up to the required 
magnetic field, therefore it is only performed if someone is in immediate danger. 
Risks associated with the handling of the super-cooling liquefied gases (cryogens) 
are minimised by all users receiving appropriate training as well as the wearing the 
appropriate protective clothing such as a mask and gloves.   
There is a considerable amount of acoustic noise associated with MRI due to the 
rapid switching of magnetic gradient coils. All subjects must wear sufficient ear 
protection to limit acoustic exposure and maintain patient comfort. At 1.5 and 3.0 
T, this protection comprises of earplugs and headphones. At 7 T (where there is 
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less space within the head coil), earplugs and foam padding are used. Rapid 
switching of gradients may cause peripheral nerve stimulation (PNS) where 
subjects may feel a twitching sensation, particularly in their extremities, due to 
induced currents along nerves. Staff should be aware of this issue and effort 
should be taken to minimise these effects when deciding on a scan protocol. For 
safety, a maximum slew rate is set. For the scope of this thesis, slew rates used 
were 160, 200 and 166 mT/m/s at 1.5, 3.0 and 7.0 T respectively. Rapid switching 
of gradient sets can induce mild heating of tissue via increased absorption of 
energy. 
Whilst in the scanner, subjects should always have access to the emergency alarm, 
which is to be tested prior to each scan. If a patient raises the alarm and needs to 
be removed from the scanner as a matter of emergency, the scanner bed may be 
undocked and removed from the magnet hall where they can then be transferred 
to the patient trolley. In the event that emergency services are required in the 
scanner hall, a member of staff must wait at the entrance in order to ensure no 
magnetic items are to be brought near the scanner. A coded door prevents 
unauthorised access to the scanner control room. 
In the case of an adverse effect whilst scanning, staff must document it on the 
scanning record, which is to be completed for each scan and also provides details 
on staff exposure to high magnetic field strength. Staff exposure is limited so as 
not to exceed the International Electrotechnical (IEC) guidelines.  
2.4.16 Ethics 
 
All human studies require prior approval from an ethics boards to ensure 
approval guidelines are in place. The University of Nottingham has its own ethics 
committee which oversees such protocols, and all research presented in this thesis 
was carried out with full ethical approval. 
All volunteers gave informed written consent prior to taking part in the studies. 
The consent forms require the volunteer to advise the experimenter on which 
course of action to take should an abnormal finding occur. In such a case, the 
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image(s) is sent for review by a radiologist, with the subjects informed of the 
results only if prior consent is granted.  
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3 Functional neuroimaging 
methods 
 
3.1 Outline 
 
The primary goal of functional neuroimaging is to develop more detailed 
knowledge of the workings of the brain. By understanding normal brain function, 
neurological dysfunction can be better interpreted, improving diagnosis and 
treatment outcomes. The first real insight into the link between brain structure, 
function and behaviour came from cortical lesion studies. However, the advent of 
neuroimaging technology allowed brain function to be investigated relatively non-
invasively. This chapter provides a basic introduction to cerebral vasculature and 
physiology, before introducing a range of widely used functional neuroimaging 
techniques. Focus will be given to the MR techniques used in this thesis; blood 
oxygen level dependent (BOLD) fMRI, arterial spin labelling (ASL), phase-
contrast MRI (PC-MRI) and magnetoencephalography (MEG). Attention is paid 
to how the physiological and biophysical processes which accompany brain 
activity can be measured. This lays the groundwork for the experimental work in 
Chapters 4-6 in which such responses are evaluated and quantified.  
3.2 Cerebral vasculature 
 
The human brain is a complex structure, accounting for only 2 % of body weight, 
yet consuming around 20 % of oxygen intake and 15 % of blood flow. Its 
structure is comprised of grey matter (cell bodies), white matter (cell fibres), 
cerebrospinal fluid (CSF) and blood vessels. The brain surface, or cortex, is highly 
folded; increasing the surface area and enabling higher cognitive function. The 
folds (gyri) and accompanying grooves (sulci) are useful in identifying landmarks 
in the brain. Brain regions can be fundamentally separated into the cerebrum 
(with left and right hemispheres), cerebellum and brainstem. The cerebrum is 
further divided into the frontal, parietal, temporal and occipital lobes; each with a 
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core set of functions. Sub-cortical structures are generally responsible for 
relatively autonomous functions; such as homeostasis, hormone production, 
circadian rhythm. However, as the quantification of the haemodynamic response 
is a central theme of this thesis, it is the cerebral vasculature which will be 
discussed in more detail. 
 
Figure 3-1) Schematic representation of the basic structures of the human 
brain (shown for a single hemisphere) adapted from [34]. Sub-cortical 
regions are found beneath the cortical lobes. 
The vascular network consists of macrovasculature (arteries and veins) and 
microvasculature (arterioles, venules and capillaries). Figure 3-2 is a schematic of a 
capilliary network, taking oxygenated blood (red) from a high pressure artery to 
the tissue, to deliver the required oxygen and nutrients, and removing waste 
products via deoxygenated blood (blue) in the low-pressure venous system. 
Capillaries therefore carry a mixture of oxygenated and deoxygenated blood 
depending on their position in the vascular network (where normal oxygenation 
levels are ~95-98 % for arteries, reducing to ~60-80 % for veins). Cerebral 
capillaries differ from those found in the rest of the body, with their endothelial 
lining constructed to increase the number of tight junctions. This restricts the 
passage of molecules from the general circulation into the brain, allowing small 
useful molecules in, whilst preventing larger harmful molecules and bacteria, from 
entering [35]. Essential nutrients such as glucose and amino acids have specified 
pathways, whilst oxygen (O2) and carbon dioxide (CO2) can freely diffuse [36].  
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Figure 3-2) Schematic of a cerebral capillary network. Oxygenated blood 
(shown in red) moves from the arterial side across the capillaries where 
oxygen and nutrients are delivered to tissue. Deoxygenated blood (blue) 
and waste products are taken away from the tissue via the venous system. 
Approximately 80 % of the arterial network supplying the brain branches from 
the common carotid artery. It ascends within the neck before bifurcating at the 
carotid body (approximate to the C3 vertebra) to give rise to the left and right 
interior and exterior carotid arteries (ICA, ECA respectively). The ICA supply 
intracranial regions, whilst the ECA supply the face and neck [37]. The ICA 
divides into the anterior common arteries and the middle cerebral arteries, the 
ACA from the left and right ICA are joined via the anterior communicating artery. 
The remaining arterial blood supply is from the left and right vertebral arteries 
(VA), stemming from the subclavian artery. The VA fuse to form the basilar 
artery (at approximately the pons level) which splits into the left and right 
posterior cerebral artery (PCA) and posterior communicating arteries. Figure 3-3 
shows schematically how these vessels are linked together, forming the Circle of 
Willis. The Circle of Willis provides collateral circulation, ensuring adequate blood 
supply in the event of vascular blockage or degradation.  
37 
 
 
Figure 3-3) Schematic* of the main arteries forming the Circle of Willis, a 
key part of the cerebral arterial network, creating collaterals which ensure 
adequate blood supply to the brain in case of arterial stenosis or blockage. * 
Not to scale 
The venous system can be divided into the deep and superficial vascular systems. 
Pial veins drain the outermost regions of the brain, feeding into the superior 
cerebral veins (draining the superior cortical regions) and eventually feeding into 
the superior sagittal sinus. Deeper cortical veins drain the sub-cortical regions into 
the lateral, straight and sigmoid sinuses [37]. Both systems drain into the internal 
jugular vein which descends in the neck. Veins in the head and neck differ to 
those throughout the rest of the human body in that they do not require valves 
due to their downwards draining nature which is in this case assisted by gravity.  
3.3 Functional MRI  
 
The notion that neural activity is accompanied by a regional increase in cerebral 
blood flow (CBF) was first introduced in the late nineteenth century [38]. With 
WKHGHYHORSPHQWRI SRVLWURQ HPLVVLRQ WRPRJUDSK\ 3(7LQ WKH ·VFDPHD
quantitative method of measuring regional blood flow and O 2 [39, 40].  MRI was 
primarily a structural technique until the widespread uptake of EPI, which allowed 
´VQDSVKRWVµRI ELRORJLFDO SURFHVVHV [41]. A dynamic technique coupled with the 
discovery that the oxygenation level of blood acts as an intrinsic contrast agent in 
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MRI (the BOLD signal) [42] led to the development of functional MRI (fMRI). 
The advent of fMRI expanded the use of MRI to assess physiological changes 
associated with neuronal activity.  
 
The BOLD response (described in detail in Section 3.3.1) relies on the spatial and 
temporal relationship between neuronal activity and CBF, a relationship better 
known as neurovascular coupling [43]. Neurovascular coupling is a complex 
process, and the BOLD signal is actually determined by the dynamic interplay of 
cerebral metabolic rate of oxygen (CMRO2), cerebral blood volume (CBV), CBF 
and neuronal activity.  
Figure 3-4 provides a schematic indication of how the BOLD response arises 
from the interaction of these physiological mechanisms. Shortly after the BOLD 
response was identified, multiple research groups observed an increase in BOLD 
signal in response to both visual activation [44-46] and a motor task [47]. This 
identified a potential role of the BOLD response in mapping functional brain 
activity.  
 
 
 
Figure 3-4) A schematic overview of the competing physiological 
mechanisms contributing to the BOLD response following a stimulus.. 
The positive BOLD response is robust and is used regularly to infer 
neuronal activity. 
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3.3.1 The BOLD response 
 
Blood is the transport medium providing nutrients to tissue via the vascular 
network. Around 45 % of human blood is red blood cells (RBC), the remainder 
made up of plasma (a straw-coloured liquid), white blood cells and platelets.  
Although it is water-bound protons which are crucial for MR signal generation, 
the RBC play a fundamental role in fMRI. Their biconcave disc shape is optimised 
to transport oxygen (O2) from the lungs to the rest of the body and return carbon 
dioxide (CO2) for excretion from the lungs to the atmosphere. There are 5 x 10
12 
RBC per litre of blood, each cell containing 280 million haemoglobin (Hb) 
molecules. Hb is made up of four polypeptide chains, each attached to an iron-
containing haem group which reversibly combines with an O2 molecule, such that 
each haemoglobin molecule can carry up to four O2 molecules.  In the oxygenated 
state, Hb is referred to as oxyhaemoglobin (HbO2) and deoxyhaemoglobin (dHb) 
in the fully or partially deoxygenated state. Approximately 95-98% of Hb in 
arterial blood is in the HbO2 form, whilst in the veins this is reduced to around 
60%. This is generally described as the blood oxygenation (Y). 
                             
3-1                                                                                           
A crucial factor in the BOLD signal is that dHb and Hb02 have different magnetic 
VXVFHSWLELOLWLHV ƅƷ:KLOVW+E22 is weakly diamaJQHWLF ƅƷHbO2 = -0.26 x 10-7), 
G+E LV SDUDPDJQHWLFƅƷdHb = +1.57 x 10-7), both with respect to water [48]. It 
follows that when blood is deoxygenated, the magnetic field will be perturbed as 
the water-bound protons in both the blood and surrounding tissue will experience 
increased dephasing. This forms the basis of the intrinsic T2
* contrast mechanism 
known as the blood oxygenation level dependent (BOLD) response. However, 
there are some counter-intuitive physiological changes which underlie the BOLD 
response.  
Ogawa et al. [1] discovered it was possible to measure the effect of a change in 
blood oxygenation on the MR signal of blood and surrounding tissue, with T2
* 
increasing with increasing oxygenation. It was shown that the BOLD signal 
dHbHbO
HbOY  2
2
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increased in response to functional activation [44-47], suggesting that neuronal 
activity leads to a counter-intuitive increase in oxygenation. 
Given a task, neural tissue becomes more active and so energy demand increases. 
Adenosine triphosphate (ATP) is an energy source for many processes within the 
brain and body, in particular re-establishing ionic gradients across cellular 
membranes following action potentials. ATP synthesis occurs in the mitochondria, 
and is necessary to allow repeated action potentials and thus neural activity. O 2 (in 
addition to glucose) is an essential substrate for ATP synthesis and so ATP 
metabolism is tightly coupled to O2 metabolism in the healthy brain [49]. Studies 
show that measurements of CMRO2 correlate with measurements of ATP 
synthesis [50, 51] which in turn is equal to ATP metabolism, a relationship unique 
to the brain [52]. Aerobic ATP synthesis is much more efficient than anaerobic 
(glucose-based) synthesis and so O2 consumption is assumed to be more closely 
linked to neuronal activity than glucose consumption (this assumption will be 
discussed further in Chapter 4). 
In order to meet this increased demand for O2, a corresponding increase in 
cerebral blood flow (CBF) is observed, termed functional hyperaemia. The 
increase in CBF has been found to surpass the increase in CMRO 2 by as much as 
50% [53, 54]. Multiple theories have been proposed as to why the relative increase 
in CBF is so large. The oxygen limitation model [55] proposes that only a small 
amount of O2 delivered to the tissue is extracted from the blood and that by 
increasing CBF the amount of O2 extracted (oxygen extraction fraction, OEF) 
actually decreases due to a decreased capillary transit time. Within this model, a 
large increase in CBF is required to support a small increase in CMRO 2 [56]. 
Following activation, the sudden influx of oxygenated blood causes the BOLD 
signal to increase. Figure 3-5 shows a typical BOLD response where a positive 
overshoot can be observed around 6 seconds after activation. The increased CBF 
is accompanied by an increase in the cerebral blood volume (CBV) as the two are 
interrelated. An increase in CBV increases the fractional volume of both arterial 
and venous blood within a voxel (and so also reduces the fraction occupied by 
tissue and CSF). Increasing the blood fraction means that more dHb is present 
and so field perturbations will be increased, attenuating the BOLD signal. This 
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actually counteracts the effect of increased oxygenation observed on activation. 
Although these physiological changes are well reported, their causative 
mechanisms are not yet fully understood. Whilst the BOLD response is associated 
with the venous and deoxygenated capilliarial networks, it is thought that it is the 
arterial dilation that drives an increase in CBV and CBF [57-60] rather than 
venous dilation [55]. CBV transients are thought to explain the post-stimulus 
undershoot (PSU) in signal which is often seen following the positive overshoot 
of the BOLD signal (Figure 3-5).  
 
Figure 3-5) Schematic of the BOLD timecourse. An initial dip (1) below 
baseline has been reported within 2 seconds of stimulus presentation, 
followed by a positive overshoot (2) at around 6 seconds. The BOLD signal 
is slow to recover to baseline, a post-stimulus undershoot (3) is observed, 
returning to baseline at around 25-60 seconds after stimulus presentation.  
There are three main mechanisms proposed to explain the origin of the PSU. 
Firstly, a decoupling between cerebral blood flow (CBF) and cerebral blood 
volume (CBV) as proposed by the balloon model [61] and Windkessel model [62] 
whereby CBV remains elevated once CBF and blood oxygenation has returned to 
baseline. Secondly, a decoupling between haemodynamics and metabolism [63, 
64], where elevated CMRO2 (but normalised CBF and CBV) leads to a reduction 
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in deoxyhaemoglobin (dHb) concentration. Finally, a decrease in post-stimulus 
CBF has been observed [54, 65, 66] but it has been argued that this may be an 
artefactual contribution from the BOLD response [67]. It is likely that more than 
one mechanism contributes to the PSU and there is a need to elucidate the 
relative contribution of each mechanism.  
There have been some reports of a temporal lag between the increase in CMRO 2 
and corresponding increase in CBF and CBV.  This is thought to give rise to the 
´LQLWLDOGLSµ[68], a drop in BOLD signal which occurs shortly after the stimulus 
(Figure 3-5) and is thought to reflect a drop in HbO2. There has been much of 
research interest in the initial dip as it is thought to have increased spatial 
localisation to the site of neuronal activity than the positive BOLD response [69]. 
In this short period, it may be possible to characterise CMRO 2 changes without 
confounding effects of CBF and CBV. However, the initial dip is elusive, so much 
so that its existence has been debated [70-72].  Whilst the initial dip has been 
observed with optical imaging techniques in animals and humans [E.g. 68, 73, 74], 
it has proven difficult to reliably and repeatedly extend to humans at the field 
strengths using MRI. 
3.3.2 fMRI data analysis 
 
fMRI experiments take the form of either a block design (stimuli repeated 
continuously over a longer time period) or event-related paradigm (a single short 
stimulus) as shown in Figure 3-6. To increase the signal to noise ratio (SNR), 
stimuli are presented multiple times with rest periods between which allow the 
haemodynamic response to recover to baseline. If stimuli are presented very close 
together, with a short rest period, the BOLD response will plateau.  
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Figure 3-6) A) In a block design paradigm a stimulus is presented 
continuously for a period of time, which is then alternated with a rest 
period. B) An event-related paradigm consists of presentation of a single 
short stimulus followed by a rest period.   
Analysis of fMRI data areimproved by a series of pre-processing steps, which will 
be briefly described here and later outlined in more detail when used in the 
experimental work in this thesis. Here, pre-processing is described within the 
context of the FMRIB Software Library (FSL, Oxford, UK), although the 
underlying theory is similar across platforms. Due to the fine spatial resolution 
used in functional MRI, even subject motion of a few millimetres or rotation of a 
few degrees can result in the same voxel corresponding to a different spatial 
location across image volumes/dynamics. This change in signal intensity can be 
larger than the BOLD effect and so be very problematic in analysis of functional 
data. In this thesis, motion correction ensures that the spatial location of voxels is 
consistent across dynamics and any movement artefacts that have occurred are 
minimised or removed. Here, motion correction is implemented using MCFLIRT 
(FMRIB, Oxford, UK), this software compares the similarities between a 
´UHIHUHQFHµ LPDJHKHUH FKRVHQWREH the first dynamic) and subsequent images 
[75]. Using a cost function, 6 rigid-body parameters are minimised (translation in 
and rotation about x, y and z directions), and a corrective translation matrix is 
created. This translation matrix is then applied to each subsequent dynamic (here 
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double echo fMRI data are collected, and the corrective translation matrix also 
applied to the data set acquired at the second echo time) using tri-linear 
interpolation.  
Spatial smoothing uses a Gaussian smoothing kernel to average the signal from 
neighbouring voxels. Spatial smoothing improves the signal-to-noise ratio (SNR) 
but at the cost of reducing the image spatial resolution. The FWHM of the kernel 
must not be too large so as to prevent image blurring; typically 1.5-2 times the 
voxel size is used. 
Temporal filtering reduces noise (thus increasing SNR) without removing the 
effect of interest. A high-pass filter is used to remove low frequency drift such as 
system noise (magnetic field drift over time), physiological noise (pulsatile effects) 
or thermal noise. If respiratory and cardiac data are recorded during acquisition, 
physiological noise can be further reduced by retrospectively correcting using 
RETROICOR software [76]. A low-order Fourier series is used to model the 
additive contributions from the respiratory and cardiac noise. This can then be 
subtracted from the fMRI timecourse.  
,QRUGHUWRSURGXFHDVWDWLVWLFDOPDSRIWKH%2/'UHVSRQVHHDFKYR[HO·VVLJQDO
time course is compared to a model of the expected signal. Analysis tools 
commonly employ a univariate General Linear Model (GLM) to assess the fit 
between the model and observed data. To obtain a good model, the model design 
is convolved with a canonical haemodynamic response function (HRF) to mimic 
the delayed physiological response of the brain (Figure 3-6). 
 
İXY  E.                                 3-2 
 
Univariate GLM analysis can be explained with a simple matrix equation 
(Equation 3-2), where Y represents the observed data in a single voxel across time, 
X UHSUHVHQWV WKH GHVLJQ PDWUL[ ZKLFK VKRXOG H[SODLQ WKH REVHUYHG GDWD Ƣ LV D
parameter estimation which defines the contribution of X to Y and is estimated to 
PLQLPLVH ƥWKH HUURU WHUP UHSUHVHQWLng the difference between Y and XƢ7KH
45 
 
result of GLM analysis is a statistical parametric map (SPM) of voxels, showing 
which effects of interest in the design matrix correlate significantly with the 
observed data in each voxel.  
 
The voxel signals which significantly correlate with the modelled data are assigned 
a t-VWDWLVWLF WKH Ƣ SDUDPHWHU HVWLPDWH GLYLGHG E\ UHVLGXDO HUURU ZKLFK FDQ EH
converted to a Gaussian Z-statistic which can then be converted to an 
uncorrected p-value. t, Z and p-values all reflect how significantly the voxel of 
interest is related to the model design. The p-value is uncorrected if the time-
course of each voxel is independently analysed. However in fMRI data, as there 
are a large number of voxels analysed, it follows that here will be a large number 
of false-positives. If p <0.01, then 1 voxel in every 100 activated voxels will not 
reflect a true correlation. The risk of a false-positive occurring within a group of 
inferences is described by the family-wise (Type I) error rate (FWE). To minimise 
FWE, it is necessary to correct for multiple comparisons such as with Bonferroni 
correction, where the p-value required for statistical significance is reduced in 
proportion to the number of statistical tests performed. However, whilst 
controlling for FWE, Bonferroni correction increases the likelihood of failing to 
detect activation (Type II error). Gaussian Random Field Theory is typically 
applied as the spatial correlation across voxels defies the assumptions made in a 
Bonferroni correction [77]. The risk of a false-positives result is further reduced 
by applying cluster-size thresholding, as clusters of activated voxels are more likely 
to reflect true brain activity. A newer alternative control is the false discovery rate 
(FDR), which assesses the proportion of false positives. Unlike FWE, the number 
of false-positives estimated by FDR scales with the number of positive results.  
3.4 Imaging cerebral perfusion and blood flow 
 
In order to maintain a steady rate of metabolism and tissue function, all cells 
require a consistent supply of O2 and nutrients. This is maintained via the process 
of perfusion; the delivery of oxygenated blood to the tissue capil lary network 
(quantified in units of ml/100g/min). After arriving at the tissue, O2 and nutrients 
exchange from the blood to tissue (using both active and passive mechanisms, 
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dependent on the substrate in question), and waste products are removed from 
the tissue. Inadequate perfusion will induce such problems as cellular acidosis (via 
accumulation of lactic acid) and ischaemia, causing potentially irreversible cerebral 
and cardiovascular damage. Accurate and rapid perfusion quantification can help 
diagnose abnormal tissue function with the potential to improve patient treatment 
and outcome. Furthermore, as outlined in Section 3.3.1, cerebral blood flow is 
assumed to be one of the driving forces behind the BOLD response and so 
accurate quantification of perfusion plays a key role in understanding the 
physiological changes which underpin neuronal activation. 
Non-MR imaging methods of perfusion measurement exist, and a brief 
introduction will be given before introducing the MR methods used in this thesis 
in more detail. As introduced in Chapter 1, PET is an imaging technique which 
uses a radiopharmaceutical tracer (E.g. 15O, 11C, 18F) to provide 3D images of both 
function (perfusion, oxygen and glucose metabolism, depending on tracer choice) 
albeit with limited spatial resolution. As the tracer decays, a positron is emitted 
which will eventually collide with an electron, causing a pair of gamma rays. A ring 
of sensors around the head are used to detect the gamma ray origin. As the 
concentration of tracer varies throughout the body, a 3D image is built up. For 
perfusion imaging with PET, H2
150 is often used (and generally considered to be 
the gold-standard clinical perfusion measurement [78])  however quantification 
requires the arterial concentration of H2
150 to be known which requires invasive 
continuous arterial sampling [79]. Furthermore, radiopharmaceuticals must be 
manufactured on-site due to their short half-life, which makes the imaging 
technique expensive. 
Single-photon emission computed tomography (SPECT) works in a similar 
manner to PET, however the signal from a gamma-emitting tracer (E.g. 99mTc or 
123I) is measured. By using a series of gamma cameras to measure single gamma 
rays, 2D images are acquired, which can be reconstructed to gain a 3D image. 
SPECT is a more cost-effective imaging method, and offers the clinical advantage 
that it can be implemented at the bedside [80]. However, the spatial resolution is 
limited by scattered photons, and so it may be more beneficial as an additional 
complementary technique to PET or MRI.  
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Whilst the nuclear methods described above are widely used in clinical settings, 
they are disadvantaged by the need for an ionising radioactive tracer, which 
necessitates limiting patient exposure to repeated scans to prevent potential tissue 
damage. MR methods offer a non-invasive, non-ionising means of perfusion 
quantification with relatively high spatial and temporal resolution. This section 
will provide a basic overview of Arterial Spin Labelling (ASL) theory and models, 
focusing on the ASL schemes used in this thesis. MR methods of perfusion 
imaging can be separated by the choice of an endogenous or exogenous tracer. 
Dynamic susceptibility contrast (DSC) [81, 82] uses an injection of an exogenous 
tracer such as gadolinium chelate (Gd-DTPA). By measuring the transverse 
relaxation of the injected bolus at a given location, this provides measurements of 
CBF, total CBV and mean transit time (MTT) of blood through the tissue. DSC is 
a relatively rapid technique with increased SNR in comparison to ASL, however, it 
generally provides relative rather than absolute measures of perfusion, and the 
contrast agent poses a risk to patient groups with compromised kidney function 
[83]. Furthermore, the invasive nature of DSC means that it is not easily repeated, 
which compromises the temporal resolution. Arterial Spin Labelling (ASL) is a 
non-invasive MR method which uses an endogenous tracer of magnetically 
labelled water protons. The remainder of this section will focus solely on ASL as a 
measurement of cerebral perfusion.  
3.4.3 Basic Principles of ASL 
 
In ASL, the longitudinal magnetisation of arterial water protons with respect to 
WLVVXH LV YDULHG VR WKDW EORRG ZDWHU LV ´ODEHOOHGµ DQG DFWV DV DQ HQGRJHQRXV
contrast agent. Typically, an RF inversion pulse is used to invert the net 
magnetisation of inflowing blood to a selected labelling plane (Figure 3-7). 
Following the labelling scheme (see Section 3.4.4 for details on the different ASL 
schemes), an image is acquired after a post-label delay (TI), which provides time 
for the blood to reach and perfuse the tissue. The ASL perfusion-weighted signal 
obtained is dependent on the perfusion rate (as protons in arterial blood exchange 
with those in tissue), but is also dependent on T1 decay. A second control image is 
then acquired, where blood is not labelled, subtracting the signal of the labelled 
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image (Mlabel) from the control image (Mcontrol) provides a difference image where 
the change in signal is dependent on perfusion [84]. The control image also 
corrects for magnetisation transfer (MT) effects. 
When labelling the water-bound protons proximal to the imaging slice, the RF 
inversion pulse is off-resonance with respect to the imaging slice. However, both 
water-bound and macromolecule-bound protons will exist in the labelling plane, 
with the frequency band of macromolecule-bound protons being much broader. 
Therefore an off-resonance RF pulse is likely to label both pools of protons and 
the magnetisation transferred (MT) between them via spin-spin interactions and 
water diffusion.  Such MT effects are compensated by acquiring a control image 
(see Section 3.4.4).  
 
Figure 3-7) Schematic representation of how ASL manipulates longitudinal 
magnetisation of blood (MZ (b lood)). In the labelled condition, a 180° RF 
pulse inverts the blood magnetisation (M0blood). The tissue magnetisation 
GLIIHUHQFH EHWZHHQ WKH FRQWURO DQG ODEHO FRQGLWLRQ ƅ0 LVPHDVXUHGDW
one or more post-label delays (TI), allowing time for blood to perfuse the 
tissue and is thus proportional to perfusion.  
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Figure 3-8) Subtraction of the label image from the control image provides 
a perfusion-weighted difference image. This dataset shows a representative 
image at a post-label delay (TI) of 1400ms. 
The signal change between label and control images is in the region of 1 -2 % 
(dependent on field strength) and so multiple averages of perfusion-weighted 
images are needed in order to improve the contrast to noise ratio (CNR). 
Furthermore, the fluctuations in signal from static tissue signal (e.g. due to subject 
motion or physiological noise) will increase the noise considerably and reduce the 
CNR of ASL images. The use of pre- and post-saturation pulses (applied 
immediately before and after the labelling scheme) ensure that the tissue signal is 
equivalent for the label and control condition at the start of each image 
acquisition [85] and also allows the use of a shorter TR. Background suppression, 
by the application of one or more global inversion pulses prior to image 
acquisition minimises physiological noise contributions in the tissue signal [86] 
(Figure 3-9). The timing of the background suppression pulses must be optimised 
according to the post-label delay and T1 of the tissue of interest so that the ASL 
readout is performed close to the time when the tissue signal has just crossed the 
null-point [87].  
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Figure 3-9) Schematic of an ASL pulse sequence. Pre- and post-saturation 
pulses are applied immediately before and after the RF labelling pulse for 
both label and control images to ensure static tissue is equivalent.  
Background suppression (BS) pulses are applied using one or more global 
inversion RF pulses in order to ensure the tissue signal is close to null at 
the readout time, TI.  
In ASL, the labelling and readout schemes can be selected independently of each 
other, with many different SE or GE based image acquisition schemes routinely 
used. 2D GE-EPI is used as the acquisition scheme for all data presented in this 
thesis, and provides the advantages of allowing rapid image acquisition of multiple 
slices before the label decays, as well as simultaneous BOLD weighted image 
acquisition. ASL has low sensitivity so a short echo time (TE) should be used in 
order to maximise the measured signal change. Longer TEs become sensitive to 
T2
* changes, which can lead to BOLD contributions in the ASL signal which can 
result in underestimation of perfusion [88], a factor discussed in Chapter 4. 
3.4.4 Labelling Sequences: 
 
There are three main labelling schemes used in ASL: Pulsed ASL (PASL) [89], 
Continuous ASL (CASL) [90]  and pseudo-Continuous ASL (pCASL) [91]. The 
ASL measurements presented in this thesis use only the PASL scheme, however a 
brief overview of each scheme is given below.  
Pulsed ASL (PASL) scheme 
PASL creates a slab of labelled blood using a single short duration adiabatic RF 
pulse (10-20 ms) [85, 89, 92, 93]. The term PASL encompasses a range of pulse 
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sequences. Figure 3-10 describes the most basic pulse sequence used in PASL, 
and the three main schemes (FAIR, EPISTAR and PICORE) are summarised 
below and shown in Figure 3-11. 
 
Figure 3-10) Schematic of a pulsed ASL (PASL) pulse sequence. Image 
acquisition (Acq.) is separated from the label/control scheme by a post-
label delay (TI).  
FAIR (Flow Alternating Inversion Recovery) [93] uses a non-selective (NS) 
inversion pulse (label) and a slice-selective (SS) inversion pulse (control). In the 
label image, all spins in the volume covered by the RF transmit coil are inverted, 
however, in the control image, the slice selective gradient inverts blood only in the 
imaging plane (Figure 3-11C).  The perfusion weighted signal for FAIR is then 
calculated as (NS) label(SS) control M -M = M' . In the FAIR scheme, blood is inverted 
both proximal and distal to the imaging plane, removing any assumptions about 
the direction of flow.  
EPISTAR (Echo-Planar MR Imaging and Signal Targeting with Alternating RF) 
[89] uses a slice-selective 180° inversion pulse (adiabatic inversion pulse with 
nominal RF power of a 360° pulse) to invert a thick slab of arterial spins proximal 
to the imaging plane (Figure 3-11A). To control for MT effects, the control 
condition consists of two consecutive slice-selective 180° inversion pulses. The 
perfusion-weighted signal for EPISTAR is therefore defined as 
labelontrolc M -M = M' .  
PICORE (Proximal Inversion Controlling for Off-Resonance Effects) [85] is a 
variation of EPISTAR which uses the same labelling sequence but for the control 
image the slice selective-gradient is removed resulting in an inversion pulse off-
resonance (Figure 3-11B).  By doing this, MT effects are matched. However, since 
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PICORE uses different gradient waveforms in the label and control conditions, 
PICORE is more susceptible to eddy current effects. 
 
Figure 3-11) Schematic of different PASL labelling schemes with label and 
control conditions shown. The imaging plane is shown in blue and the 
labelling plane in red.  
Continuous ASL (CASL) scheme 
CASL involves labelling over a long period of time in a given labelling plane in the 
neck. This causes the longitudinal magnetisation of protons in arterial blood to 
undergo flow driven adiabatic inversion via a field gradient applied simultaneous 
to a continuous low power RF pulse (Figure 3-12) [84, 90]. Approximate RF 
amplitude is 3.5 ƬT for a gradient strength of 1 mT/m [91], applied for ~1.5 s. A  
label and control image are acquired, with the frequency of the RF inversion pulse 
inverted for the control image so that the labelling plane is now moved distal to 
the imaging plane [94]. Whilst CASL offers benefits such as increased perfusion 
signal [84], the extended length of the RF pulse results in higher SAR than PASL 
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² limiting its use at ultra-high field strengths. MT effects can be limited by the use 
of separate labelling and imaging coils, so that only the spins in a selected 
upstream artery are saturated. However, this requires specialised hardware. 
 
Figure 3-12) Schematic of a continuous ASL (CASL) pulse sequence. 
Image acquisition (Acq.) is separated from the label/control scheme by a 
post-label delay (TI). 
Pseudo-Continuous ASL (pCASL) 
pCASL is an extension of CASL and offers the combined benefits of both PASL 
and CASL [87]. By using a train of short low flip-angle RF pulses (typically 1500 
RF pulses of flip angle 18, each lasting 0.5 ms and repeated every 1 ms [95, 96]), a 
continuous flow-driven adiabatic inversion label can be produced, thus increasing 
labelling efficiency whilst maintaining a comparatively lower SAR and removing 
the need for a specialised labelling coil (Figure 3-13). The control image is 
acquired for the same train of pulses but with 180° phase shifts between pulses, 
such that the average B1 is zero.  Despite these advantages, pCASL is susceptible 
to errors in quantification due to changes in eddy currents and B0 inhomogeneity 
particular of ultra-high field. Although pCASL has lower SAR than CASL, it is 
still significantly higher than in PASL, which remains problematic (limiting the 
SNR per unit time) at ultra-high field strength [94]. 
 
Figure 3-13) Schematic of a pseudo-continuous ASL (pCASL) pulse 
sequence. Image acquisition (Acq.) is separated from the label/control 
scheme by a post-label delay (TI). 
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3.4.5 Quantifying perfusion from ASL data 
 
As previously described, perfusion is the delivery of nutrients to tissue via the 
blood. Therefore, when quantifying perfusion, it can be broken down into tissue 
and blood signal. In the simplest of cases, a single compartment model is used, 
modelling the signal from either the blood or tissue perspective. Here the tissue-
based model will be introduced. The more complex two compartment approach 
considers signal contribution from both compartments and how the exchange 
across time as the tissue is perfused with labelled blood. 
Single compartment model 
Detre et al. [90] combined the Bloch equation for longitudinal relaxation with a 
single well-mixed compartment model in order to quantify the perfusion-weighted 
difference image. The change in tissue signal (M) can be described by Equation 3-
3, where M0 is the fully relaxed signal, f  is regional perfusion, Mb is the blood 
VLJQDODQGƫLVWKHEORRGEUDLQSDUWLWLRQFRHIILFLHQWW\SLFDOO\VHWWRPOJ[97]). 
7KH ƫ WHUP DFFRXQWV IRU WKH ORZHU FRQFHQWUDWLRQ RI ZDWHU DQG FRQVHTXHQWO\
magnetisation) in tissue relative to blood.  
O
fMfM
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dt
tdM
b  
1
0)(                    3-3 
The positive term fMb denotes fresh blood flowing into the imaging slice and the 
negative term fMƫ denotes blood flowing out of the slice. M0 (the tissue 
equilibrium magnetisation) can be obtained from the signal recovery curve fitted 
to the Bloch equation for longitudinal relaxation or taken from a separate M0 
calibration image which has been acquired at an equivalent TE. Assuming that the 
T1 of tissue (T1t) is equal to that of blood (T1b), for FAIR, the signal following a 
slice-selective (SS) inversion pulse will recover according to the apparent T1 (T1app) 
(Equation 3-4),  
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with the magnetisation (MSS) at time t can be described by: 
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Following a non-selective inversion pulse, the magnetisation recovers as: 
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The measured signal difference between the non-selective (MNS) and slice-selective 
(MSS) signal is then given by 
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Assuming full inversion efficiency, Equation 3-7 can be modified to Equation 3-8 
for IWƫ much less than 1 such that the last term can be ignored.. 
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A schematic of the perfusion-weighted signal difference according to the single 
compartment model is shown in Figure 3-14.  
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Figure 3-14) Schematic of perfusion-weighted signal as a function of post-
label delay (TI).  
The assumption that labelled blood will arrive instantly at the tissue (i.e. fast 
exchange) is over-simplistic. The above model can be extended to take account of 
the blood arrival time (time taken for blood to reach the tissue). The general 
kinetic model [98] is a popular model which  relaxes the assumption of 
instantaneous blood exchange and encompasses the dynamic behaviour of blood 
by considering the delivery and clearance of labelled blood in addition to the 
magnetisation relaxation.  
Blood and tissue model 
Perfusion quantification can be made more physiologically plausible by increasing 
the number of compartments in the model. By modelling both blood and tissue, 
the effect of blood transit time can be more easily accounted for. Francis et al. [99] 
assume a multi-compartment vascular model (Figure 3-15); the arterial component 
outside the imaging slice (compartment 1), the intravoxel arteriolar component 
(compartment 2) and the exchange site between the capillary bed and tissue 
(compartment 3). The absolute signal is modelled within each compartment at 
regular time intervals (~200 Ƭs), and the weighted sum of the difference signal (SS 
minus NS) between compartments 2 and 3 gives rise to the perfusion signal. A 
brief overview of the signal model and associated parameters for each 
compartment is given below as this model is used in experimental work presented 
in Chapters 4 and 6. 
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Figure 3-15) A) Schematic of the multi-compartment model developed by 
Francis et al. [99].  
From Figure 3-15 it can be seen that the selective inversion slab is wider than the 
imaging slab to allow 100% inversion over the imaging plane. This leads to an 
arterial transit time (ƅD), the time for the labelled blood to reach the arteriolar part 
of the voxel. Labelled blood remains in the arterial compartment IRU WLPH Ƥ
before perfusing the tissue. W represents the bolus duration for the NS case, i.e. 
the additional time taken for the labelled blood to enter the imaging slice in the 
non-selective condition. Assuming a square inversion profile and constant blood 
velocity across the vessel cross-VHFWLRQLH´SOXJIORZµWKHIROORZLQJFRQGLWLRQV
hold true for the selective condition. M(0) refers to the magnetisation flowing into 
the voxel and Mb0 describes the initial magnetisation of the blood signal.  
If t < ƅD    M(0) = - Mb0 ,                 3-9 
if ƅD  < t < W + ƅD   M(0) = -Mb0 ,                    3-10 
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where + Mb0 is the resultant signal for the non-selective condition 
If t > W + ƅD    M(0) = +Mb0 .                                     3-11  
The behaviour of Mb at time t in compartment 2 (the intravoxel arteriolar 
component) can be described by Equation 3-12. F is the normalised arterial blood 
flow per unit volume of voxel, and Min and Mout reflect the magnetisation flowing 
into and out of the compartment respectively.  
)()()()(
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b
bbb                 3-12 
Where Mout is calculated in small (200 Ƭs) iterative steps and takes account for the 
arteriolar blood being exposed to successive RF pulses with each additional 
readout. By modelling Mb  it is possible to estimate  F and Ƥfrom which aCBV can 
be quantified. This is used in Section Effect of isocapnic hyperoxia on aCBV4.4.2. 
Compartment 3 is where the capillary blood magnetisation exchanges with the 
magnetisation of the extravascular component. The change in Mlabel across time is 
described by Equation 3-13, the solution to which describes the signal recovery 
between each RF pulse (Equation    3-14), where f is the voxel perfusion rate and 
T1app has the same definition as in the general kinetic model for single-TI 
measurements (Equation 3-4). Figure 3-16 shows the cerebral blood flow and 
volume weighted signal as a function of post-label delay. 
)()()()(
)(
1
0 tfMtMf
T
tMM
td
tdM
label
out
t
labellabellabel  O            3-13 
 
                         
3-14 
 
a pp
ba pp
a ppb
a pp
T
t
olabel
appb
T
t
appb
T
t
out
appb
T
t
appb
T
t
T
t
labellabel
eM
TT
fe
TT
fe
tM
TT
fe
TT
fe
eMtM
1
11
11
1
1111
1111
0
1111
)(
1111
1)(




¸¸
¸¸
¸
¹
·
¨¨
¨¨
¨
©
§
¸¸¹
·
¨¨©
§ 

¸¸¹
·
¨¨©
§ 

¸¸
¸¸
¸
¹
·
¨¨
¨¨
¨
©
§
¸¸¹
·
¨¨©
§ 

¸¸¹
·
¨¨©
§ 
 
OO
OO
59 
 
 
Figure 3-16) Schematic of perfusion-weighted signal as a function of post-
label delay. Here the effect of transit time is accounted for, according to the 
multi-compartment kinetic model of Francis et al. [99]. Labelled blood 
arrives at the tissue within the imaging plane at time (ƅF=ƅD +Ƥ) and 
after time Ƥ begins to exchange with the tissue. 
Tissue perfusion is typically the main focus of ASL sequences. The measured ASL 
signal will contain a contribution from both aCBV and CBF (Figure 3-16). Bipolar 
gradients can be DSSOLHGWRSURYLGH¶YDVFXODUFUXVKLQJ·WRHOLPLQDWHDUWHULRODUDQG
arterial blood signal.  
3.4.6 Readout sequences 
 
Single TI 
Early ASL experiments perform one image acquisition after a single post-label 
delay (TI). An acquisition at a single TI is easy to implement, however, taking a 
single TI measurement is likely to introduce errors as the blood arrival time (time 
taken for the labelled blood to reach the tissue) is unknown and cannot be taken 
into account in the fit. This is especially true when studying a dynamic process 
such as the response to a functional task or gas challenge. In single TI sequences, 
it is either necessary to assume a value for the arrival time; selecting a TI which is 
long enough to ensure that the labelled blood has arrived, but short enough to 
ensure that sufficient signal remains, or to repeat the experiment across a range of 
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TIs to estimate arrival time. The suitability of single-TI acquisitions will be 
discussed in more detail in Chapter 6, with particular emphasis on hypercapnia 
measurements.  
Multiple TI  
The accuracy of perfusion measurements can be increased by acquiring images at 
multiple post-label delays (TI, separated by time interval TA) across the perfusion-
weighted signal recovery curve. By combining Look-Locker (LL) sampling with 
FAIR labelling and EPI readout schemes (LL FAIR ASL or multiphase ASL), 
perfusion and transit time (which may vary across brain regions, activation state 
and individual subjects) can be measured with high temporal resolution [99]. A 
single inversion pulse is followed by a series of low angle flip-angles from which 
the longitudinal magnetisation recovery can be followed. 
It is important that the effect of multiple RF pulses on the magnetisation of 
arteriolar blood is taken into account, else perfusion will be underestimated. The 
stepwise multi-compartment kinetic model of Francis et al. [99], refined earlier 
LL-FAIR methods [100, 101] by modelling the expected arteriolar signal 
suppression prior to its exchange with tissue magnetisation. 
In LL-FAIR ASL, the flip angle of the readout pulses in this scheme is kept low 
(typically 35°) to maximise the tissue signal.  By alternatively minimising tissue 
signal and maximising arterial blood signal, LL-FAIR ASL in combination with a 
2 compartment vascular kinetic model can also provide a measure of arterial CBV 
(aCBV) [102]. Rapid application of an increased flip angle (~45°) suppresses 
signal from the tissue exchange compartment (minimising sensitivity to perfusion), 
while the inflow of blood refreshes the signal of the arterial non-exchange 
FRPSDUWPHQW7KHXVHRI D VKRUW7, DQGƅ7, UHVXOW LQ WKHEORRGEHLQJ UDSLGO\
refreshed so that the inflowing signal remains high. aCBV is thought to drive the 
hyperaemic response and so an accurate non-invasive aCBV measurement 
technique offers a useful investigative technique for investigating brain function as 
well as a potentially useful clinical tool [E.g. 103, 104-106] 
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Figure 3-17) Schematic of the LL-EPI FAIR ASL scheme. A 180° inversion 
pulse is used in both the label and control conditions, both are followed by 
multiple EPI readouts which occur after a smaller RF pulse is applied 
(typically 35°). The first EPI readout occurs after time TI, with subsequent 
spacing described by time TA.  
3.4.7 Phase Contrast Magnetic Resonance Angiography 
 
Rather than measuring tissue perfusion, blood flow in vessels can be assessed 
using MR angiography (MRA). There are two types of MRA; Time of Flight 
(TOF) and Phase Contrast MRA (PC-MRA), both of which rely on the ability to 
visualise moving blood, generally, without the use of exogenous contrast agents 
[107]. Unenhanced MRA gives images of only blood flowing through the vessel 
and not the vessel itself [108].  
In TOF, signal from stationary spins in the vessel and surrounding tissue is 
saturated, while the signal from moving spins in the inflowing blood is 
unsaturated. As blood flows into the imaging slice it brings with it unsaturated 
spins which receive RF excitation for the first time and so enhance vasculature 
contrast [109]. Signal enhancement in TOF is based on inflow effects, and the 
induced changes depend on longitudinal or T1 relaxation as for ASL [108].  
The alternative scheme is PC-MRA which uses the phase shift of transverse 
magnetisation to estimate blood flow; contrast relies on the motion of spins with 
respect to linear gradients. PC-MRA thus provides a T1-independent method of 
measuring blood velocity. Here, the phase shift is induced by moving spins 
experiencing a change of phase relative to stationary spins as they flow along the 
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magnetic field gradient [108]. For a linear field gradient, the phase shift is 
proportional to velocity [110]. Two datasets are acquired; the first image has equal 
phase modulation for both stationary and moving spins, but the second image is 
flow-sensitive, using a gradient of equal strength but opposite polarity to produce 
a flow encoding phase-shift (Figure 3-18) [108]. Subtraction of the bipolar 
datasets suppresses any shifts in phase caused by parameters other than velocity 
[111]ZLWKWKHUHPDLQLQJSKDVHGLIIHUHQFHƖXVHGLQDYR[HO-wise calculation of 
velocities [108, 112].  
 
The strength of the bipolar gradient determines the velocity encoding (VENC) 
where VENC = ʌ/(Ȗƅ01), where M1 is the product of bipolar gradient strength 
and duration squared  (M1 = GT
2) [113]. It follows that slower velocities need a 
stronger gradient to achieve the same phase shift as faster velocities with a weaker 
gradient.  The correct choice of VENC ensures that the maximal phase shift is 
induced in flowing spins in order to produce hyper-intense vessels in the resulting 
magnitude images. The VENC value must be set close to the maximum velocity 
of the flowing blood. If the blood velocity exceeds the VENC value then aliasing 
will occur and an abrupt change in signal intensity will be seen where there is a 
loss of signal in high flow regions [108].  
 
The data acquired using PC-MRA can be used to produce both magnitude and 
phase images. Magnitude images give the signal intensity of each voxel (with 
arteries and veins hyper-intense) but lacks information on flow velocity and 
direction. Phase map images allow quantification of both flow velocity and flow 
direction, with the signal intensity depicting the SKDVHGLIIHUHQFHƖZKLOHWKHVLJQ
RI Ɩ GHSLFWV IORZ GLUHFWLRQ EULJKWHU RU GDUNHU WKDQ WKH JUH\ VWDWLF WLVVXH
dependent on direction).  PC-MRA is described in detail in Chapter 4 where it is 
used to measure the effect of isocapnic hyperoxia on blood flow in the internal 
carotid arteries (ICA). 
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Figure 3-18) After the RF pulse, spins are in phase, with both stationary 
and flowing spins experiencing equal phase shift at the start of the first 
bipolar gradient.  After the second bipolar gradient, the stationary spins are 
repKDVHG ƅΚ=0) but the moving spins have acquired additional phase, 
ZKHUH ƅΚ ƣY01, where v is the veolcity and M1 is the product of the 
bipolar gradient strenth and duration squared.  PC-MRA is only sensitive to 
spins within and flowing perpendicular to the imaging slice. Adapted from 
[114]. 
PC-MRA can be used to measure the velocity of blood in any blood vessel which 
is perpendicular to the imaging slice. Both 2D and 3D PC-MRA sequences exist 
[115]. 2D PC-MRA has a shorter acquisition time whilst still remaining flow 
sensitive and so can provide a relatively quick snapshot of blood vessels in the 
head and neck, from which single imaging slices can be selected for 3D PC-MRA, 
ensuring that they are placed perpendicular to vessels of interest. 3D PC-MRA 
offers superior spatial resolution and SNR, however uses longer acquisition times, 
pulsatile flow variation over the cardiac cycle is more likely to be problematic and 
may cause phase encoding artefacts [116]. Synchronising data acquisition with the 
cardiac cycle, as with prospective cardiac gating, eliminates motion associated with 
the systolic phase of the cardiac cycle by collecting only over the diastolic phase ( 
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Figure 3-19). The R-peak of the ECG/VCG waveform (as used here) or 
alternatively the systolic peak of the PPU waveform act as a trigger to start data 
acquisition. Data are collected over a pre-determined number of points (phases) 
across the cardiac cycle, after which the acquisition is paused until the end of the 
R-R interval to compensate for any physiological variation in the length of the 
cardiac cycle [110]. 
 
 
 
 
 
 
 
 
 
 
Figure 3-19) With ECG/VCG gating, the R-peak (point with greatest signal 
amplitude) is used to trigger the sequence, since the R-R interval is the 
time between two sequential R-peaks and is determined by the patient 
heart rate, the TR is heart rate dependent. Data are acquired after the 
systolic period to minimise phase misshaping due to pulsatile flow and 
cardiac motion. Adapted from [109]. 
3.5 Measurements of electrophysiology 
 
Despite the high spatial resolution of fMRI, it has relatively low temporal 
resolution (on the order of seconds) and remains an indirect measure of brain 
activity. There are a range of electrophysiological techniques, from invasive 
techniques such as single unit recordings and electocorticography to non-invasive 
techniques such as electroencephalography (EEG) and magnetoencephalography 
(MEG). Electrophysiological recordings directly target neuronal activity, however 
the spatial resolution of non-invasive techniques is limited (as discussed below). 
Single-unit recordings have high temporal and spatial resolution, and 
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contributions have been invaluable in characterising electrical activity within the 
brain and establishing basic neuronal behaviour [117]. From a clinical perspective, 
ECoG aids pre-surgical planning and surgical resectioning, whilst offering good 
spatial resolution. However, these methods are very invasive. Non-invasive 
methods offer a simple repeatable method in which both the healthy and diseased 
brain can be studied. The remainder of this section will outline the theory and 
methodology of such non-invasive measures, focusing on MEG as this is used in 
Chapter 4 to assess the impact of isocapnic hyperoxia on neuronal oscillations.  
Neuronal signal is transmitted between neurons across synapses. The synapse is 
the extracellular space between the axon terminal of one neuron and the dendritic 
fibres of one or more others. Upon receiving a signal, a post-synaptic potential 
(PSP) travels down the dendritic fibre to the axon hillock, where an action 
potential may be initiated, continuing the transmission process. An excitatory PSP 
is a temporary wave of depolarisation, with the flow of current creating both local 
electrical and magnetic fields. In magnetoencephalography (MEG), it is generally 
the PSPs of the pyramidal cells that are of interest.  
A measurable magnetic field can be produced from the summed synchronised 
activity of large groups of similarly oriented pyramidal cells. This allows the group 
of neurons to be approximated as a single current dipole (Figure 3-20), which is a 
reasonable approximation [118]. The summed intracellular current flow is known 
as the primary or impressed current. The extracellular current flow which is 
established by the repolarisation of the neuronal membrane is not measured in 
MEG and together with signal from the skull and scalp is known as the secondary 
or volume current. It is not practical to consider the current flow established by 
an action potential along a neuronal axon as the transmission is too fast and this 
activity is more asynchronous across cells.  
 Magnetoencephalography (MEG) measures this neuromagnetic flux non-
invasively and thus provides a direct non-invasive measure of functional brain 
activity. Electroencephalography (EEG) offers an affordable alternative 
electrophysiological measure and can provide a convenient method of translating 
some MR findings to a clinical setting. EEG detects electric potentials via scalp 
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electrodes rather than magnetic fields and as such, it is the volume current 
measured with EEG. Whilst both MEG and EEG have relatively high temporal 
resolutions, in comparison to fMRI, the spatial resolution is limited.  
 
Figure 3-20) Synchronised postsynaptic potentials (and the corresponding 
wave of depolarisation) along dendritic fibres are the main source of 
primary current which induces the neuromagnetic field measured by MEG. 
Current flow along an individual dendrite is extremely small and so large 
synchronous groups are modelled as a single current dipole, with a current 
source and a current sink.  
In EEG, it is necessary to translate the voltage distribution measured on the scalp 
to a spatial distribution of dipoles inside the brain. In MEG, it is necessary to link 
the magnetic distribution measured outside the head to the current distribution 
inside the head. Unfortunately, there are multiple dipole configurations that will 
give rise to the same surface measurement. This is called the inverse problem and 
is ill-posed with no unique solution, requiring complex algorithms in order to 
solve it. The advantage of MEG over EEG is that the signal source localisation is 
more straightforward as neuromagnetic fields are not distorted by the skull or 
scalp. However, EEG is inexpensive, portable and readily available making it a 
popular clinical technique for a range of neurological conditions to include non-
convulsive seizures, brain injury and psychiatric disorders [119-121]. Whilst MEG 
is more expensive, systems tend to include around ten times more sensors than 
with EEG.  
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MEG relies on a head model, which is fundamentally spherical (number of 
spheres and positioning varies across models) and is thus insensitive to dipoles 
which are positioned radial to the scalp (i.e. pointed directly towards or away from 
the scalp), whilst EEG is sensitive to both radial and tangential sources.  
The approximate dipole moment from the summed activity of 106 pyramidal 
neurons is on the order of 25 nAm [122]. The use of extremely sensitive signal 
detectors is crucial for measuring such small signal changes. Multiple 
Superconducting Quantum Interference Devices (SQUIDS) are situated within 
the super-cooled dewar helmet so that they will cover a spherical section over the 
head about 2-3 cm apart. Each SQUID simultaneously measures the magnetic 
field at a specific spatial location. The fluctuations in neuromagnetic field are 
UHODWLYHO\ZHDN LQ FRPSDULVRQ WR WKH(DUWK·V PDJQHWLF ILHOG DQG PDJQHWLF ILHOG
disturbance caused by objects such as computers and cars. For this reason, the 
MEG system is placed within a magnetically shielded room, which blocks most 
external magnetic fields. In addition, to distinguish between neuromagnetic fields 
induced by neuronal activity and residual external magnetic fields, the gradient of 
the magnetic field is measured by gradiometers. First-order gradiometers consists 
of two coils (a pickup and a compensation coil), placed in series but wired in 
opposing directions [123]. The gradient of background magnetic fields will be 
near constant and so the signal from the pickup coil and compensation coil will 
cancel out. In contrast, the neuromagnetic field will show a steeper gradient (as 
the signal extends only a few centimetres beyond the head) and so produces a net 
change which it transmits to the SQUID via a flux transformer.  
As introduced above, the acquired data must be converted from sensor space to 
source space i.e. from scalp to brain. There are many methods to do this; in this 
thesis, a scalar beamformer [124] is used to spatially filter the data. The source 
localised signal for a dipole at location y and orientation ƨ (yƨ) can be defined by 
Equation 3-15, where b(t) is the time course of measured signal summed across 
each channel and W ƨ
T is a transposed matrix of channel weights, which is derived 
from the lead field vector and the covariance data of measured data. 
)(.)( tty T bWTT                        3-15 
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The lead field vector is simply the solution to the forward problem for an 
instantaneous unit dipole at a defined location and orientation. By comparing the 
sensor signal with the expected signal from the lead field vector, the signal to 
noise ratio can be maximised and the optimal dipole position identified.  
The scalar beamformer (Equation 3-15) is repeated across time such that a time 
course summed across weighted channels can be acquired. This time course can 
be separated into frequency bands using a band pass filter. Whilst frequency band 
definitions are subject to subtle differences in definition, they can be generally 
categorised as delta (<4 Hz), theta (4-8Hz), alpha (8-13 Hz), beta (13-30 Hz) and 
gamma (30-100 Hz) [122]. Further methods are provided in Chapter 4.  
3.6 Summary 
 
Having introduced the basic principles underlying BOLD fMRI, ASL, PC-MRA 
and MEG, Chapters 4-6 will implement these techniques to assess the 
physiological and physical impact of modulating O2 and CO2. By using multiple 
techniques to measure different response to such respiratory challenges, it is 
possible to gain a more quantitative insight in to the BOLD response. 
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4 The effect of hyperoxia on 
neurophysiology 
4.1 Introduction 
 
This chapter describes the effect of hyperoxia, (raising the inspired fraction of 
oxygen (FiO2) above normal physiological levels (0.21)), on physiology and 
neuronal activity. Hyperoxic modulation is often used in the calibration of the 
BOLD signal [8] under the assumption that increased oxygenation has no 
significant impact on neurophysiology or neuronal activity. The first aim of this 
chapter is to provide an experimental measure of these effects, to assess the 
validity of hyperoxia calibrated BOLD. The second aim is to use the isocapnic 
hyperoxia to investigate the effect of hyperoxia in functional hyperaemia.  
This chapter reviews the published effects of hyperoxia and discusses the 
possibility that some findings on the response to hyperoxia may be confounded 
by fluctuations in carbon dioxide (CO2).  First, the hyperoxia calibrated BOLD 
model will be outlined to provide an understanding of the motivation behind the 
experimental work. Three experiments will then be presented to assess the effect 
of hyperoxia on the following baseline measures: (i) mean blood flow (MBF), (ii) 
arterial cerebral blood volume (aCBV) and (iii) neuronal oscillations. Secondly, the 
regulatory mechanisms in functional hyperaemia will be discussed. Experimental 
work will assess the impact of hyperoxia on task-evoked cerebral blood flow 
changes (CBF).  
4.2 Hyperoxia calibrated BOLD 
 
Calibrated functional magnetic resonance imaging (fMRI) provides a non-invasive 
method to quantify the fractional change in cerebral metabolic rate of oxygen 
(CMRO2) consumption which gives rise to the BOLD signal change during an 
fMRI experiment [7, 66, 125-128]. CMRO2 is thought to be more closely coupled 
to neuronal activity than the BOLD signal and therefore provides a means of 
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quantification, which is crucial in order for a method to be established as a reliable 
clinical technique.  
In the original quantitative calibrated fMRI model of Davis et al. [7], the effect of 
hypercapnia on CBF was used to normalise the BOLD signal in order to remove 
vascular contributions which did not directly reflect neuronal activity. Whilst a 
well-established and popular research technique, hypercapnia-based BOLD 
calibration is likely compromised by the known reduction in electrophysiological 
activity that accompanies hypercapnic stimuli, which may impact the measured 
value of CMRO2 [129-133]. It is worth noting, that such a reduction in CMRO 2 
has been contested [134] .  
Hyperoxia has been proposed as an alternative means of BOLD signal calibration 
[8, 135], providing the advantages of a more precise estimate of CMRO2 and a 
more tolerable stimulus which can be applied for longer periods. Hyperoxia 
increases arterial oxygen content (mostly through an increase in O 2 dissolved in 
blood plasma), thus increasing venous oxygen saturation, and hence decreasing 
the concentration of dHb in capillaries and veins [136]. dHb is paramagnetic and 
so a reduction in dHb will increase the transverse relaxation time (T2
*) of blood in 
vessels (intravascular component) and the surrounding tissue (extravascular 
component) causing a global increase in the BOLD signal [42, 137].  
The original hyperoxia model [8] is simply an adaptation of the hypercapnia 
calibration model [7], however, rather than a vasodilatory stimulus modulating 
CBF, with hyperoxia it is venous oxygenation that is modulated. The hyperoxia 
model originates from the same expression for BOLD signal change (Equation 4-
1)  as used in the hypercapnia model [138],  
*
2
0
RTE
BOLD
BOLD ' '  ,         4-1 
and uses the expression for R2
* defined by [139] (Equation 4-2): 
> @ EvdHbCBVAR  *2   ,                                                                                    4-2 
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 where [dHb]v is the venous concentration of deoxyhaemoglobin, A is a 
proportionality constant (incorporating field strength and susceptibility shift) and 
Ƣ is a constant which expresses the power relationship between oxygenation and 
R2
*Ƣ is generally assumed to be ~1.5 at 1.5 T, reducing to ~ 1.3 at 3 T and 1 at 7 
T (see Chapter 5 for a further discussion).  
Equation 4-2 can be substituted into Equation 4-1 for the stimulus and rest 
conditions (where the subscript 0 denotes the rest condition) to give Equation 4-3. 
M is the calibration parameter identical to that in Davis et al. [7].  
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Under the assumption that a hyperoxic stimulus has no significant effect on CBF 
CBV or OEF, Equation 4-4 simplifies to: 
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After calculation of the calibration parameter M from a hyperoxia challenge  
Equation 4-6 can be used to calculate the relative change in CMRO 2 from an 
activation task such as a finger tap, in which BOLD and CBF are measured. 
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As with the hypercapnia calibration model, hyperoxia calibration also relies on the 
assumption that the stimulus is isometabolic i.e. CMRO2 does not change. To date, 
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there remains some doubt as to the effect of the hyperoxia stimulus on tissue 
blood flow and neuronal activity (Section 4.4), and any such changes would 
complicate or undermine the use of hyperoxia-based BOLD calibration. More 
recently, a combined method of hyperoxia-hypercapnia BOLD calibration has 
been proposed [10, 141], with the potential to offer a clinically viable alternative to 
PET for quantification of baseline rather than relative CMRO 2. However, this 
method will combine the potential pitfalls associated with the separate delivery of 
hyperoxia and hypercapnia, and so even greater emphasis must be placed on the 
accuracy of these separate calibration methods. 
Sections 4.7-4.8 of this chapter assess the physiological assumptions made in the 
above model; whether CBF and CBV remain constant under hyperoxia, and if 
hyperoxia is an isometabolic stimulus. This experimental work focuses only on the 
effects of isocapnic hyperoxia, in order to remove the potentially confounding 
effects of CO2 fluctuations. Therefore it is first necessary to understand how 
isocapnic hyperoxia is established and administered.  
4.3 The RespirActTM 
 
Previous studies have attempted to control arterial gases, however most methods 
are complex leading to potential errors. A closed-loop system to target end-tidal 
values by adjusting inspired gas concentrations on a breath-by-breath basis is ideal 
[142-144]. However this method requires sophisticated and relatively expensive 
VRIWZDUH 7KLV ¶HQG-WLGDO IRUFLQJ· WHFKQLTXH UHOLHV RQ UHVSLUDWRU\ IUHTXHQF\ DQG
tidal volume and may lead to the need for conflicting actions [145]. Many clinical 
studies [146, 147] use a self-regulating breathing system which allows maintenance 
of isocapnia and iso-oxia without requiring complex feedback [145]. However, 
these simple circuits are unable to target end-tidal partial pressures of CO2 and O2 
(PETCO2, PETO2) precisely or independently of each other. Additionally, the effects 
observed with a simple breathing mask are unpredictable and difficult to 
reproduce. For hypercapnic sequences, a popular and easy to implement method 
is breath-holding [148-150], but breath-holding can be complicated by the 
variability of an individual·s breathing, such as how long each breath lasts and 
how controlled their exhalation is (so that PETO2 and PETCO2 can be measured). 
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However, recent work suggests that the effects of such inter-subject differences 
can be minimised by monitoring PETCO2 via a nasal cannula and using this trace 
as a regressor [151]. 
Paced breath-holding can be combined with visual feedback to induce controlled 
hypoventilation or hyperventilation in order to target a specific PETO2 or PETCO2  
[152], but this requires training and is difficult to implement in an MRI scanner as 
it requires a metronome to pace breathing. 
The RespirActTM (Thornhill Research Inc., Toronto, Canada) is a feed-forward 
low gas-flow system which is used with a sequential gas delivery (SGD) circuit 
(Figure 4-1). It uses a blend of source gases; 100 % O2, medical air and two blends 
of O2, CO2 and N2 gas (each containing a minimum of 10 % O2 for safety 
purposes) to precisely target PETCO2 and PETO2 independently of each other 
following the approach developed by [145]. SGD circuits provide sequential flow 
RI ´IUHVKµ JDV DQG ´QHXWUDOµ JDV7KHQHXWUDO JDV LV GUDZQ IURPD UHVHUYRLU RI
previously expired gas and so does not alter CO2 levels [153]. The aim of the 
RespirActTM system is to independently control PETCO2 and PETO2, allowing the 
user to both target and clamp end-tidal gases at a steady value.  
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Figure 4-1) A) Sequential gas delivery (SGD) circuit based on [145]. B) 
Flowchart depicts inspiration and expiration through a sequential gas 
delivery circuit. G1 and G2 refer to fresh and exhaled gas respectively, VE 
refers to minute ventilation.  
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4.3.1 Basic principles 
 
Using the RespirActTM, PETO2 and PETCO2 can be prospectively calculated in 
spontaneously breathing subjects using four rules, derived from basic 
physiological principles outlined in Slessarev et al. (2007). 
Rule 1: If the flow of newly inspired gas is less than or equal to alveolar 
ventilation, then this flow rate determines alveolar ventilation. 
If the flow of newly inspired gas entering the fresh gas inlet decreases below 
minute ventilation (volume of air expired from lungs in one minute), the negative 
pressure will cause the crossover valve in the bypass conduit to open so that the 
VXEMHFW´UHEUHDWKHVµWKHLUSUHYLRXVO\H[SLUHGJDV,QLWLDOO\WKHSUHYLRXVO\H[SLUHG
gas will fill only anatomical dead space (as the lung is near full of freshly inspired 
gas) and so the fractional end-tidal concentration of CO2 (representing the 
alveolar concentration of CO2, FETCO2) will not change. The RespirAct
TM relies 
on the opening of the crossover valve to remove the physiological dependence of 
alveolar ventilation on minute ventilation. It is vital that the fresh gas and 
previously expired gas flow in sequence, hence the RespirActTM system is used 
with a SGD circuit. 
Rule 2: A component of a gas mixture can be assumed neutral with respect 
to alveolar ventilation if the concentration equals that in the mixed alveolar 
gas. 
If the flow of newly inspired gas is less than or equal to alveolar ventilation, the 
alveolar gas filling the anatomical dead space is previously expired gas. During 
rebreathing, it simply re-enters the anatomical dead space and so will not affect 
the alveolar fractional concentration of CO2 and O2 (FACO2, FAO2). The gas 
concentrations between anatomical dead space and alveolar mixed gas are equal 
and only an increase in lung volume will be observed. CO 2 and O2 can be treated 
as independent components of alveolar gas in terms of neutrality, such that 
inhalation of previously expired gas can be neutral with respect to CO 2 only, 
whilst still altering FETO2. 
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Rule 3: The fractional end-tidal concentrations of O2 and CO2 (FETO2, 
FETCO2) are independent of minute ventilation if the flow of newly inspired 
gas is less than or equal to alveolar ventilation. 
If there is an increase in respiratory frequency, there will be a corresponding 
decrease in the fraction of newly inspired gas obtained with each breath. 
Nevertheless, minute ventilation cannot exceed alveolar ventilation and so is 
constrained by the flow of newly inspired gas. Similarly, if tidal volume increases 
then FETO2 will increase and FETCO2 will decrease. If the flow of newly inspired 
gas does not meet the rate of alveolar ventilation, gas will be drawn from the 
expiratory reservoir, thus filling the anatomical dead space with neutral gas with 
respect to alveolar ventilation. This will have no impact on either FETCO2 or 
FETO2 
5XOH7KHIORZRIQHZO\LQVSLUHGJDVFDQEHGLYLGHGLQWRD´QHXWUDOJDVµ
DQGD´IUHVKJDVµZKLFKFRQVWLWXWHVDOYHRODU ventilation.  
The flow of newly inspired gas can be divided into two virtual components, one 
with CO2 which determines alveolar ventilation and one which is CO 2 neutral 
which has zero impact on CO2 exchange. This simple concept allows FETCO2 and 
FETO2 to be independently targeted and maintained. Assuming that the flow of 
newly inspired gas remains constant, when alveolar ventilation exceeds the flow of 
newly inspired gas it is susceptible to changes in CO2 concentrations which can be 
used to manipulate alveolar ventilation independently of minute ventilation. 
Under the same assumption, the manipulation of O2 concentrations in newly 
inspired gas will alter alveolar ventilation for O2 and so PETO2. 
4.3.2 Limitations of RespirActTM 
 
Slessarev et al. [145] allow only for the distribution of gas to anatomical dead 
space (mouth, trachea etc.) and to well-perfused alveoli. Yet inspired air will be 
distributed both to anatomical dead space and alveolar dead space (regions of 
alveoli which do not partake in gas exchange), the sum of which is deemed the 
physiological dead space. In healthy people, anatomical dead space is roughly 
equivalent to physiological dead space as alveoli are very well perfused, however 
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in patients with lung disease, the alveolar dead space may be significantly 
increased [154-156]. This highlights the need for healthy subjects who have no 
prior history of lung disease.  
While the RespirActTM can independently control end tidal gas concentrations it is 
still constrained by physiological limitations. Traditionally, transitions between end 
tidal gas concentrations should be as rapid as possible (square-wave) and 
reproducible. However, control over end tidal values will be sacrificed at 
transition periods due to the need for a sudden change in flow to reach the new 
targeted value. For example, in a transition from baseline PETO2 to moderate 
hyperoxia, the RespirActTM will deliver a sudden burst of gas of pure O2 in order 
to rapidly raise PETO2. This means that there is no CO2 delivered for a short 
period of time (compared to the standard 0.03%) and this change immediately 
reduces the control the system has over PETCO2. With hyperoxia, achieving the 
target gradually rather than with a square-wave step provides much tighter control 
over end tidal O2 and CO2 as it minimises the change in flow rates and so prevents 
D ´EXUVWµRI JDV XSRn transition. Although this ramped approach increases the 
sequence length, accuracy and patient comfort are improved. Further, this method 
allows the assessment of sinusoidal transitions, such as has been used for 
cerebrovascular reactivity maps [157].  
The subject may not continue to rebreathe if the flow of freshly inspired gas 
exceeds their minute ventilation. In this case, a proportion of the fresh gas will 
overflow into the expiratory reservoir meaning that this gas is no longer neutral 
and there will be a change in alveolar ventilation. The software will assume that all 
fresh gas was inspired and future inhaled gas concentrations will be incorrectly 
calculated on this assumption. Again, this specific limitation can be overridden by 
programming a slow gradual transition which minimises any changes in flow such 
that the subject can maintain their minute ventilation. 
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4.4 The effect of hyperoxia on the resting-state brain 
 
Hyperoxia is a popular tool in both clinical treatment and research as it is readily 
available, portable and cost-effective. Normobaric hyperoxia (1 ATA) has been 
proposed as a treatment for cerebral ischemia [158-160], traumatic brain injury 
[161-163] and cluster headaches [164]. With regards to research, hyperoxia is a 
well established non-invasive exogenous (originating outside the body) contrast in 
MRI [136, 165, 166]. It is not only used to provide a method of calibrating the 
blood oxygenation level dependent (BOLD) effect [8], but also to study venous 
blood oxygenation and venous blood volume [135, 167-169].  
The following studies were approved by the University of Nottingham Medical 
School Ethics Committee. MR scanning was performed using a 7 T Philips 
Achieva system with head volume transmit and 32 channel SENSE receive coil 
with foam padding used to reduce head motion. MEG recordings were made 
using a 275-channel axial gradiometer CTF MEG system (MISL, Port Coquitlam, 
BC, Canada) 
4.4.1 Effect of isocapnic hyperoxia on mean blood flow brain 
 
A hyperoxia-induced decrease in CBF was first noted by Kety and Schmidt [170] 
using a nitrous washout technique, now deemed the Kety-Schmidt method. 
Despite shortcomings, such as the assumption that the jugular venous blood is 
fully representative of cerebral blood and that cerebral blood can be fully 
saturated with nitrous oxide within 15 minutes [171], this method paved the way 
for many future methods and studies into CBF measurements. Many recent 
studies agree with the findings, and again suggest that normobaric hyperoxia 
decreases CBF [152, 165, 172], concluding that hyperoxia has vasoconstrictive 
properties.  
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However, it is worth noting that previous studies may have been confounded by 
associated arterial hypocapnia. Hyperoxia increases minute ventilation (leading to 
hyperventilation) and reduces arterial CO2 (PaCO2) via the Haldane effect (a 
reduction in CO2 carrying capacity of oxyhaemoglobin (Hb02) during hyperoxia) 
[173, 174]. Since the vasculature is very sensitive to changes in blood levels of 
CO2 [175], a relatively low level of concomitant hypocapnia may significantly 
decrease blood flow. Therefore to properly characterise the effect of hyperoxia it 
is important to control or monitor any confounding changes in the level of CO 2.  
For this reason, the work presented herein uses isocapnic hyperoxia as a stimulus, 
where CO2 is maintained constant throughout (see Section 4.3).  
An additional complication when characterising the hyperoxia-CBF relationship is 
that the technique of Arterial Spin Labelling (ASL), which is frequently used to 
measure cerebral blood flow (CBF) and can also be used to measure aCBV, is 
dependent on the tissue and blood longitudinal relaxation times (T1). On 
hyperoxia, dissolved plasma oxygen shortens the T1 of blood [176, 177] and tissue 
[178] which would lead to an under-estimation of CBF/aCBV on hyperoxia if not 
properly accounted for when modelling the data. 
The following experiment was designed to provide a T1-independent measure of 
baseline blood flow on hyperoxia to test the assumption made in hyperoxia 
calibrated BOLD that hyperoxia has no significant effect on CBF [8]. 
4.4.1.1. Experiment protocol 
 
Six subjects (aged 24-28 years, 4 female) participated and gave prior informed 
written consent. Prior to the MRI measurements, each subject sat upright on the 
scanner bed while baseline metabolic values were estimated and targeted. The 
subject then lay supine in the scanner connected to the RespirAct circuit, with 
medical air administered until the respiratory challenge commenced. The 
respiratory challenge consisted of 1 minute of normoxic baseline (subject-specific 
PETO2 and PETCO2), followed by 5 minutes of isocapnic hyperoxia (PETO2 = 
500mmHg, equivalent to FiO2    VXEMHFW·V UHVWLQJ 3ETCO2), and then 5 
minutes of normoxic baseline. This was then followed by 2 cycles of 2 minutes of 
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K\SHUFDSQLDVXEMHFW·VUHVWLQJ3ETO2, PETCO2 = baseline + 8mmHg), separated by 
2 minutes of baseline, followed by 1 minute of baseline ( 
Figure 4-2 4-2). The total duration of the respiratory challenge was 20 minutes, 
including transitions between the blood gas levels. All hyperoxia transitions 
consisted of a graded increase/decrease in target PETO2 (between subject specific 
baseline and 500mmHg across 1 minute). This graded change minimises 
discrepancies between targeted and actual PETO2, allowing a steady-state to be 
reached near instantaneously.  
 
Figure 4-2) Targeted respiratory paradigm: isocapnic hyperoxia (P
ET
O
2
 = 
500 mmHg) followed by 2 cycles of iso-oxic hypercapnia (subject specific 
baseline P
ET
CO
2 
+ 8 mmHg). The one minute transitions can be seen for 
hyperoxia. Requested end tidal pressure of O
2
 is traced in black and CO
2
 in 
grey.    
Mean blood flow (MBF) was measured in the left and right internal carotid 
arteries (ICA). The ICAs are the main supply of oxygenated blood to the brain 
(Chapter 3). Furthermore, the left and right vessels are approximately parallel, 
allowing blood flow to be measured within a single phase-contrast acquisition. To 
allow vessel visualisation, 2 slices of sagittal and coronal 2D PC-MRA data were 
acquired with the imaging parameters TR/TE = 14/7.6 ms, flip angle (FA) = 20°,  
slice thickness 30 mm, FOV = 230 x 230 mm2, SENSE acceleration factor 2, vENC 
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= 30 cm/s. The scan duration was 47 s for 4 averages. Blood flow was then 
measured using a vectorcardiogram (VCG) gated, 2D PC-MRA acquisition on a 6 
mm axial slice perpendicular to the targeted ICA. Imaging parameters were 
TR/TE = 15/6.5 ms, FA = 25°, FOV = 280 x 77 mm2, 0.75 x 0.75 x 6 mm3 
reconstructed, SENSE acceleration factor 4, vENC = 100 cm/s, and 0 cm/s. The 
scan duration was 1 min 25 s for 2 averages. The measurement plane was 
positioned through the C1 segment of the spinal cord, where the left and right 
ICA were approximately parallel (Figure 4-3). PC-MRA data were collected 
throughout the 20 minute respiratory challenge, resulting in a minimum of 16 and 
maximum of 25 phases across the cardiac cycle. The number of PC-MRA repeats 
ZDV GHWHUPLQHG E\ WKH VXEMHFW·V KHDUW UDWH UHVXOWLQJ LQ D UDQJH RI  -4 repeats 
across the group. The repeated data acquisition allowed the variance of the flow 
measurement to be assessed and so the minimum detectable change (MDC) 
observable with PC-MRA at 7 T to be quantified. 
 
Figure 4-3) Schematic drawing of the main arteries which supply the brain, 
modified from [179]. The C1 cervical vertebrae is highlighted to depict 
placement of the imaging slice. The angle of the imaging plane was 
dependent on the vessel orientation to ensure it was perpendicular to the 
left and right internal carotid arteries.  
4.4.1.2. Data Analysis 
 
PC-MRA flow data were analyzed using QFlow software (Philips, Best, 
Netherlands).  Regions of interest (ROIs) were drawn manually around the lumen 
of the carotid arteries on each phase contrast modulus image (Figure 4-4C), and 
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contour detection software was used to improve the ROI accuracy. These 
automated ROIs were then manually checked against the phase images (Figure 
4-4D). The mean signal intensity in the ROIs reflected the flow velocity for each 
cardiac phase in cm/s. The cross-sectional area of each vessel lumen was 
calculated (± 0.1 mm2) and multiplied by the mean velocity, to compute, for each 
cardiac phase, the carotid artery flux in ml/min. The flux data were then averaged 
across left and right ICAs, and repeated measurements, to give an average carotid 
artery flux waveform at normoxia, hyperoxia and hypercapnia. The data within a 
waveform were then averaged across all phases of the cardiac cycle to provide a 
single estimate of mean blood flow (MBF) at normoxia, hyperoxia and 
hypercapnia. The variance between repeated measures of MBF under normoxia 
was assessed, and the minimum detectable change (MDC) calculated from the 
standard error in mean (SEM) using a 95 % confidence level, calculated according 
to SEMMDC x2x96.1 . Statistical tests were performed using SPSS 16, 
Chicago, IL, USA.   
 
Figure 4-4) Localisation of the 2D PC-MRA imaging slice (dashed white 
line) perpendicular to left and right internal carotid arteries was based on 
the A) 2D sagittal phase-contrast angiogram and B) 2D coronal phase-
contrast angiogram. C) 2D PC-MRA modulus and D) phase images, where 
cross-section of internal carotid arteries are highlighted in red. 
4.4.1.3. Results 
 
One of the six subjects was excluded due to the tortuous configuration of their 
ICAs, preventing the imaging slice being placed perpendicular to both left and 
right ICA simultaneously. The mean hyperoxic step was 460 ± 13 mmHg, with a 
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baseline of 111 ± 7 mmHg (mean ± SEM across subjects), while PETCO2 varied 
by less than 1 mmHg.  The average hypercapnic step was 4.2 ± 0.5 mmHg, while 
PETO2 varied by less than 1 mmHg.  
Hyperoxia did not cause a significant change in mean blood flow from normoxia 
(paired t-test, power = 0.8, p = 0.80), as shown in Figure 4-5 and Table 4-1. A 
95 % confidence interval of -3.2 to +3.3 % was observed, suggesting that less 
than 5 % of results would show the 4 % reduction in blood flow reported in 
previous literature for a comparable increase in FiO 2 of 0.6 [165]. The minimum 
detectable change for p = 0.05 was assessed from repeated measures of normoxic 
MBF and found to be 3.6 %, again, this is less than the previously reported 
reduction. As expected, an increase in MBF occurred during hypercapnia 
compared to normoxia, with MBF being found to increase by 6.8 ± 1.5 % per 
mmHg of CO2 (power = 0.8, p = 0.03).  
 
Figure 4-5) The effect of normoxia (grey solid line), hyperoxia (black solid 
line) and hypercapnia (black dashed line) on the mean average carotid 
artery flux waveform averaged across subjects. Error bars indicate the 
standard error of mean. 
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 MBF (ml/min) 
Normoxia 201 ± 11 
Hyperoxia 201 ± 12 
Hypercapnia 272 ± 14*  
Table 4-1) Effect of isocapnic hyperoxia, iso-oxic hypercapnia and 
normoxia (mean ± SEM) on mean blood flow (MBF), averaged across left 
and right ICA and all subjects. * denotes statistical significance from 
normoxia (p<0.05). 
4.4.1.4. Discussion 
 
A phase contrast based MR blood flow measure was used to ensure insensitivity 
to any changes in the T1 relaxation time of the blood or tissue on hyperoxia. The 
phase contrast sequence monitors the (velocity induced) phase shift of the blood 
signal in the lumen of vessels across the cardiac cycle to estimate MBF, as such it 
is independent of changes in absolute phase of the blood due to hyperoxia. Here, 
MBF sensitivity to hyperoxia was measured in the internal carotid arteries to give 
maximum sensitivity to global changes in CBF. Whilst measurement in the 
internal carotid arteries neglects the posterior contribution to global CBF, it has 
been shown that the anterior circulation provides up to 82 % of cortical flow [180, 
181], with both systems reacting equally to external stimuli [182].  
The PC-MRA blood flow results presented here support the findings of a recent 
ASL study [183] which found no significant change in grey matter CBF in 
response to isocapnic hyperoxia. However, the ASL study did not correct for a 
change in T1 blood relaxation time on hyperoxia which would lead to an 
underestimation of CBF on hyperoxia, potentially masking an actual increase in 
CBF. Previously reported reductions in CBF [184] may be attributed to 
accompanying hypocapnia since the PETCO2 level was not controlled.  
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4.4.2 Effect of isocapnic hyperoxia on aCBV 
 
As a change in cerebral blood volume (CBV) is thought to drive both CBF and 
the BOLD response [57, 102], this is an important determinant factor when 
investigating flow-metabolism coupling. Whilst the effect of hyperoxia on CBV is 
still under debate [152, 185], it is generally assumed to have no significant effect 
on CBV at low-levels and hyperoxia has been used to measure CBV [168, 169] . 
The following experiment assesses the effect of isocapnic hyperoxia on aCBV to 
test the assumption made in hyperoxia calibrated BOLD that CBV is constant 
under hyperoxia [8].  
4.4.2.1. Experiment protocol 
 
Seven subjects (age 24-48 years, 3 female) participated and gave prior informed 
written consent. Prior to MRI measurement, the subject sat upright on the 
scanner bed connected to the RespirAct circuit while baseline metabolic values 
were estimated and targeted. This experiment comprised 1 minute of baseline 
followed by 2 minutes of isocapnic hyperoxia (PETO2    PP+J VXEMHFW·V
resting PETCO2) and 1 minute of baseline (Figure 4-6). PETCO2 was maintained at 
subject specific resting levels throughout. The duration of the respiratory 
challenge was 6 minutes, including transitions. 
 
Figure 4-6) Targeted respiratory paradigm: isocapnic hyperoxia (P
ET
O
2
 = 
500 mmHg), P
ET
CO
2
 targeted at subject-specific baseline throughout. 
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Flow-sensitive alternating inversion recovery (FAIR) Arterial Spin Labelling (ASL) 
was combined with a Look-Locker (LL) sampling scheme to map aCBV using a 
two compartment vascular kinetic model (Chapter 3) [99, 102]. The acquisition 
parameters were: initial inversion delay (TI) = 150 ms, readout spacing (TA) = 
100 ms, TR = 3000ms, FA = 45°, SENSE factor 2 and  21 readout phases per TR. 
Images were acquired with a GE-EPI readout; single axial slice of 3 mm thickness, 
TE = 16ms, in-plane resolution of 2 x 2 mm, FOV = 192 x 192 mm. In addition, 
at normoxia, a base magnetisation image was acquired and a series of inversion 
recovery EPI images (10 inversion times, 100 - 2600 ms) which were fitted for T1.  
A grey matter (GM) mask was then formed by thresholding the T1 PDSDW
T1 VD&%9-weighted difference images were formed by subtraction of the 
label from control images (Figure 4-7A). The average aCBV difference signal 
within the GM mask for each LL-readout was then estimated, for both the 
normoxia and hyperoxia periods. These signal curves were normalised to the base 
magnetisation blood signal from the middle cerebral artery, and the resulting 
normalised aCBV signal curves at normoxia and hyperoxia fitted for GM aCBV 
DQGƅarterial using the model described in [102]. 
Fitting the signal for aCBV required an estimate of T1blood on normoxia and 
hyperoxia. The measurement of T1blood at normoxia and hyperoxia in vivo in 
humans at 7 T is difficult due to its fast flow rate and the limited coverage of the 
head transmit coil, therefore the T1 of arterial blood (FiO2 = 0.2) is assumed to be 
2200 ms at 7 T (T1blood normoxia) [186, 187]. To estimate T1blood on hyperoxia at 7 
T we can first use the T1 of arterial blood at 7 T together with the value at 1.5 T 
of 1205 ms [176] to calculate the exponent in the expression of Rooney et al. [188] 
relating T1 to field strength (B0), giving T1 = 839(B0)
0.39. Using this expression, we 
can then extrapolate the value of T1blood = 979 ms at FiO2 = 1 measured at 1.5 T  
[176] to 1792 ms at 7 T. These 7 T values of T1blood at FiO2 = 0.2 and 1, can then 
be exponentially interpolated [165] to estimate the T1blood at 7 T for FiO2 = 0.6  of 
1986 ms (T1blood hyperoxia).  
Significant effects of hyperoxia on mean aCBV and arterial transit time were 
assessed across subjects using a non-parametric Wilcoxon Signed Rank test. 
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4.4.2.2. Results 
 
The mean hyperoxic step (± SEM) was 486 ± 12 mmHg, with a baseline of 119 ± 
1 mmHg averaged across subjects, while PETCO2 varied by less than 2 mmHg. 
Figure 4-7A shows the aCBV-weighted LL-FAIR ASL data in a representative 
subject, from which the mean GM aCBV was measured to be 1.2 ± 0.4 % during 
normoxia and 1.1 ± 0.3 % during hyperoxia (Table 4-2). This reduction was not 
significant (power = 0.8, p = 0.64, paired t-test), with a 95 % confidence interval 
of -0.21 to +0.31%. There was no significant change in mean arterial transit time, 
ƅa which was found to be 318 ± 7 ms during normoxia and 309 ± 4 ms on 
hyperoxia (power = 0,8, p = 0.68, paired t-test), with a 95 % confidence interval 
of -69 to +95 ms.  
 
Figure 4-7) A) Example perfusion weighted LL-FAIR aCBV data. The 
effective post label delay is given in milliseconds. B) GM aCBV weighted 
normalised LL ASL signal curves at normoxia (grey solid line) and 
hyperoxia (black solid line). Data averaged across subjects. Error bars 
indicate the standard error of mean (SEM). 
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 GM aCBV (%) ǻarterial (ms) 
Normoxia 1.2 ± 0.4 0.32 r 0.07 
Hyperoxia 1.1 ± 0.3 0.31 r 0.04 
Table 4-2) Effect of hyperoxia on mean arterial cerebral blood volume 
D&%9 DQG DUWHULDO WUDQVLW WLPH ƅarterial), averaged across cortical grey 
matter in all subjects. 
4.4.2.3. Discussion 
 
aCBV reflects vasoconstriction of the arterioles which controls blood flow 
through the capillaries and hence tissue perfusion. The aCBV compartment is 
known to be more responsive to activation compared to the venous blood 
volume [102]. Using intravenous perflurocarbon in anesthetised rats, Lee et al. 
showed that the relative increase in aCBV in response to a hypercapnic challenge 
was 5.3 times larger than the relative increase in venous CBV (vCBV) [189]. Using 
electrical forepaw stimulation in anesthetised rats, Kim et al [59] investigated 
regional responses using ASL. No significant differences were observed between 
aCBV and total CBV, suggesting a negligible change in vCBV in response to 
functional activation.  
Here, aCBV was measured using LL-FAIR ASL which is a multiphase readout 
ASL sequence. This had a relatively high flip angle and small readout spacing, 
allowing aCBV and arterial transit time to be fitted simultaneously. It is important 
to assess both measures since a change in aCBV is often also accompanied by a 
change in transit time. Therefore if a constant transit time is assumed at a single 
inversion time, changes in aCBV may be masked. Further, the reduction in T1blood 
that occurs on hyperoxia can cause an apparent change in the ASL aCBV-
weighted signal in the absence of any true change in aCBV. This was accounted 
for by assuming a reduction in T1blood on hyperoxia (from 2200 ms at normoxia to 
1986 ms at hyperoxia) when fitting the aCBV data. 
To investigate the potential effect of neglecting such a reduction in T1blood on the 
fitted value of aCBV, the aCBV weighted signal was simulated using the LL-FAIR 
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ASL sequence timings used in this experiment [102]. Additional simulation 
parameters are given in Table 4-3. Simulating aCBV weighted LL-FAIR ASL data 
(100 iterations, SNR = 100:1) with T1blood of 1986 ms (shortened by ~ 10 % at 7 T 
on hyperoxia) and fitting the data assuming T1blood of 2200 ms (as for normoxia) 
led to an underestimation of aCBV by 10 ± 0.3 % (error in fitted mean ± SEM 
across iteraWLRQVZKLOHƅarterial remained largely unaffected (underestimated by 0.6 
± 0.5 %).  
Parameter Value 
Blood volume, aCBV (%) (assumed using a bulk flow 
UDWH)RIPOJDQGH[FKDQJHWLPHǻRIPV
(model described in [57, 102]. 
1.2 
Longitudinal relaxation time of tissue, T1tissue (ms) ([188] 2200 
$UWHULDOWUDQVLWWLPHǻarterial (ms) 100 
Bolus duration, W (ms) 1200 
Equilibrium magnetisation, M0 1 
Simulated T1blood (ms) at 7 T for FiO2 (%) = 0.2, 0.4, 0.6, 
0.8, 1.0 (Extrapolated from [188] and (Bulte et al. 
2007b)) 
2200, 2144 
2090, 2037, 1986 
Table 4-3) Parameters used to simulate aCBV data, as described in 
(Brookes et al. 2007). 
It has also been shown that CBF changes would be underestimated if the effect of 
hyperoxygenation on T1blood was ignored [190] and another study has shown no 
change in CBF when correcting for the arterial blood T1 decrease [190, 191]. The 
aCBV signal is derived solely from the arterial blood compartment due to the 
suppression of the tissue signal by the rapid sequence (every 100ms) of high flip 
angle (45°) pulses in the LL sequence, and therefore it is insensitive to any 
changes in tissue T1 which in any case are likely to be small in the brain. Although 
this simulation was carried out for aCBV-weighted ASL data, these results 
highlight the more general importance of accounting for any change in T1blood 
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when fitting ASL signal curves for both aCBV and CBF quantification on 
hyperoxia. 
No significant change in aCBV was found on hyperoxia, in agreement with the 
MBF results of Section 4.4.1. The results presented in Section 4.4 have important 
implications for calibrated BOLD measurements using hyperoxia [8, 135, 192], 
and the more recent combined O2 and CO2 calibrated BOLD methods [10, 141]. 
The results imply that isocapnic hyperoxia based methods of BOLD calibration 
need not be corrected for changes in baseline CBF or CBV [8]. Hyperoxia can 
also be used to investigate vascular function and structure, as highlighted by its 
recent use in venous CBV estimations [169] and vessel size imaging [193], 
techniques for which the lack of any change in blood flow on  hyperoxia is 
important.  
4.4.3 Effect of isocapnic hyperoxia on CMRO2 
 
The effect of hyperoxia on neuronal activity has previously been studied using 
electrophysiology. Using electroencephalography (EEG) to assess the effect of 
35% O2 on cognitive performance and brain activity, a reduction in beta and 
gamma power, increase in delta power and reduction in alpha power was observed 
[194]. However, others [195-197] found no significant effect of a change in blood 
oxygenation level on electrophysiology signals. Unfortunately, to date, these 
studies have either employed scalp level electric field measures with limited spatial 
resolution,  or very focal invasive electrode recordings (rat whisker studies [195]). 
Section 4.4.3 presents data collected with magnetoencephalography which 
provides a non-invasive method of spatially resolving the electrophysiological 
effects of hyperoxia across cortical grey matter. 
4.4.3.1. Experiment protocol 
 
Nine subjects (23-30 years, 4 female) participated and gave prior informed written 
consent. Prior to the MEG measurements, subjects sat upright on the scanner bed 
connect to the RespirAct circuit, whilst baseline metabolic values were estimated 
and targeted. The respiratory paradigm involved 1 minute of baseline followed by 
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2 cycles of 5 minutes of isocapnic hyperoxia (PETO2 = 500mmHg, VXEMHFW·V
resting PETCO2) separated by 5 minutes of baseline with a final 1 minute of 
baseline (Figure 4-8). The duration of the respiratory challenge was 21 minutes, 
including transitions.  
 
Figure 4-8) Targeted respiratory paradigm: 2 cycles of isocapnic hyperoxia 
(PETO2=500 mmHg), PETCO2 targeted at subject-specific baseline 
throughout.  
MEG data were acquired using a 275-channel CTF MEG system (MISL, Port 
Coquitlam, BC, Canada), at a rate of 600 Hz, with a 150 Hz anti-aliasing hardware 
filter and with synthetic third order gradiometer interference suppression. Subjects 
were instructed to lie supine on the MEG bed and to fixate their eyes on a dot 
presented on a screen located around 40 cm in front of them. For head 
localisation, three electromagnetic coils were placed on the head (nasion, left 
SUHDXULFXODU DQG ULJKW SUHDXULFXODU WKHSRVLWLRQRI WKHVH FRLOV RQ WKH VXEMHFW·V
head were measured using a 3D digitiser (Polhemus isotrack). These coils were 
energised to locate the position of the subjeFW·VKHDGZLWKLQWKH0(*KHOPHW. An 
MPRAGE structural scan was acquired using a Philips Achieva 3 T MR scanner. 
Imaging acquisition parameters were TI/TE/TR = 960/3.9/8.3 ms, FOV = 256 
x 256 x 160 mm, 1 mm3 isotropic resolution, FA = 8q, SENSE acceleration factor 
= 3. The locations of the fiducial markers and MEG sensors with respect to the 
brain anatomy were determined by matching the digitised head surface to the 
head surface extracted from the structural MRI.  
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MEG data were processed using the method previously described to study the 
effect of hypercapnia on electrophysiological signals [130]. First 4 
dimensional/volumetric maps of the timecourse of the change in electrical 
oscillatory amplitude for the theta (4 ² 8 Hz), alpha (8 ² 13 Hz), beta (13 ² 30 Hz) 
and low gamma (30 ² 50 Hz) bands, were derived using the beamformer approach 
on a 5 mm grid [198-204] spanning the whole brain. For all voxels and frequency 
bands, the difference in the mean amplitude envelope between the hyperoxia and 
normoxia time windows (discarding transition periods) was computed and 
normalised by the normoxic value. Statistical significance in the difference 
between normoxia and hyperoxia was assessed using a Monte Carlo technique 
[205-207] LQ ZKLFK  ¶IDNH· SVHXGR-T statistical images were calculated with 
active and control windows randomly switched. Voxels were conservatively 
identified as having statistically significant changes if they fell in the upper 5th 
percentile of T-values computed in the randomised images. 
Regions of interest were probed further in finer frequency bands using local 
beamformer estimates of neural oscillatory amplitude; the 17 frequency bands 
used were: 1 ² 4 Hz, 2 ² 6 Hz, 4 ² 8 Hz, 6 ² 10 Hz, 8 ² 13 Hz, 10 ² 15 Hz, 13 ² 
20 Hz, 15 ² 25 Hz, 20 ² 30 Hz, 25 ² 35 Hz, 30 ² 40 Hz, 35 ² 45 Hz, 40 ² 50 Hz, 
45 ² 55 Hz, 50 ² 60 Hz, 55 ² 65 Hz and 60 ² 80 Hz. Since no prominent areas of 
oscillatory amplitude change were observed on the initial beamformer images, we 
chose to probe three brain locations in which changes had been previously 
observed for hypercapnia; the occipital lobe (MNI [-8 -80 -6] mm), the right 
motor cortex (MNI [34 -24 54] mm) [130] and the medial frontal cortex (MNI [-2 
36 32] mm), an area associated with cognitive processing in working memory 
[207]. Hilbert envelopes for each frequency band were averaged across periods of 
hyperoxia and normoxia, and the resulting spectra averaged across subjects. 
Significant differences between hyperoxia and normoxia were tested using a non-
parametric Wilcoxon Signed Rank test with Bonferroni correction for multiple 
comparisons.  
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4.4.3.2. Results 
 
The mean hyperoxic step was 471 ± 13 mmHg, with a baseline of 116 ± 3 mmHg 
averaged across subjects, while PETCO2 varied by less than 1 mmHg. There was 
no significant change in breathing rate (Pearson correlation, p = 0.49) or alpha 
band oscillatory amplitude (Pearson correlation, p = 0.23) across time, suggesting 
VXEMHFWV·DOHUWQHVVGLGQRWGLPLQLVKZLWKWDVNGXUDWLRQ 
Hypercapnia data has been previously published by Hall et al. [130], and uses the 
same experimental paradigm (subjects focused on a fixation cross throughout). 
Figure 4-9A depicts group averaged maps of neural oscillatory amplitude in 
response to hyperoxia in the alpha, beta and gamma frequency bands and the 
equivalent hypercapnia images (in response to ƅ3ETCO2 = 6.7 ± 0.7 mmHg) [130] 
are also shown (Figure 4-9B).  
 
Figure 4-9) Group maps of the reduction in neural oscillatory amplitude in 
response to hyperoxia in the alpha (8-13 Hz), beta (13-30 Hz) and gamma 
(30-50 Hz) bands, (3-15 %). B) This is contrasted with a previously 
reported hypercapnic stimulus (3-15 %) [130] which produced a robust 
global desynchronisation, evident across all subjects, (3-15%). C) The 
regions where a hypercapnia induced change is greater than a hyperoxia 
induced change are shown in dark/light blue (0.5-7 %). Regions where a 
hyperoxia induced change is greater are shown in red/yellow (0.5-7 %).  
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Whereas hypercapnia elicited large scale, robust changes in MEG measured 
oscillatory amplitude, the equivalent changes observed using hyperoxia involve 
small focal areas of amplitude reduction, predominantly in occipital brain areas. 
Figure 4-9C shows the difference in oscillatory response between hypercapnia and 
hyperoxia, with a positive difference on hypercapnia shown in blue and hyperoxia 
in red. It should be noted that regions in red are predominantly in the cerebellum, 
spatial locations where the SNR of MEG is limited. Maps of change in the theta 
band (not shown) showed no robust changes for either hyperoxia or hypercapnia.  
Figure 4-10A-C show the spectral changes in neural oscillatory amplitude elicited 
by hyperoxia and hypercapnia [130] in three selected brain regions. Figure 4-10D-
F show the corresponding changes in amplitude across the alpha, beta and gamma 
band. As seen in Figure 4-9A, the most pronounced change occurred in the 
occipital lobe (MNI [-8 -80 -6] mm) across the alpha band (8-13 Hz) where a 
reduction of 0.5 ± 0.06 nAm was observed under hyperoxia. 
These figures allow the change in neuronal oscillations in response to isocapnic 
hyperoxia to be contrasted with previous results from an iso-oxic hypercapnic 
stimulus.  Previously reported hypercapnia data [130] produced a robust global 
desynchronisation, evident across all subjects. In the hyperoxic case, changes are 
smaller in magnitude and spatial extent, and are less robust across subjects. 
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Figure 4-10)  The reduction in neural oscillatory power (mean ± SEM) was 
interrogated across A) the motor cortex,  B) the occipital lobe and C) the 
medial frontal cortex (F) in response to hyperoxia (black) and hypercapnia 
(grey) (Hall et al. 2011).  D-F) This power change is further compared in 
the same regions across the alpha, beta and gamma band. * denotes where 
p < 0.05 (Wilcoxon Signed Rank test).  
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4.4.3.3. Discussion 
 
The results from this study show that hyperoxia produces a small focal change in 
spontaneous MEG signals. This is in contrast to previous findings of a global 
effect of greater amplitude on hypercapnia [130, 133]. Both of these findings 
could significantly impact on the fundamental assumptions regarding the 
isometabolic nature of hyperoxia and hypercapnia for calibrated BOLD, albeit to 
different extents. Although there is no causal link between neuronal oscillations 
and changes in CMRO2, it is believed that MEG signals are generated by 
synchronised, post-synaptic current flow in the dendrites of pyramidal neurons, 
and theoretical evidence [208] suggests that the majority of energy use in the brain 
is involved with similar post synaptic events. This suggests, albeit indirectly, that a 
change in the MEG signal is associated with energy demand. This has been 
supported by invasive studies in animals [209] and humans [210, 211], as well as 
non-invasive studies using MEG [124, 212-215] which suggest a relationship 
between task driven modulations of neural oscillations and the BOLD response. 
Furthermore recent evidence [216] shows that hypercapnia induces measurable, 
spatially-dependent changes in CMRO2 which are in good agreement with the 
electrophysiological oscillatory changes previously reported [130]. Therefore it 
seems unlikely that the observed changes in neural oscillations observed can occur 
without concomitant changes in cerebral energetics.  
The significant reduction in amplitude of low frequency neural oscillations in the 
occipital lobe in response to hyperoxia is consistent with the reduction in alpha 
power in previous EEG recordings [194]  and  may reflect an increase in vigilance 
with supplementary O2 [217]. Confounding effects due to patient discomfort and 
somatosensory activation are minimised, as hyperoxia is difficult to distinguish 
from medical air, as highlighted by its use in placebo-controlled trials [217-219]. 
The proposed role of hyperoxia on altered vigilance, task performance and 
cerebral metabolism needs further investigation, with particular emphasis on the 
dynamic relationship between these factors.   
As discussed, it is likely that the altered neural oscillatory processes induced by 
both hyperoxia and hypercapnia [130] will indeed impact on the assumption of 
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iso-metabolism made in BOLD calibration. However, the finding that isocapnic 
hyperoxia induces neural oscillatory changes that are smaller in magnitude, smaller 
in spatial extent and less robust across subjects compared to iso-oxic hypercapnia 
implies that isocapnic hyperoxia is a more appropriate stimulus than hypercapnia 
for calibrating the BOLD response [8]. This said, the small focal effect of 
hyperoxia on neural signals in the occipital lobe remains significant, suggesting 
that further investigation is required in order to determine if the observed change 
may lead to an under/overestimation of CMRO2 in these areas. The significant 
but differential effects of hyperoxia and hypercapnia on neural oscillatory 
processes may be of even greater importance to the more recent combined 
calibrated BOLD models [10, 141].  Further investigation would allow 
quantification of separate hyperoxia and hypercapnia CMRO2 error terms. 
4.5 Effect of isocapnic hyperoxia on functional 
hyperaemia 
 
The coupling of blood flow and neuronal activity is fundamental to the 
interpretation of haemodynamic responses. The cardinal study by Roy and 
Sherrington gave rise to the idea that increased neuronal activity coincides with an 
increase in local CBF [38] and gave rise to an entire research field. This evoked 
response is known as functional hyperaemia, and the mechanisms which govern it 
have been an area of great research interest for over 100 years. The mechanisms 
behind the coupling between neuronal activity and vascular changes are still 
poorly understood. Whilst a brief overview will be given here, the available 
physiological and biochemical data far surpasses the scope of this thesis. Here, the 
role of functional hyperaemia is considered within the context of oxygen delivery. 
This section first introduces the key proposed mechanisms and later presents 
results which address fundamental question, is the evoked CBF increase caused by 
decreased O2 concentration? 
At rest, the majority of baseline energy required for ATP turnover is from 
oxidation of glucose via the TCA cycle [220]. With the reported mismatch of 
CMRO2 and CBF increases in response to functional activation it was proposed 
that CMRO2 and CBF uncouple [53, 221]. However, Buxton and Frank [61] 
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proposed that rather than uncoupling, the much larger CBF increase is necessary 
to ensure the adequate delivery of O2. During activation, the coupling of CBF and 
CMRO2 is non-linear. The Oxygen Limitation Model (OLM) assumes that tissue 
pO2 is so low such that capillary pO2 determines the diffusion gradient and 
increased perfusion acts to increase delivery of oxygen to the tissue.  
The key assumption that tissue pO2 is close to zero (that CMRO2 cannot increase 
without a rise in CBF) has been challenged by experimental evidence. Whilst 
capillary pO2 has been found to be 40-50 mmHg [222], tissue O2 remains ~ 20-30 
mmHg [223-226]. Further research into the maintenance of tissue pO2 [225] 
proposed that the increase in CBF maintains pO2  in distal regions with low levels 
of pO2 and increases pO2 in regions with high levels of pO2. In essence, the 
hyperaemic response serves as an evolutionary safety mechanism to prevent 
dangerously low pO2 levels during transient activation-induced periods of hypoxia. 
It is not clear whether the depletion of O2 directly triggers the hyperaemic 
response. Mintun et al [227], assessed the effects of mild hypoxia [Fi02 = 0.12] on 
the evoked local CBF in response to a visual activation task using 15O PET and. 
results showed that the evoked response under visual activation was equivalent 
between normoxia and hypoxia. They concluded that the increase in CBF 
observed in response to functional activation is not driven by the need to match 
local O2 concentration to CMRO2. Paradoxical findings have been presented from 
the Akita Laboratory, Japan, where they have investigated the effect of 
supplementary O2 on evoked responses[228, 229]. It was demonstrated in 
anesthetised rats that the magnitude of the evoked local CBF (lCBF) response 
(due to hind paw electrical stimulation of 5Hz frequency) increased by 64-68% 
under 100% O2 inhalation as measured with laser Doppler flowmetry (LDF).[228, 
229]. They reported a similar effect in the human visual cortex [230], assessing 
amplitude and temporal dynamics of the BOLD response. On visual activation 
the hyperoxic BOLD response was 13% higher than normoxic conditions, which 
was supported by a reduced rise time (from 5.3 to 5.1 s), but this was not 
significant ( p = 0.06). Under 100% O2, the hyperoxic BOLD response at rest was 
found to be approximately 1.1% higher than under normoxia. Whilst the authors 
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propose the BOLD results support an increase in evoked CBF on hyperoxia, a 
lack of direct perfusion measurement limits the interpretation of the results.   
Roy and Sherrington hypothesised that neuronal activity is coupled to the evoked 
blood flow response via vasodilative by-products of metabolism [38]. It is 
plausible that other non-oxidative metabolic products regulate CBF. These could 
include (but are not limited to) adenosine [231, 232], nitric oxide [233] or 
arachidonic acid and associated derivatives [234-236]. However the involvement 
of these neurotransmitters could also play a feed-forward signalling role, whereby 
increase glutamatergic signalling results in vasodilation before CMRO 2 is 
necessarily required [237]. It has been proposed that a post-synaptic increase in 
calcium ion (Ca2+) plays a significant role in modulating the arachidonic acid 
pathways in astrocytes [238]. However, controversy exists over the temporal 
mismatch between Ca2+ dynamics, functional hyperaemia and the role of 
astrocytes (a non-neuronal cell which can detect synaptic activity [239]) in 
neurovascular coupling [237, 238, 240]. The inability to distinguish between 
common pathways held by feedback and feed-forward signalling further 
complicates this issue [238]. 
Previous research into the effects of O2 on functional hyperaemia have observed a 
concomitant change in baseline CBF [227-229]. The results in section 4.4.1 have 
confirmed that it is unlikely that O2 is an active vasoconstrictor, suggesting that 
observed changes in CBF on hyperoxia [152, 165, 172] reflect CO2 fluctuations. It 
is likely that an alteration in baseline state will impact on O 2 extraction and alter 
the functional response.  
The aim of the present study is to assess the effect of isocapnic hyperoxia on 
evoked CBF, where baseline CBF remains constant across conditions. Following 
the same principles as Matsuura et al. [229], it is hypothesised that if O2 
concentration serves as a trigger for functional hyperaemia, the evoked CBF 
response will be reduced under hyperoxia.  
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4.5.3.1. Experimental protocol 
 
The study was approved by the University of Nottingham Medical School Ethics 
Committee, twelve subjects (age 24-48 years, 4 female) participated and gave prior 
informed written consent. MR scanning was performed using a Philips Achieva 7 
T system with head volume transmit and 32 channel SENSE receive coil with 
foam padding used to reduce head motion.  
Prior to the MRI measurement, the subject sat upright on the scanner bed while 
baseline metabolic values were estimated and targeted. The hyperoxic challenge in 
this experiment involved 7 minutes of baseline, 7 minutes of isocapnic hyperoxia 
(PETO2  PP+J VXEMHFW·V UHVWLQJ3ETCO2), presented in a pseudo-random 
order, followed by a final minute of baseline normoxia.   
An initial functional localiser scan (GE-EPI, SENSE factor 2, 
TE/TR=25/3000ms, 2x2x3mm3 resolution, FOV=192x192x45mm3) was 
acquired to identify slices comprising the motor cortex via IViewBOLD (Philips, 
Best, Netherlands). During the localiser, subjects were required to perform a 5 
minute bilateral finger-tap task (30 s rest, 30 s tap).  At rest, a small white fixation 
cross on a black background was projected on a screen at the end of  the magnet 
bore, ZLWKWKHDFWLYHFRQGLWLRQFXHGE\DODUJHUHG´7$3µRQDEODFNEDFNJURXQG
Subjects wore prism glasses throughout in order to view the screen.  
The main functional task consisted of  a bilateral finger-tap (30 s tap, 30 s rest) 
repeated throughout the respiratory challenge (Figure 4-11). A LL-FAIR 
(multiphase) ASL scheme (selective and non-selective imaging volumes of  45 and 
250 mm respectively) with in-plane saturation was used to measure CBF. 
Acquisition parameters were FA = 35°, TI/TA/TR=200/300/3000 ms and 8 
readout phases per TR. Vascular crushing was applied using a bipolar gradient of 
10 ms duration with vENC = 50 mms
-1. Images were acquired using a GE-EPI 
readout; 5 contiguous slices per TR, 2x2x3 mm3, FOV = 192x192x45 mm3, TE = 
25 ms (minimum due to applying vascular crushing), SENSE factor 2. A 90° pulse 
was applied to the final phase to increase the BOLD weighting. This allowed the 
simultaneous measure of  CBF and BOLD on normoxia and hyperoxia in 
101 
 
response to a functional challenge (Figure 4-11B and C). Inversion recovery (IR) 
data were acquired across 10 inversion times (100-2500ms) for T1 mapping, from 
which to create a GM mask defined as those voxHOVZLWK71V 
 
 
Figure 4-11) A) Schematic of the respiratory and functional paradigm. The 
normoxic (white) and hyperoxic (light grey) stimuli both lasted for 7 
minutes, with 1 minute transition periods to and following hyperoxia (dark 
grey).  Stimuli were presented in a pseudo-random order, with one minute 
baseline period presented at the end or start of the sequence depending on 
whether normoxia was presented first or second respectively. The subject 
was required to perform a bilateral finger-tap of 30 s rest/tap cycles 
throughout the respiratory challenge. B) Schematic of Look-Locker-EPI 
ASL (LL-EPI ASL) control signal (TI/TA = 200/300 ms, 8 readouts) as a 
function of  post-label delay (TI). A 90° RF pulse applied at the final TI 
increases the BOLD weighting. The perfusion-weighted difference signal 
is shown in C), phases 4-6 (TIs 1100 ms - 1700 ms) provide maximal 
perfusion weighting and are used in the GLM analysis.    
 
102 
 
4.5.3.2. Data Analysis 
 
Label and control images were subtracted to produce perfusion weighted 
difference image for each readout phase, with an effective temporal resolution of 
6 seconds. Perfusion weighted images were visually inspected for motion artefacts 
PRVW HDVLO\ LGHQWLILHGE\ ´ULQJLQJµRI H[WUHPHO\KLJKRU ORZ VLJQDO Lntensity in 
these difference images) and 1 subject with severe motion artefacts were discarded. 
To increase the contrast-to-noise ratio, the perfusion-weighted (PW) difference 
images from phases 4-6 were averaged to form a single PW image on which GLM 
analysis could be performed. Phases 4-6 7,·VPV² 1700 ms) were selected 
as they represent time points where there should be a large PW signal difference 
between rest and activation. Data were smoothed with a 5 mm FWHM Gaussian 
kernel and a temporal filter with 120 s cut-off was applied (twice the length of a 
single rest/activation trial). Maps of  statistical significance of  the CBF response 
to the motor task were formed using GLM analysis in FEAT (FSL, FMRIB). The 
resulting activation maps were converted to binary masks (where Z > 2.3 and p 
<0.05) in MATLAB. The CBF ROI was used for both CBF and BOLD analysis. 
Close agreement is observed between the perfusion and BOLD activation maps, 
shown for an example subject in Figure 4-12. However, CBF activation is limited 
to the primary motor cortex, rather than additional supplementary motor area 
activation. 
 
Figure 4-12) Motor cortex activation maps from GLM analysis for a 
representative subject. The CBF response (red) shows a smaller spatial 
extent than the BOLD response (blue), there is close agreement between 
the two ROIs. 
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The motor ROI identified from the GLM analysis was multiplied by the GM 
mask to ensure that it included only GM voxels within the motor cortex, to 
prevent confounds from white matter voxels (where perfusion values are expected 
to be lower). To assess baseline perfusion, a baseline GM mask was created by 
subtracting the motor GM ROI from the full GM mask (Figure 4-13). LL-FAIR 
datasets (for the motor ROI), were divided into active and rest conditions at both 
normoxia (NO) and hyperoxia (HO). The GM ROI and baseline GM ROI were 
interrogated for all conditions. Data across transition periods was discarded. Data 
were averaged within an ROI to obtain a perfusion-weighted signal time-course 
across the 8 readout phases for each of  the four conditions (NO-rest, NO-tap, 
HO-rest, HO-tap). Normoxic M0 was estimated from the T1 map according to the 
equation S(t) = M0(A ² e(-t/B)) using a least squares fit and accounting for the 
successive flip angles. The change in T2
* induced by motor activation and 
hyperoxia LQ WKH ¶0RWRU 52,· was calculated from phase 8 of  the LL-control 
BOLD, and this modulation was used to scale M0 for hyperoxia and activation [67]. 
The timecourses were normalised by the respective M0 values and using the 
kinetic model of  Francis et al. [99], the normalised time courses were fitted for 
CBF, transit time (ƅaDQGH[FKDQJHWLPHƤZKHUHWLVVXHDUULYDOWLPH, ƅtissue, can 
be estimated from ƅa Ƥ The T1 of  blood was assumed to be 2.2 s at NO [186, 
187] and 2.0 s at HO [7,8], whilst the T1
 
of  grey matter (GM) was assumed to be 
constant at 2.0 ms.  
 
 
Figure 4-13) A ¶baseline grey matter (GM) mask· was created on an 
individual subject basis by subtracting the ¶motor ROI· from the ¶GM 52,·.   
The 90° flip angle used for the last readout phase provided sufficient sensitivity to 
assess BOLD weighting in the label and control data. The average BOLD signal 
was measured within the CBF motor ROI for normoxic and hyperoxic periods 
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(with transitions discarded) for tap and rest conditions. The percentage BOLD 
signal change was measured between the tap and rest conditions for normoxia and 
hyperoxia. Statistical significance of  changes was assessed with a non-parametric 
Wilcoxon Signed Rank test (SPSS 16, Chicago, IL, USA).  
4.5.3.3. Results 
 
 On hyperoxia PETO2 increased by 359 ± 14 mmHg (mean ± SEM across 11 
subjects) from a baseline of  118 ± 5 mmHg. PETCO2 varied by less than 1.5 
mmHg. Figure 4-14A shows example CBF weighted images overlaid with a CBF 
statistical activation map to finger tapping, all subjects showed robust activation 
of the motor cortex in response to the task. Example perfusion time courses from 
the motor ROI are shown for each condition in Figure 4-14B.  
 
Figure 4-14) A) Example CBF-weighted images for each label delay (in ms) 
overlaid with active regions defining the motor ROI as produced in FEAT 
(FSL, FMRIB). B) LL-EPI FAIR timecourses across the 8 readout phases 
for normoxia (NO, grey) and hyperoxia (HO, black) IURPWKH¶0RWRU52,·. 
The rest condition is depicted by a solid line and the tap condition by a 
broken line.  
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Table 4-4 shows the absolute and relative CBF and ƅtissue in the ¶0otor ROI· for 
normoxic and hyperoxic conditions. Hyperoxia had no significant effect on CBF 
or ƅtissue at rest (Figure 4-15) or under motor activation (Figure 4-16). For both 
normoxia and isocapnic hyperoxia a significant increase in CBF and reduction in 
ƅtissue in response to the motor task was seen (p < 0.05, Wilcoxon Signed Rank 
test).  
 CBF 
 (ml/min/100g)  
Tissue Arrival 
Time (ms)  
 
Normoxia  
 Rest  64.4 ± 5.6  581.5 ± 105  
Tap  101.0 ± 11.6  417.8 ± 64.5  
Evoked response 
(%)  
64.0 ± 11.1  -23.5 ± 5.8  
 
 
Hyperoxia  
 Rest  54.9 ± 5.2  566.7 ± 78.5  
Tap  82.0 ± 8.9  453.1 ± 72.2  
Evoked response 
(%)  
55.5 ± 15.7  -17.8 ± 6.9  
Table 4-4) Absolute CBF (ml/min/100g), tissue arrival time (ƅtissue, ms) 
IURP WKH ¶0RWRU 52,· IRU WKH WDS DQG UHVW FRQGLWLRQ DQG &%) HYRNHG
responses to the fingertap (% change) under both normoxia and isocapnic 
hyperoxia.  
In WKH ¶%DVHOLQH GM 52,·, resting state perfusion was found to be 57 ± 5 
ml/min/100g under normoxia, and 54 ± 5 ml/min/100g under hyperoxia (Figure 
4-15Bii). Tissue arrival time was found to be 441± 36 ms under normoxia and 423 
± 47 ms under hyperoxia (Figure 4-15Bi). There were no significant differences in 
baseline GM CBF or ƅtissue, between normoxia and hyperoxia.  
The resting BOLD signal increased by 2.1 ± 0.4% going from normoxia to 
hyperoxia (p < 0.001). The BOLD response to the motor task was found to be 10 
± 7 % higher under hyperoxia (Figure 4-16B), however the increase was not 
significant (p = 0.25, Wilcoxon Signed Rank Test).  
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Figure 4-15) Absolute measurements for rest and tap conditions under 
normoxia (pale grey) and isocapnic hyperoxia (dark grey) IURPWKH¶0RWRU
R2,·. A) i) CBF from the motor ROI and ii) Absolute tissue arrival time 
ƅtissue). B) i) Measurements for the ¶%DVHOLQH GM ROI· L &%)DQG ii) 
Resting-VWDWH ƅtissue. Hyperoxic results did not differ significantly from 
normoxic results in either condition or ROI (Wilcoxon Signed Rank test).  
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Figure 4-16) Percentage change in A) CBF  and B) BOLD signal in the 
¶0RWRU52,· in response to motor activation during normoxia (blue) and 
hyperoxia (red) averaged across subjects. Individual changes are shown for 
C) CBF and D) BOLD signal.  
4.5.3.4. Discussion 
 
Here, the role of O2 in modulating the hyperaemic response was investigated 
using an isocapnic hyperoxic stimulus. If the hyperaemic response is triggered by 
the depletion of O2, the delivery of supplementary O2 would be expected to 
modulate this. Previous research in both animals [228, 229, 241] and humans [230]  
has found a paradoxical increase in local CBF in response to functional activation 
under hyperoxia. The results presented show no significant change in task-evoked 
CBF or BOLD signal under hyperoxia, with a trend for CBF change to be 
reduced. They support the notion that functional hyperaemia is not triggered by a 
reduction in O2. From these findings, it was concluded that the evoked response 
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was independent of metabolic demand but that O2 may interact with the pathways 
which regulate changes in local CBF.  
This study differs from previous research in that baseline CBF was not allowed to 
significantly fluctuate under O2 modulation (in agreement with PC-MRA 
measurements of mean blood flow under isocapnic hyperoxia presented in 
Section 4.4.1). Under hypoxia, a global increase in CBF has been reported [227], 
whilst under hyperoxia, a reduction has been reported [228-230, 241]. When 
modulating O2, it may not be sufficient to normalise the evoked response by the 
stimulus-specific baseline as it is possible that OEF will be augmented. This was 
highlighted in the recent study of Tajima et al. [241] who used the Hyder model 
[242] to explain the increased evoked local CBF response. The Hyder model 
amends  the OLM [61], allowing O2 diffusivity (D) to vary with O2 tension and 
CBF. It relates OEF to O2 diffusivity (D) and CBF, according to Equation 4-7 
and in turn relates CBF to CMRO2 (Equation 4-8). 
CBFDeOEF /1                                4-7 
)1.(. /2 CBFDeCaCBFCMRO                    4-8 
Here diffusivity is considered proportional to both CBF and capillary blood 
volume [242]. Tajima et al. [241] report a constriction of capillaries, as such 
assuming reduced  O2 diffusivity under hyperoxia. Under this assumption, a larger 
CBF increase would be needed to support an equivalent CMRO 2 change under 
normoxic functional activation. However, the experimental results in this chapter 
(here using ASL to assess CBF, in Section 4.4.1 using PC-MRA to assess MBF 
and Section 4.4.2 using ASL to assess aCBV) have demonstrated that isocapnic 
hyperoxia does not  have vasoconstrictive properties. It is perhaps more likely that 
the reduction measured in response to 100% O2 reflects the vasoconstrictive 
properties of induced hypocapnia.  
Over recent years, there has been a shift away from the original idea that CBF and 
CMRO2 are modulated by a single process. The present results provide support 
DJDLQVW WKH WKHRU\ RI ´R[\JHQ OLPLWDWLRQµ %X[WRQ KDV LQVWHDG SURSRVHG D
dichotomous interpretation of CBF/CMRO2 coupling; independent 
109 
 
haemodynamic and metabolic responses working in parallel [243]. This raises the 
fundamental question of which aspects of neural activity drive changes in 
perfusion and which drive metabolism. This question remains unanswered, 
leaving a potential for future research.  
The effect of hyperoxia on the BOLD response was smaller than might be 
expected. A previous study by this research group reported an increase in baseline 
BOLD signal of 6.7 ± 0.8 % (B0 = 7 T, TE = 25 ms) in response to an equivalent 
increase in PETO2 [244]. In contrast, the observed change is more line with results 
observed in response to 100 % O2, where a change of 1.1 % has been observed in 
humans [230] and 1.7 % in anesthetised rats [245]. Similarly, an evoked change in 
BOLD signal of less than 3 % in response to a motor task was observed for both 
normoxia and hyperoxia conditions, which whilst significant, was less than the 
expected value closer to 5 % at 7 T. The differences may have arisen from the use 
of a different functional paradigm (where 2 x three minute blocks of hyperoxia 
were used in [244] ) or ROI definition (the intersection between CBF and BOLD 
52,·VZHUHXVHGWRIRUPD¶FRPELQHG52,· in [244]).  
The reduced BOLD sensitivity to isocapnic hyperoxia could perhaps be explained 
by the use of a combined ASL/BOLD measurement. Here BOLD is assessed by 
increasing the flip angle of the final readout phase of the LL readout from 35° to 
90° to yield BOLD weighting. However, the baseline BOLD signal is limited by 
the recovery time between readout phases (TA). In Chapter 6, a modified LL-EPI 
FAIR sequence will be presented, which increases the recovery time before the 
final readout phase in order to increase BOLD sensitivity whilst obtaining good 
CBF and transit time sensitivity.  
Whilst ASL depends on longitudinal relaxation, the detrimental contribution of a 
change in T2
* on activation, particularly at ultra-high field, has been highlighted in 
the literature [67, 88, 246, 247].  The observed increase in BOLD signal in 
response to hyperoxia and motor activation reflects a change in T2
*, therefore, 
here, the contribution of T2
* to the ASL signal was accounted for when estimating 
M0 [67]. Failure to account for an increase in M0 (due to increased T2
*) would 
likely lead to an overestimation of perfusion on activation. At normoxia, failure to 
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account for a change in T2
* increased the measured task-evoked CBF under both 
normoxia and hyperoxia ERWKUHODWLYHWREDVHOLQHQRUPR[LDIRUWKH¶PRWRU52,· 
(Figure 4-17). However these changes were not significant (p = 0.08 and 0.43 
respectively, Wilcoxon Signed Rank test). Future work could also extend the T2
* 
correction to account for the gradient in oxygenation (and so T2
*) between the 
venous and arterial sides of the capillary network [88]. By incorporating a more 
dynamic measure of T2
*, this would increase the sensitivity to detecting changes in 
perfusion between rest and activation.  
 
Figure 4-17) Failure to correct for a change in T2
* (pale grey) led to an 
increase in the task evoked CBF under both normoxia and hyperoxia when 
compared to the corrected measure of CBF (dark grey). These change were 
not significant (Wilcoxon Signed Rank Test). Data areaveraged across 
subjects (± SEM).  
Owing to the complex biochemical pathways under investigation, much of the 
research to-date has been performed in-vitro or using in-vivo animal models. This 
study has used isocapnic hyperoxia in awake volunteers to remove some of the 
confounds of earlier work, such as fluctuating CO2, baseline CBF or neuronal 
activity. As such, these results support the theory that a change in O2 
concentration is not responsible for the evoked CBF response. Whilst researchers 
have discussed the relative merits of the metabolic and neurogenic hypotheses, 
given the breadth of research to date and the lack of definitive answers, it is likely 
to be an interaction of biochemical pathways.  
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4.6 Conclusion 
The results presented in this chapter have investigated the effect of isocapnic 
hyperoxia on neurophysiology both at rest and under activation. It was shown 
using PC-MRA and LL-EPI FAIR ASL that isocapnic hyperoxia does not have a 
vasoconstrictive effect on mean blood flow in the ICA or arterial CBV, 
supporting the use of isocapnic hyperoxia as a stimulus in calibrated BOLD. 
Isocapnic hyperoxia was found to have a significant impact on neuronal 
oscillations in the occipital lobe, most likely attributed to a change in subject 
vigilance under hyperoxia. However, the measured changes are smaller than 
previous changes observed under hypercapnia [130]. These results suggest that 
hyperoxia is a more reliable stimulus than hypercapnia for calibrated BOLD. After 
establishing that isocapnic hyperoxia did not have significant vasoconstrictive 
effects, the role of oxygen in functional hyperaemia was assessed using LL-EPI 
FAIR ASL. Whilst previous studies have reported in an increased evoked CBF 
response under 100 % O2 [228, 229, 241], here no significant change in evoked 
CBF was found between normoxia and isocapnic hyperoxia. These findings 
suggest that the task-evoked CBF increase is not caused by a decreased O 2 
concentration.  
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5 Dependence of R2
* on 
oxygenation across field strength 
 
5.1 Outline 
 
Chapter 3 introduced the physiological and biophysical origins of the BOLD 
signal. This chapter further investigates the biophysical dependence of the 
apparent transverse relaxation (R2
*) on fractional oxygenation changes. In simple 
terms, R2
*=A.CBV[dHb]Ƣ [7], where A is a constant, CBV is cerebral blood 
volume and ƢLVWKHSRZHUODZUHODWLQJFRQFHQWUDWLRQRIGHRxyhaemoglobin (dHb) 
to R2
*ƢKDVWUDGLWLRQDOO\EHHQSUHGLFWHGIURPVLPXODWLRQVDQGPRGHOV [139, 248, 
249] and more recently, experimental measures have been published [9, 250-252]. 
However, while theoretical values do not fully account for intravascular signal 
contributions, experimental values to date are subject to concomitant changes in 
CBV, both of which will bias results. 
This chapter first introduces the basic theory underlying models of R2
* and then 
GLVFXVVHVWKHRUHWLFDODQGH[SHULPHQWDOYDOXHVRIƢLQWKHOLWHUDWXUH)LQDOO\DQRYHO
PHWKRG RI H[SHULPHQWDOO\ PHDVXULQJ ƢZLWKout confounding changes in CBV, 
will be presented and evaluated.  
5.2 Introduction 
 
The transverse signal relaxation rate (R2
*, where R2
* = 1/T2
*), from which the 
BOLD signal arises from a change in this parameter, has both intravascular (IV) 
and extravascular (EV) signal contributions. Whilst the EV signal has been well 
characterised by numerical simulations [139, 248] and analytical models [249], the 
IV component was initially neglected, due to the limited space occupied by blood 
vessels. Intravascular R2
* (R2
*
IV) is more commonly measured through in-vitro 
experiments [20, 253]. 
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5.2.1 Extravascular Signal  
 
Extravascular R2
* (R2*EV) depends on the spatial distribution of 
deoxyhaemoglobin (dHb) within blood vessels in a given voxel, the diffusion of 
water protons through the resulting field gradients surrounding blood vessels, as 
well as the underlying R2
*. R2
*
EV  has been extensively modelled [E.g. 139, 248, 249, 
254, 255],  and whilst some models considered blood vessels as spherical 
perturbers [254, 256], the idea of a blood vessel as an infinite cylinder is more 
physiologically  plausible [E.g. 139, 248, 249].  
Figure 5-1 shows the basic concept of the infinite cylinder model, where it 
generally assumes a voxel contains a series of randomly oriented vessels which 
each contain dHb and occupy a volume fraction f.  
 
Figure 5-1) The concept of modelling a blood vessel as a magnetised 
infinite cylinder embedded in a medium where their susceptibilities differ 
underlies many BOLD models which assume a voxel containing a series of 
randomly oriented vessels[E.g. 139, 248, 249]. The cylinder (with radius rb) 
LV RULHQWHG DW DQJOH ƨ IURP the applied B0 field and the proton position 
defined by vector 
o
r , which is at an angle Κ to the component of B0 in the 
normal plane.  
If a blood vessel exists in a tissue medium with a magnetic susceptibility 
GLIIHUHQFHRIƅƷEHWZHHQEORRGDQGPHGLXPWKHQWKHYHVVHOPDJQHWLFILHOGZLOO
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be perturbed around the vessel. This perturbation will lead to a dephasing of 
protons and so a decay of signal. Ogawa et al. [248] and Weisskoff et al [48] 
showed that the nuclear processional frequency of spins (ƅƹ) in an inhomogenous 
field can be characterised by Equation 5-1. It can be seen that the ƅƹdepends on 
WKH VXVFHSWLELOLW\ GLIIHUHQFH ƅƷ LQGXFHG E\ D FKDQJH LQ R[\JHQDWLRQ  -Yv) 
and/or magnetic field strength (B0), where Yv is the venous oxygenation fraction 
which is inversely proportional to the concentration of dHb in the blood.  
0).1.(..3
4
. BY' ' FSJZ                     5-1 
For a given vessel, the field gradient is proportional to the vessel radius and so the 
spin dephasing regime is dependent on the vessel size. If the diffusion path length 
(LD) is of the order of field perturbations, spins can sample all possible field values 
during the echo time (TE) and so experience diffusive dephasing (motional 
narrowing) (Figure 5-2A). If LD is smaller than the field perturbation (comparable 
to vessel radius), then static dephasing occurs (Figure 5-2B) where on average a 
near constant field is experienced by each spin leading to a near constant rate of 
dephasing between different spins and a linear relationship between R2· and 
intravascular frequency offset. The effects of diffusive dephasing are time-
dependent as the spin diffuses, various different field offsets are experienced and 
so dynamic averaging must be used, leading to a quadratic relationship between 
5·DQGHFKRWLPH[248], i.e. as the echo time increases, spins experience a larger 
range of field perturbations. The static and diffusive terms in R2
* are described by  
Equations 5-2 and 5-3 respectively [257],  
21
*
2 )( kfbkR LVLV ' Z ,                                                                               5-2 
2
2
1
*
2 )( kfbkR SVSV ' Z  ,                                                                            5-3 
where k1 and k2 DUHFRQVWDQWVƅƹLV the frequency offset between the surface of 
the blood vessel and tissue space, and bLV and bSV are the blood volumes for large 
and small vessel  respectively. 
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Figure 5-2) Static and diffusive (motional narrowing) averaging is 
dependent on the length of the diffusion pathway relative to the vessel 
radius (r) and hence the extent of field gradient . Figure adapted from [257].  
5.2.2 Intravascular Signal 
 
R2
* within a blood vessel (R2
*
 IV) can arise from either erythrocyte-plasma proton 
exchange or from diffusion of protons through field gradients local to 
erythrocytic membranes. It has been demonstrated in bovine blood that the 
diffusive effects are predominant [258]. The erythrocyte dimensions are very small 
in comparison to the diffusion pathway and so it is possible to average the 
intravascular dephasing effects dynamically, and thus it follows that there will be a 
quadratic dependence of R2
*
IV on frequency shift. 
 
In-vitro measures of human blood have achieved a large range of oxygenation 
values by bubbling 100% O2 through heparinised blood samples, and shown that 
whilst there is a quadratic dependence of R2
*
IV on fractional oxygenation, a linear 
approximation can be made across the limited range of oxygenation of 0.6-0.8 
expected from a functional response [20, 259]. In-vivo measurements of blood 
oxygenation are difficult to obtain, due to the long echo times required and effects 
of pulsatile flow. The TRUST technique [260] provides a measure of global 
venous oxygenation taken from the sagittal sinus. A CPMG T2 measurement is 
used in combination with ASL labelling to identify the venous blood and quantify 
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oxygenation from the estimated T2. However there are difficulties associated with 
isolating a pure blood voxel. 
 
It may be naive to neglect the IV signal contribution, as the field gradients 
established around each deoxygenated erythrocyte are much larger than 
extravascular gradients. This is due to the close proximity of the erythrocyte 
which houses the dHb to the protons in the plasma [261]. A greater field gradient 
results in an increased phase change and a larger change in IV signal between rest 
and activation in comparison to EV signal. It has been shown that at low field 
strengths, the intravascular transverse decay constant (T2
*
IV)  is over an order of 
magnitude larger than the extravascular T2
* (T2
*
EV) and so intravascular signal 
dominates despite occupying only a small voxel fraction [139, 248]. The IV signal 
component has been shown to account for 53-100% of the BOLD response at 
1.5 T and 23-60% at 3 T [262-264]. At high field however, the IV component is 
significantly reduced in comparison to the EV component [262, 265] due to the 
very short T2
* of blood [66], shown to be 4.3 ms at 7 T (in-vitro measure) [20]. 
In fMRI, it is the change in BOLD signal between rest and activation which is 
generally of interest. This change in signal is dependent on field strength, where 
vascular contribution to ƅ52* decreases with increased field strength. This leads to 
a change in the IV:EV signal ratio with field strength, such that at 7 T, the signal 
will be dominated by extravascular signal from the microvasculature. As both the 
IV and EV compartments will exhibit a degree of diffusive dephasing, both 
compartments (and the ratio between them) will also depend on TE, the time 
DYDLODEOHIRUVSLQVWRGHSKDVHDQGSKDVHRIIVHWVWRDFFXPXODWH6KRUWHU7(·VZLOO
increase the IV weighting as the signal will not yet have fully decayed. However, at 
ORQJHU7(·VVXFKDVWKRVHXVHGLQDVWDQGDUGI05,H[SHULPHQWat 7 T there will 
be little signal arising from the IV compartment.  
5.2.3 ƅ52* dependence on fractional oxygenation  
 
The calibration of the BOLD fMRI signal was introduced in detail in Chapter 4 
and the physiological assumptions assessed. It is also necessary to assess the 
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biophysical parameter that is included in calibrated BOLD models [7, 8]; the 
SRZHU ODZ Ƣ ZKLFK UHODWHV ƅ52* to fractional venous oxygenation (1-Yv). It is 
wLGHO\DFFHSWHGWKDWƢ DW T and decreases with field strength, VRWKDWƢ
~1 at 7 T. These values were initially taken from the aforementioned Monte Carlo 
simulations [139, 248] and analytical models, which were based on the EV signal 
contribution (discussed below). 
,Q WKH(9FRPSDUWPHQW Ƣ LV GHWHUPLQHGE\ WKH LQWHUSOD\RI VWDWLFDQGGLIIXVLYH
GHSKDVLQJUHJLPHVVRWKDWƢ$V%0 increases, the vessel size limit where the 
transition is made from one regime to the other reduces, such that at high field 
strength, the limit where static dephasing occurs is reduced [254] and the majority 
of vessels are in tKHVWDWLFUHJLPHVXFKWKDWƢWHQGVWR [139, 248, 249]. The limit 
where static dephasing occurs will also depend on echo time, TE, as this 
determines the length of the diffusive pathway. This is the basis for the assumed 
YDOXHVRIƢLQFDOLEUDWHG%2/'PRGHOVDVGHVFULEHGDERYH 
5.2.4 Simulating signal perturbation  
 
7KHLQLWLDOYDOXHRIƢof 1.5 as used in the original Davis model [7] was based on 
Monte Carlo simulations by Boxerman et al [139] which investigated the 
relationship between tissue parameters, imaging parameters and susceptibility 
contrast. Their work expanded previous simulations of spherical perturbers [256] 
to magnetised cylinders. By including a network of magnetised cylinders, the 
model was more physiologically plausible than previous work based on a single 
cylinder [248] or four nearest neighbours [254].  
For an echo time of 60 ms,  (assumed typical of clinical applications at 1.5 T), a 
proton takes 50 random steps (in the xÙ  , yÙ  and zÙ  GLUHFWLRQV SHU ƅ7(  PV
ZLWKVWDQGDUGGHYLDWLRQ$ ¥'7(ZKHUH'LVWKHGLIIXVLRQFRHIILFLHQWIRU
cerebral cortex D = 1 x 10 -5 cm-2s-1 [266, 267]). At each proton position, the field 
perturbation of Bz is calculated by summing the intravascular and extravascular 
perturbations by each cylinder (assuming non-interacting fields). After repeating 
until t = TE, the phase accumulated by the nth proton (Κn) is calculated according 
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to tBt zn '' ' ..)( JI  and the resulting signal from Equation 5-4 as outlined in 
[256], 
¦
 
 
N
n
ti ne
N
tS
1
)(1)( I  .                                                                                          5-4 
The signal can then be converted to R2
*  using Equation 5-5 as in [248], 
TE
TESR )(ln*2
  .                                                                                              5-5 
By repeating simulations across a range of vascular concentrations of Gadolinium 
DTPA (Gd-DTPA), the concentration dependence of R2
* was established (Figure 
5-3). For the frequency shift induced by 0-1mM Gd-DTPA which approximates 
the BOLD contrast due to 60 % oxygenation at 1.5 T, the relationship is close to 
quadratic (power = 2.0), remaining supralinear (power > 1.0) for 1- mM Gd-
DTPA (equivalent to BOLD contrast due to 60 % oxygenation at 3 T).   
 
Figure 5-3) Derivative of log (relaxivity, R2
*) versus log([Gd-DTPA]) 
provides the power relationship between concentration of Gd-DTPA and 
ƅ52* (dashed line). Reproduced from Boxerman et al. [139] 
7KHQRWLRQWKDWƢWHQGVWRDWKLJKHUILHOGVWUHQJWKLVLQJRRGDJUHHPHQWZLWKWKH
DQDO\WLFDOH[SUHVVLRQIRUƅ52* by Yablonskiy et al [249]. This model is also based 
on a network of randomly oriented magnetic cylinders, which is then applied to 
the specific case of a blood vessel network.  
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7KH UHODWLRQVKLSEHWZHHQƅ52* DQGƅƹ LV OLPLWHG WR WKH VWDWLF GHSKDVLQJ UHJLPH
(where the signal decay time is much smaller than the time taken for a proton to 
GLIIXVHDGLVWDQFHHTXLYDOHQWWRWKHEORRGYHVVHOƴDDQGVRƅ52* estimations are 
accurate only for medium-ODUJHYHVVHOQHWZRUNVGXHWRLQFUHDVHGƴD) and/or high 
field strengths (where the signal decay time is shorter). Thus it is predicted that at 
1.5 7IRUVPDOOYHVVHOQHWZRUNVRQO\WKHXSSHUOLPLWRIƅ52* would be accurately 
estimated. Nonetheless, it is now known that large vessels dominate at lower field 
strength and so the static dephasing model may be more applicable at lower field 
strength than originally thought. However, as previously mentioned, failing to 
include the IV contribution in signal decay will have larger impact at lower field 
strengths [263, 268]. 
There have been attempts to experimentally test the models on which the 
DVVXPHG YDOXHV RI Ƣ DUH EDVHG HDFK WDNLQJ D VOLJKWO\ GLIIHUHQW DSSURDFK %\
repeating a motor task at 1.5, 3 and 7 T, Van der Zwaag et al. [250] used the 
change in field strengtKWRPRGXODWHƅƹILQGLQJDOLQHDUGHSHQGHQFHRIƅ52* on 
field strength. Similarly, the use of hypercapnia to measure BOLD 
cerebrovascular reactivity (CVR) at 3 and 7 T found a linear dependence on field 
strength [251]. Most recently, a combined hyperoxic and hypercapnic stimulus 
was used to directly measure the voxelwise dependence of R2
* on 
deoxyhaemoglobin concentration at 3 T [9]. Crucially, the validity of these studies 
LQ HVWLPDWLQJƢLV OLPLWHGE\ the concomitant changes in CBV, with an increase 
being observed either due to a hyperaemic response to a motor task [250] or due 
to vasodilation in response to hypercapnia [9, 251]. The role of CBV as a 
physiological parameter of the BOLD response was introduced in Section 3.3.1 
and Equations 5-2-5-3 VXJJHVW WKH OLQHDU GHSHQGHQFH RI ƅ52* on CBV. To 
DFFXUDWHO\ GHWHUPLQH Ƣ DV D WUXH ELRSK\VLFDO SDUDPHWHU LW LV WKXV QHFHVVDU\ WR
UHODWH ƅƹ WR ƅ52* without any accompanying physiological changes. Rossi et al 
[252] tackled this problem by using 100% O2 WR PRGXODWH ƅ52*. However, as 
discussed in Chapter 4, it is thought that CBV will be altered by the 
vasoconstrictive effects of induced hypocapnia which accompany inhalation of 
100% O2. 
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By use of a dynamic isocapnic hyperoxic stimulus, this study presents a novel way 
of measuring the relationship between R2
*and oxygenation without a change in 
CBV. Performing this experiment at 1.5, 3 and 7 T, we are able to investigate how 
this relationship changes across field strength.  
5.3 Experiment protocol 
 
This study was approved by The University of Nottingham ethics committee and 
subjects gave prior informed written consent. Six subjects (24-27 years, 3 female) 
were scanned at three field strengths (1.5, 3.0 and 7.0 Tesla Philips Achieva 
systems). The MRI systems were equipped with 8/32/32 channel receive coils 
respectively. 
5.3.1 Respiratory paradigm 
 
A feed-IRUZDUG ORZ JDV IORZ V\VWHP 5HVSLU$FW 7KRUQKLOO 5HVHDUFK ,QF
Toronto, Canada) and a sequential gas delivery (SGD) breathing circuit were used 
to target end-tidal PCO2 (PETCO2) and PO2 (PETO2) independently (Chapter 3.4, 
Slessarev et al., 2007). Prior to MR measurement, the subject lay supine on the 
scanner bed while baseline metabolic values were estimated and targeted. Whilst 
in the scanner, the subject received medical air until the respiratory challenge 
commenced.  
Three PLQXWHVRIEDVHOLQHQRUPR[LDGHILQHGDVHDFKVXEMHFW·VUHVWLQJ3ETO2 and 
PETCO2) was followed by a 4 minute linear increase in PETO2 to 500 mmHg (on 
average 8mmHg targeted increase in PETO2 with each breath), and a 4 minute 
linear decrease to baseline, which was maintained for 1 minute, giving a total 
paradigm duration of 12 minutes (Figure 5-4). PETCO2 was maintained at a subject 
specific baseline throughout. 
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Figure 5-4) Targeted respiratory paradigm: Graded hyperoxia (peak at 500 
mmHg O2). P
ET
CO
2
 targeted at subject-specific baseline throughout. 
5.3.2 Acquisition 
MR Signal was measured dynamics using a double echo gradient echo EPI 
sequence (SENSE=2.5, FA = 90°, TR=3 s) at two echo times (as shown in Table 
5-1) across 240 dynamics. 5 slices were imaged, positioned superior to the 
ventricles to provide good grey matter coverage. Images consisted of 2x2x3 mm3 
voxels, with a field of view of 212x188x60, 212x184x60 and 192x192x15 mm3 at 
1.5/3/7 T respectively. Inversion recovery EPI (IR-EPI) images were collected 
(with the same geometry as the DE-EPI data) at 10 post-label delays ranging from 
0.1-3 s, from which a grey matter mask was formed. Multi-HFKR(3,LPDJHV7(·V
ranging from 25-80 ms) were acquired from which to acquire a mask of large 
vessels.  
Field Strength (T)  TE
1 
(ms)  TE
2
 (ms)  
1.5  25  80
 
 
3  22  60
 
 
7  16
 
 47
 
 
Table 5-1) Double echo times (TE1 and TE2) for each field strength. 
5.3.3 Analysis 
Brain masks were created from the first echo time (TE1) GE-EPI images using 
the Brain Extraction Tool (BET, FSL) to remove any non-brain tissue from the 
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image (Figure 5-5A). IR-EPI images were fitted for M0Tissue, T1Tissue and inversion 
flip angle to form T1Tissue maps. These tissue maps were then thresholded to obtain 
grey matter (GM) masks (Figure 5-5B) Threshold values were 1800-2100 ms for 7 
T, 1450-1750 ms for 3 T and 1000-1300 ms for 1.5 T. IR-EPI images were 
acquired with the same geometry as DE-EPI data and so no further registration 
was required.  
After multiplying the DE-EPI images by both the brain and GM masks (Figure 
5-5C), visual inspection showed that it was likely that there was some remaining 
contribution from CSF and large blood vessels. After applying the GM and brain 
masks, remaining voxels were sorted in order of signal intensity and the top 3 % 
were removed in order to remove CSF contribution. To remove large blood 
vessels the bottom 3 % was removed. This resulted in two GM masks: total GM 
and masked GM (with CSF and large vessels removed). 
 
Figure 5-5) Grey-scale Images shown for a representative subject at 3 T.  A) 
Brain mask produced using the Brain Extraction Tool (BET, FSL) applied 
to the EPI collected at TE1 (22 ms). B) GM mask produced from 
thresholding the T1Tissue map obtained from fitting the IR-EPI data from 
1450 ² 1750 ms. C) EPI collected at TE1 (22 ms). D) EPI after being 
multiplied by the masks in (A) and (B). 
The simplified Bloch equation for transverse signal decay can be adapted to 
*
2/
12
TTEeSS '  to account for the dual echo acquisition. This can be rearranged 
to Equation 5-6,  
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where S1 and S2 denote the MR signal from TE1 and TE2 respectiveO\DQGƅ7( 
TE2 - TE1. Using Equation 5-6, R2
* maps were calculated on a voxel-wise basis for 
masked GM (i.e. minus CSF and large vessels). This was repeated for each subject 
at each field strength, using the DSSURSULDWHƅ7(0HDQEDVHOLQH52* was taken 
from the normoxic period and subtracted from each hyperoxic value of R2
* to 
REWDLQƅ52*.  
The arterial partial pressure of O2 can be inferred from PETO2 and using the 
method outlined in [8] this can be used to calculate the O2 saturation of arterial 
and venous blood (SaO2 and SvO2 respectively). O2 saturation reflects the 
proportion of heme sites which are bound to O2 and its relation to the partial 
pressure of O2 is described by the O2 dissociation curve. O2 dissociation is 
affected by temperature and pH, but for the general conditions of 310 K and 
blood pH of 7.4 it can be described by Equation 5-7 [269]: 
  ¸¸¹
·
¨¨©
§ 
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SaO  .                  5-7 
After determining PaO2 and SaO2, the arterial concentration of O2 (CaO2) can be 
calculated from Equation 5-8,  
   HI .]..[ 222 PaOSaOHbCaO  ,                                                                 5-8 
where Κ is the O2 carrying capacity of Hb (1.34 mlO2/gHb IRUKXPDQVDQGƥLVWKH
solubility coefficient of O2 (0.003 mlO2/(dlblood.mmHg). It is assumed that the 
concentration of Hb is 15 g/dlblood [8]. Unlike PaO2 and SaO2, which are unitless 
values, CaO2 is measured in mlO2/dl.  
Assuming a constant oxygen extraction fraction (OEF), the venous concentration 
of O2 (CvO2) can be calculated from Equation 5-9, where OEF was assumed to 
equal 0.4. This can be reformulated to correspond to venous O2, with the partial 
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pressure of venous O2 neglected as venous heme sites are unlikely to be saturated, 
thus no O2 will be dissolved in venous blood.   
 OEFCaOCaOCvO |222                                                                            5-9 
Using the calculated CvO2 the venous O2 saturation (SvO2) can be obtained by 
 22 ]..[ SvOHbCvO I . Since it is the venous oxygenation (henceforth termed Yv) 
ZKLFKSULPDULO\GHWHUPLQHVƅ52* (the BOLD contrast), it is this relationship which 
will be further investigated. 
Using the above method each PETO2 value was converted to Yv and the PETO2 
trace linearly interpolated so that it was sampled every 3 s, rather than on a breath-
by-breath basis, to be in line with the scanner acquisition. Yv was averaged across 
the normoxic period to obtain baseline venous oxygenation Y v0.  
To enable group averaging of the signal time courses, data bins were created to 
cover Yv values across the full theoretical range of 0.6-0.7, in steps of 0.025. R2
* 
data were binned and averaged accordingly.  
To investigate tKHHIIHFWRIILHOGVWUHQJWKRQWKHUHODWLRQVKLSEHWZHHQƅ52* and (1-
Yv), the data was fit to a DOLQHDUSDUDPHWHUOHDVWVTXDUHVILWƅ52* =A(1-Yv)+C) 
to provide the gradient A7RLQYHVWLJDWHƢWKHUHODWLRQVKLSEHWZHHQƅ52* and (1-
Yv), a nonlinear three parameter least squares fit was performed to the power law 
(   CYAR v  ' E1.*2  RQ DQ LQGLYLGXDO VXEMHFWV EDVLV Ƣ ZDV WKHQ DYHUDJHG
across subjects to obtain a mean value for each field strength.  
5.4 Results 
 
Three data sets were discarded, due to excessive noise in the R2
* time course 
(where the variance in R2
* masked the change observed in response to hyperoxia), 
so 6 subjects were analysed at 1.5 T, 4 subjects at 3 T and 5 subjects at 7 T.  Out 
of these, three subjects were scanned at all three field strengths.  
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 PETO2 (mmHg)  Interpolated venous Oxygenation (Yv)  
B0  (T) Baseline Peak Baseline Peak 
1.5 115.0 ± 3.4 481.8 ± 11.1 0.600 ± 0.001 0.670 ± 0.002 
3 108.5 ± 3.1 484.6 ± 9.2 0.600 ± 0.001 0.680 ± 0.001 
7 118.6 ± 1.8 490.2 ± 12.6 0.600 ± 0.001 0.670 ± 0.003 
Table 5-2) For each field strength (B0), the baseline and peak PETO2 values 
are given with the corresponding venous oxygenation (Y v) according to the 
interpolation method outlined in [8]. 
The average baseline and peak PETO2  for each field strength are shown in Table 5-
1, along with the corresponding interpolated Yv values. The maximum fluctuation 
in PETCO2 was 1.6 % and so was assumed to have minimal influence on R2
*. 
There was an inverse correspondence between Yv DQG ƅ52* as shown for a 
representative subject at 7 T in Figure 5-6. 
 
Figure 5-6) Interpolated venous oxygenation (Yv) time course (solid grey) 
from a representative subject with the accompanying LQGXFHG ƅ52* (s-1) 
response at 7 T overlaid (solid black). 
As expected, baseline (normoxic) R2
* increased significantly with field strength as 
shown in Table 5-3, (p<0.05, wilcoxon signed rank test). Figure 5-7 depicts the 
HIIHFW RID FKDQJH LQR[\JHQDWLRQRQƅ52* across field strength. The gradient of 
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ƅ52*/(1- Yv) was measured across field strength on an individual subject basis and 
then averaged (Table 5-3).  
 
 
Figure 5-7) The effect of altering venous oxygenation (Yv) on masked GM 
ƅ52* (s-1) is shown at 1.5 T (black circle), 3 T (white square) and 7 T (black 
triangle). Data arebinned and averaged across subjects. A nonlinear three 
SDUDPHWHU OHDVW VTXDUHV ILW VKRZHG WKDW IRUPDVNHG*0Ƣ   DFURVV DOO
field strengths (Table 5-4). There were no significant differences across 
field strength (Kruskall-Wallis one-way ANOVA).  
Removing large vessels had a significant effect on the gradient at 1.5 T (p <0.02, 
wilcoxon signed rank test), but not at 3 T or 7 T (Table 5-3). Whilst the gradient 
at 7 T was significantly steeper than the gradient at 1.5 T or 3 T (p =0.043, 
Kruskall-Wallis one-way ANOVA), no significant difference was observed 
between 1.5 T and 3 T. 
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 B0 (T) R2* (s -1) ǻ52*/(1-Yv) (s -1) 
Total GM 1.5 12.8 ± 0.2 4.3 ± 0.5 
3 19.5 ± 1.0 4.0 ± 0.3 
7 33.3 ± 0.7 13.0 ± 2.0 
Masked GM 1.5 12.7 ± 0.2 4.1 ± 0.4 
3 19.5 ± 0.5 3.9 ± 0.3 
7 33.2 ± 0.7 13.2 ± 2.0 
Table 5-3) Baseline R2
* (s-1) and WKHƅR2* /(1-Yv) gradient (assuming linear 
model), for total and masked GM (removing large vessels) grey matter (GM) 
across field strength. Data (mean ± SEM) has been binned and averaged 
across subjects.  
 
ȕ 
Subject 1.5 T 3 T 7 T 
1 0.4 Excluded 0.3 
2 1.0 Excluded -- 
3 0.7 0.6 1.3 
4 0.5 0.7 0.6 
5 0.6 0.9 0.4 
6 0.8 0.9 -- 
7 -- -- 0.9 
8 -- -- Excluded 
Mean (± SEM) 0.7 ± 0.1 0.8 ± 0.1 0.7 ± 0.2 
Table 5-4) 0HDVXUHGYDOXHVRIƢPHDQ6( for masked grey matter (GM) 
across field strength for individual subjects.  The dashed line (--) shows 
that a subject was not scanned at that particular field strength.  
Table 5-VKRZVWKHH[SHULPHQWDOPHDVXUHRIƢIURPILWWLQJWRWKHSRZHUODZIRU
masked GM) across subjects, where the average across subjects was <1 at all field 
strengths. There was no significant difference across field strengths (Kruskall -
Wallis one-way ANOVA)  
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5.5 Discussion 
5.5.4 0HDVXULQJƢDFURVVILHOGVWUHQJWK 
In this study the dependence oIƅ52*GM on fractional venous oxygenation (1-Yv) 
was assessed across three field strengths; 1.5, 3 and 7 T.  This was achieved using 
a graded hyperoxic paradigm which allowed multiple levels of oxygenation to be 
reached in a single short scan session. The GHSHQGHQFH RI ƅ52*GM on (1-Yv) 
SURYLGHG D PHDVXUHPHQW RI Ƣ DQ LPSRUWDQW SDUDPHWHU IRU FDOLEUDWLRQ RI WKH
BOLD signal to estimate CMRO2 ,PSRUWDQWO\ WKH PHDVXUHG YDOXHV RI Ƣ
presented here are not confounded by a change in CBV, as has been the case in 
previous studies where CBV has been altered by motor activation [250], the 
vasodilative effect of hypercapnia [9, 251] or non-isocapnic hyperoxia [252].  The 
GHSHQGHQFHRIƅ52*GM on (1-YvWKHILWWHGYDOXHRIƢ was found to be <1 at all 
field strengths and did not scale with field strength in the manner expected. This 
section addresses why this may be the case, and whether it may have implications 
RQXVLQJYDOXHVRIƢZKLFKDUHQRWH[SHULPHQWDOO\GHWHUPLQHG 
Equation 5-10 describes the dependence of the frequency shLIWƅƹRQ-Yv) and 
field strength (B0),  
)1.(..'.' 0 vYBk ' ' FJZ ,                               5-10 
ZKHUHN··LVDFRQVWDQWUHIOHFWLQJYHVVHOJHRPHWU\ƣLVWKHJ\URPDJQHWLFUDWLRDQG
ƅƷWKH change in PDJQHWLFVXVFHSWLELOLW\,WFDQEHVHHQWKDWƅƹLVOLQHDUO\
dependent on B0, tKHUHIRUHLQVLPSOHWHUPVƅƹZLOOLQGXFHDODUJHUFKDnge in R2* 
at higher field strength and so the R2
*/(1-Yv) is predicted to be steeper. The 
LPSDFWWKDWƅƹKDVRQ52* LVWKHUHODWLRQVKLSƢ. 
Baseline (normoxic) R2
* values shown in Figure 5-8 scaled linearly with field 
strength,  in agreement with other cross-field values reported in the literature [250, 
252], (Figure 5-8). The variance in R2
* at each field strength is most likely 
explained by the different acquisition sequences used (single and multi-echo), 
different methods of ROI selection and different methods of shimming employed 
in previous studies [250, 252].   
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Figure 5-8) Comparison of measured GM tissue R2
* (s-1) ( mean ± SEM, 
shown in red) with published GM values ([250] shown in black and [252] in 
grey).  
The JUDGLHQWRIƅ52*GM/(1-Yv) scaled with field strength between 7 T and 1.5/3 T 
did not scale with field strength. However, the gradient at 1.5 T was slightly 
steeper than 3 T, although this difference was not statistically significant. (Figure 
5-7 and Table 5-3). From the measured data, it was possible to use a 3 parameter 
OHDVWVTXDUHVILWWRTXDQWLI\Ƣ:KLOVWLWKDVEHFRPHZLGHO\DFFHSWHGWKDWƢ DW
1.5 T [7, 139], ~1.3 at 3 T [183, 270, 271] and 1 at 7 T [135, 139, 249], here it has 
EHHQ VKRZQ H[SHULPHQWDOO\ WKDW Ƣ LV OHVV WKDQ  DFURVV all field strengths. The 
results presented here do not agree with the predicted trend for the gradient to 
scale with B0 RUƢWREHFRQVWUDLQHGZLWKLQDOLQHDUDQGTXDGUDWLFUHJLPH 
The idea of a sub-linear regime for Ƣ has previously been proposed [272]. By 
suggesting the original meDQLQJRIƢEHUHOD[Hd so that it also captures the effect 
of CBV on activationDQRSWLPLVHGƢ ZDVVXJJHVWHGIRU T. It was further 
argued WKDW WKHSUHVHQW XVHRIƢ LQWKH'DYLVPRGHO [7] is an oversimplification 
and that the use of a single value per B0 cannot capture the complex dependence 
of R2
*  on physiological and imaging parameters. This argument is further 
supported by the modelling work of Martindale et al [273] who used a Monte 
Carlo simulation of IV and EV BOLD signal sources to develop a look-up table 
RIƢYDOXHVfor different values of B0 and TE. The following section will use these 
results in combination with IV literature values to investigate the separate 
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contributions of the IV and EV signal to the dependence of ƅR2* on a change in 
fractional oxygenation.  
5.5.5 Modelling the intravascular and extravascular signal 
 
7R IXOO\ XQGHUVWDQG Ƣ DQG WKH GHSHQGHQFH RI ƅR2* on a change in fractional 
oxygenation (1-Yv), it is necessary to consider both IV and EV signal 
contributions. However, thHDVVXPSWLRQWKDWƢ DW7DQGWHQGVWRDW
T is based on Monte Carlo and analytical models which do not account for the IV 
signal contribution. Furthermore, using the method presented above and real 
fMRI experiments, it is not possible to separate fully IV and EV compartments 
and this must be taken in to account. 
Whilst voxels containing large vessels were removed from the region of interest  in 
this study, it is important to note that an average GM voxel is still likely to contain 
some blood vesVHOVWKHFHUHEUDOEORRGYROXPHIUDFWLRQ¦7KH*0YR[HOV thus 
represent D FRPELQDWLRQ RI ,9 DQG (9 VLJQDO 7KHUHIRUH WKH Ƣ UHODWLRQVKLS
between fractional oxygenation (1-Yv DQG ƅ52*EV cannot be directly quantified 
from the given data. Since the BOLD data area combination of both IV and EV 
signal, DƢrelationship which reflects two compartments may be more informative 
for the calibration of the BOLD signal. As outlined in section 5.1.2, the ratio 
between tissue and blood compartments varies with field strength and echo time 
and this may explain the unexpected variation in the gradient of  (1-Yv) and GM 
ƅ52*  with field strength.  
As discussed in Section 5.2.2, the effect of a change in fractional oxygenation on 
the R2
* of blood (R2
*
IV) has been investigated in-vitro [20, 253]. Across a large range 
of susceptibility changes, IV R2
* has been shown to vary quadratically with Yv, but 
this can be viewed as a near-linear relationship across a typical physiological range 
of 0.6-0.8. Using the in-vitro measurements of R2
*
Blood  from [20], the linear 
relationship between R2
*
IV  and 1-Yv was estimated across the range of oxygenation 
achieved in this study (0.6-0.7) using a two parameter fit and converted to ƅ52*IV  
assuming Y0 = 0.6. Figure 5-9A shows the expected change in R2
*
IV in response to 
a graded change in fractional oxygenation. 
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The value of ƅ52*IV FDQ EH FRPELQHG ZLWK PHDVXUHG ƅ52* GM to simulate the 
change in ƅ52* EV as follows: 
Using the simplified solution to the Bloch equation for transverse relaxation, the 
measured signal can be written in a generalised form Svoxel, measured at time TEX, 
from the sum of the IV and EV contributions. It is necessary to assume a venous 
EORRGYROXPHIUDFWLRQ¦v) to model the contribution of signals: 
 EVXIVX RTEvRTEvvoxel efefMS *2*2 ..0 ).1(.   .                                  5-11 
This equation assumes that each compartment exhibits a monoexponential decay 
and there is no exchange between IV and EV compartments, which is justified in 
fMRI by the relatively long time water resides in the capillaries (~500ms [274]) in 
comparison to T2
* and TE. It is assumed that M0 is equal between tissue and 
blood and whilst tissue has a lower water content than blood, the commonly used 
scaling factor of 0.98 of spin density (where M0tissue = 0.98M0blood) [98] is unlikely 
to make a significant impact on the model. The ratio of signals collected at TE1 
and TE2 can be written as: 
EVIV
EVIV
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For substitution into Equation 5-6. Note this model ignores T1 effects which are 
likely to be neglibile. T1tissue is shorter than the T1blood which will lead to the IV 
signal being slightly suppressed relative to tissue for TR = 3s (as used in this 
study). However, spin density and T1 effects act in opposite directions and will 
approximately cancel each other out. 
Using the interpolated R2
*
IV values from [20] and measured signal R2
*
GM, Equation 
5-12 can be solved for R2
*
EV according to Equation 5-6 (Figure 5-9¦v is assumed 
to be 3 %; in keeping with a total blood volume fraction of 4.4 % [275], of which 
75 % is venous [189]. It can be seen from Figure 5-9 that by removing an 
assumed IV blood component from the measured GM signal to obtain a pure 
extravascular R2
*, results in gradients of R2
*/(1-Yv) which increase with field 
strength as initially expected. From Equation 5-12 it can be seen that when fitting 
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decay curves described by Equation 5-12 to a single exponent, the apparent R2
* 
will depend on the choice of TE, which in turn determines the IV/EV ratio. 
 
Figure 5-9A) Expected change in R
2
* in the intravascular (solid lines) and 
extravascular (dashed lines) compartments in response to a graded change 
in fractional venous oxygenation (1-Yv), for the echo times used in this 
study (Table 5-1) across field strengths. IV data has been linearly 
interpolated from [20] across the relevant range of Yv.  EV data has been 
modelled using Equation 5-12 and the group-averaged GM values and 
LQWHUSRODWHGƅ52* values from [20]. B) The data in (A) is shown magnified 
across a smaller range of ƅR2* (0-1 s-1) in order to better visualise the 
extravascular component. This EV component should be compared with 
WKHƅ52*GM shown in Figure 5-7.  
This approximate model assumes a linear dependence of R2
*
IV on (1-Yv) and 
assumes a linear relationship between R2
*
GM and (1-Yv), therefore the resulting 
dependence of estimated R2
*
EV on (1-Yv) is linear. The short T2
* of blood means 
that for the TEs used in this study (Table 5-1), the IV signal is much more 
sensitive to changes in fractional oxygenation than the EV signal (Figure 5-10), 
particularly at lower field strengths. In a simple 2 compartment model and these 
echo times, the EV signal will contribute more at high fractional oxygenation (low 
1-Yv) than at Yv0.  
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Figure 5-10) Intravascular (IV) and extravascular signal (EV) under 
normoxia (NO, where 1-Yv = 0.34 ) and hyperoxia (HO, where 1-Yv = 0.39) 
at each echo time (TE) across field strengths.  Data areaveraged across 
subjects. It can be seen that the signal change in response to hyperoxia is 
greater for the intravascular compartment for the echo times used in this 
study (Table 5-1). Normoxia and hyperoxia EV data overlaps on the small 
scale due to the small difference in signal. 
Figure 5-11 demonstrates the estimated dependence of the E signal fraction 
(using interpolated R2
* values from [20]) on fractional oxygenation for the echo 
times used in this study for each TE and field strength. If we now assume a 
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quadratic dependence of R2
*
IV on (1-Yv) and a linear dependence of R2
*
EV on (1-Yv) 
for the echo times used in this study, it can be seen that if the total signal becomes 
increasingly weighted towards the EV contribution as (1-Yv) increases, then the 
resulting dependence of R2
*
GM on (1-Yv) could be sub-linear.  
 
Figure 5-11) Relative extravascular signal contribution (SEV/Stotal) at each 
echo time (TE) as a function of fractional oxygenation (1-Yv). Solid lines 
denote the first echo time (TE1) and broken line the second echo time 
(TE2).  
As discussed in Section 5.2.2, the IV contribution is significantly less at higher 
field strengths and T2
*
IV much shorter, such that for TE2 of 47 ms at 7 T the 
intravascular signal is nearly fully attenuated. The IV signal fraction depends on 
TE, scaling linearly with fractional oxygenation irrespective of vessel size [276]. In 
order to further investigate the confounding effect of TE on the dependence of 
IV/EV ratio on fractional oxygenation, it would be useful in future work to 
increase the number of echoes in order to gain a more accurate measure of R2
*.   
The findings presented in this chapter agree with the notion that ƢUHOLHVRQWRR
many experimental factors (notably B0, IV/EV ratio, TE and CBV) for a single 
value at each B0 to be quoted in the calibration of the BOLD response. 
Nonetheless, for the current experimental protocol a sublinear dependence of 
R2
*
GM on (1-Yv) was found across all field strengths. It is thought that this can be 
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attributed to the changing IV/EV signal ratio with changing fractional 
oxygenation.  
5.5.6 $VVXPLQJDOLQHDUƢUHODWLRQVKLS 
 
Whilst a 3 parameter fit yielded ƢDFURVVDOOILHOGVWUHQJWKVDSRVW-hoc test for 
the coefficient of determination (R2 ) showed a linear dependence fitted the data 
equally well (0.76< r2 <0.98,  p< 0.05). This suggests that whilst the true 
dependence of R2
*
GM on (1-Yv) may be sub-linear at the echo times used in this 
study, across the limited range of (1-Yv) = 0.3-0.4, a linear approximation 
sufficiently describes the observed behaviour. This is demonstrated in Figure 5-12, 
ZKHUHLWFDQEHVHHQWKDWZKLOHWKHHIIHFWRIƢKDVDGLVWLQFWHIIHFWRQWKHVKDSHRI
the curve across a range of 0-1, when the range is restricted to 0.3-0.4, the curves 
appear linear. Data shown in Figure 5-12 was simulated according 
to CYAx  E)1( .  Constants A and C were arbitrarily set to 4 and -1.5 
UHVSHFWLYHO\LQRUGHUWRURXJKO\FDSWXUHWKHEHKDYLRXURIWKHPHDVXUHGƅ52* data. 
'DWD ZHUH VLPXODWHG IRU D UDQJH RI Ƣ YDOXHV     DFURVV WKH IX ll 
theoretical range of fractional oxygenation (0-1). The region shaded grey shows 
the induced change in fractional oxygenation in response to 500 mmHg hyperoxia 
(0.3-0.4).   
 
Figure 5-12) Graphical depictioQ RI WKH HIIHFW RI Ƣ RQ WKH PRGHO
x = A(1-Y)Ƣ. Constants A and C have been arbitrarily set to 4 and -1.5. The 
shaded grey region reflects the approximate range of fractional 
oxygenation observed in BOLD fMRI (0.2-0.4).   
136 
 
Thus, for the FXUUHQWH[SHULPHQWDOSDUDPHWHUVWKHDSSUR[LPDWLRQRIƢHTXDOWR
across all field-strengths appears reasonable. This assumption could simplify the 
calibration of the BOLD signal. In order to fully capture the dynamic relationship 
oxygenation values close to the maximum and minimum of the full theoretical 
range must be targeted (0-1). This is not physiologically relevant and would 
require a hypoxic stimulus, which may then invoke additional vascular responses.  
Before extending these findings across all experimental parameters, further work 
is required to investigate the effect of different echo times across a greater 
physiological range of blood oxygenation. However, this method provides a 
framework for doing so and the hyperoxia paradigm offers a means of rapidly 
achieving a range of Yv values without altering CBV.  
5.6 Conclusion 
 
 7KLVZRUNSUHVHQWVWKHILUVWH[SHULPHQWDOPHDVXUHRIƢLQKXPDQVZKLFKLVQRW
confounded by a change in CBV due to functional activation or modulation of 
PETCO2 during a respiratory challenge. Whilst a sub-linear relationship between 
ƅR2*GM and (1-Yv) was observed, in agreement with previous simulations which 
relaxed the interpretation of  Ƣ to account for a change in Ƣ [272], a linear regime 
is a reasonable approximation. The measured GM signal was combined with in-
vitro literature values of  R2
*
IV, to elucidate a pure extravascular contribution. 
Whilst the dependence of  ƅR2* on (1-Yv) did not scale with field strength for total 
GM, when corrected for the IV component this was found to be true. This 
highlights the need for models of  the BOLD signal to take into account both 
intravascular and extravascular compartments, including how their ratio will 
depend on TE and oxygenation. As such, the current practice of  using a single 
YDOXHRI  Ƣ DW HDFK ILHOG VWUHQJWK LV LQVXIILFLHQW DW FDSWXULQJ WKHGHSHQGHQFHRI
ƅR2* on (1-Yv). However in practice the final results are not strongly dependent on 
ƢDQGDYDOXHRI Ƣ FRXOGUHDVRQDEO\EHXVHGIRUPRVWVWXGLHV 
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6 Quantification of hypercapnia-
induced perfusion changes with 
arterial spin labelling.  
 
6.1 Introduction 
 
This chapter introduces a modified LL-EPI pulse sequence for multiphase ASL 
data acquisition (multiple TI data following a single label period), whilst providing 
high sensitivity to the BOLD signal and applies this method to study the response 
to hypercapnia. Multiphase ASL provides an ideal method to assess changes on 
hypercapnia, where assuming a single transit time can cause significant perfusion 
quantification errors. Experimental results highlight potential issues encountered 
when quantifying perfusion changes in response to a hypercapnic stimulus, and 
how these might be minimised. Calibrated BOLD requires simultaneous 
acquisition of BOLD and CBF, here, a comparison is made between single and 
multiphase ASL techniques, and the impact that the choice of scheme will have 
on calibration of the BOLD signal using the Davis model [7]. This chapter 
provides a framework for future studies where simultaneous measures of CBF, 
BOLD and CBV will improve our understanding of cerebral haemodynamics in 
both health and disease. Simultaneous acquisitions cannot be performed unless 
the sensitivity to all these physiological measures is enhanced.   
6.2 Effect of hypercapnia on cerebral haemodynamics 
 
Hypercapnia is an increase in the amount of carbon dioxide (CO2) in the arterial 
blood and is a widely used investigative tool in the calibration of the BOLD 
response, where it is induced by either CO2 inhalation [7] or breath-holding [277].  
This Chapter will focus on moderate hypercapnia induced by raising the inspired 
fraction of CO2 (from FiCO2 = 0.035 to ~0.05) and the associated effects on 
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cerebral haemodynamics. However, it is worth noting that permissive hypercapnia 
can result from mechanical ventilation in medical conditions such as chronic 
obstructive pulmonary disease (COPD), obstructive sleep apnea or asthma [278]. 
Increased arterial CO2 leads to an increase in hydrogen ions (H
+) in blood due to 
the production of carbonic acid. This lowers the arterial pH [279-281], which is 
detected by central and peripheral chemoreceptors and induces a change in both 
the ventilation and vascular tone [282]. Hypercapnia stimulates ventilation by 
increasing both the frequency and tidal volume in a bid to clear the excess CO 2 
and restore pH.   
Hypercapnia is recognised as a potent vasodilator [283], with a reduction in 
vascular resistance leading to an increase in cerebral blood flow (CBF) [279]. The 
vasodilation induced by a reduction in pH is thought to be neuroprotective in a 
bid to prevent an excess of H+ [284]. The increase in CBF in response to 
hypercapnia has been well established with different imaging modalities and 
sequences [E.g. 7, 140, 279, 281, 285-287]. Using the nitrous-washout technique, 
Kety and Schmidt first reported an increase in global CBF of 8.3 ± 1.4 %/mmHg 
CO2 (mean ± SEM) [279]. This is in reasonable agreement with a more recent 
PET study which reports a change of 6 ± 2.6 %/mmHg, averaged across the 
frontal, parietal, temporal and occipital lobes [281]. When specifically investigating 
grey matter (GM) perfusion, the increase is slightly lower, but consistent across 
the literature, and measured to be an increase of 3-6 %/mmHg with arterial spin 
labelling [7, 287-289]  and 4.8-5.2 %/mmHg with PET [286].  
fMRI studies such as calibrated BOLD rely on both CBF and CBV. As 
introduced in Section 4.2, the coupling between CBF and CBV is often described 
E\*UXEE·V FRQVWDQW ơZKHUH Grubb et al. observed a linear dependence of the 
change in total cerebral blood volume (CBV) on increasing CO2 partial pressure 
(PaCO2) using PET in anaesthetised rhesus monkeys [140]. A non-linear 
dependence of CBV on CBF was reported, according to the relationship CBV = 
0.8.CBFơZKHUHơ *UXEE·VFRQVWDQWIn fMRI studies, it is venous CBV 
Y&%9 ZKLFK LV RI LQWHUHVW DQG VR *UXEE·V FRQVWDQW ZKLFK UHIOHFWV total 
CBV/CBF coupling may not be accurate. Recent fMRI studies have shown the 
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FRXSOLQJFRQVWDQWơWREHVOLJKWO\ lower [289, 290], with 0.2 now generally chosen 
as the assumed value. Using MRI, Chen et al. [289] assessed the effect of 
hypercapnia on CBF (measured with PASL) and vCBV (measured with VERVE), 
reporting a smaller coupling constant of 0.18 ± 0.02. In response to moderate 
hypercapnia (9mmHg), they reported ƅ&%)PETCO2 = 7.2 ± 0.5 %/mmHg and 
ƅvCBV/PETCO2 = 5.5 ± 1.0 %/mmHg.  This supports the findings from PET 
that the induced changes in blood volume are smaller than those of CBF, 
suggesting that it is both an increase in vessel diameter and flow velocity which 
contribute to the observed increase in CBF7KHƅ&%)ƅvCBV relationship was 
shown to be consistent across both hypercapnia and neuronal activation [289]. 
Hypercapnia is often assumed to be isometabolic, an important assumption for its 
use in calibrated BOLD [7]. Chen et al. [134] provide evidence to support this 
assumption, however there is strong support from both animal and human studies 
which contest this [129-133]. To date, the exact effect of hypercapnia on cerebral 
metabolism remains controversial [291], as discussed in Chapter 4. The significant 
global impact of hypercapnia on neuronal oscillations makes it a less ideal 
stimulus for calibrated BOLD than isocapnic hyperoxia.  
Hypercapnia remains a popular investigative tool; it is cost-effective, portable and 
readily available.  It is non-invasive and can be precisely controlled and terminated, 
making it advantageous over vasoactive stimulants such as acetazolamide [292]. 
The ability to induce hypercapnia via a simple breath-hold means it can be easily 
implemented. Whilst the increase in PETCO2 in response to a breath-hold can be 
extremely variable across individuals, monitoring PETCO2 via a nasal cannula 
allows individual effects to be accounted for, improving the robustness of this 
technique [151, 293]. Furthermore, combined hyperoxic-hypercapnia techniques 
have recently been proposed [9, 10], where both CBF and arterial oxygenation are 
modulated (via hypercapnia and hyperoxia respectively) to yield absolute 
measurements of CMRO2.  
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Hypercapnia is also a useful tool for the assessment of cerebrovascular reactivity 
(CVR). CVR assesses the change in blood flow in response to a vasoactive 
stimulus and is already a key research tool in disorders such as AlzheimHU·VGLVHDVH
[294-296], carotid artery disease (see Gupta et al. [297] for a review) and moya 
moya disease [298-300], with the potential to become a powerful clinical tool [301]. 
Mandell et al. [302] showed good agreement between ASL and BOLD 
measurements of CVR in both healthy volunteers and patients with steno-
occlusive disease. A significant correlation was also found using simultaneous 
CBF and BOLD measures of CVR in ischemic cerebrovascular disease [303]. 
While BOLD reactivity offers increased SNR over ASL measures, the BOLD 
response is influenced by physiological parameters other than CBF, such as CBV 
and CMRO2, and so simultaneous BOLD/CBF measurements are ideal for 
investigating the compromised haemodynamics which underlie altered CVR in 
disease.  
In order for the use of hypercapnia to become a recognised reliable clinical tool, 
robust measurements of CBF are required [304]. As introduced in Chapter 3, MR 
methods, in particular ASL, have proven ideal to provide measures of non-
ionising, repeatable perfusion quantification. However, ASL is sensitive to 
changes in transit time and ASL has inherently low SNR and so can struggle to 
detect small signal changes in response to hypercapnia, as opposed to the larger 
response to neuronal activation. The remainder of this chapter will assess the 
optimal method of arterial spin labelling (ASL) for simultaneous measurement of 
hypercapnia induced perfusion and BOLD changes.   
6.3 Perfusion measurements with arterial spin 
labelling 
 
An increase in CBF is typically associated with a reduction in transit time of 
arterial blood from its labelled location to the imaging plane (Figure 6-1), faster 
flowing blood will arrive at the tissue sooner than slower flowing blood. Further, 
transit time is known to be heterogeneous across the cortex, with shorter transit 
time closer to large arterial branches [305]. This can lead to potential confounds in 
CBF quantification based on single phase ASL (one post-label delay (TI)) which 
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assume a single transit time. As hypercapnia is a known vasodilator (thought to 
increase both vessel diameter and flow velocity), it follows that hypercapnia will 
also cause a significant reduction in transit time [306-308] and so it is unlikely that 
a technique which lacks temporal information, such as single phase ASL, can 
accurately quantify these perfusion changes. QUIPSSII (Quantitative Imaging of 
Perfusion using a Single Subtraction) [309] minimises the sensitivity to transit time 
by applying a saturation pulse after the labelling scheme so as to create a finite 
bolus of labelled blood. However, in cases of high global flow such as 
hypercapnia, the labelled blood may have left the saturation plane before 
saturation is applied and so QUIPSSII may be ineffective [310]. Therefore for 
accurate CBF quantification, where transit time sensitivity remains a significant 
confound, a multiphase ASL scheme (where multiple readout pulses are collected 
following each label pulse) is ideal, as has been recognised by the recent White 
Paper on ASL which aims to reflect the opinions of the ASL research community 
as a whole [311]. 
 
Figure 6-1) Schematic representation of the perfusion-weighted percentage 
signal change at rest and in response to a task. An increase in perfusion is 
characterised by an increase in peak signal change with an accompanying 
reduction in transit time. 
An advantage of single phase ASL is the ability to obtain simultaneous measures 
of CBF and BOLD [85]. Concurrent ASL and BOLD acquisition has a number of 
key advantages for many studies of cerebral haemodynamics. With the ability to 
distinguish between neural deactivation and altered neurovascular coupl ing [312, 
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313], it also offers the potential to dissociate the physiology underlying changes in 
the BOLD response in ageing and disease [314]. Perfusion maps are likely to be 
better localised to the site of neuronal activation, as the BOLD response can be 
dominated by draining veins [315, 316]. At a spatial resolution of  2x2x3 mm3, 
Pfeuffer et al. [317] showed that only 50 % of voxels showing significant 
activation were common to both perfusion and BOLD weighted signals in 
response to a visual stimulus. Furthermore, simultaneous acquisition is 
advantageous for the estimation of CMRO2 via calibrated BOLD, as the temporal 
variations in the two signals are minimised [318]. The need to assume a constant 
physiological response across repeated acquisitions is also removed (important for 
stimuli where habituation may occur which limits sequential ASL and BOLD 
measures).  
Secondary advantages are also obtained. ASL data arenotoriously difficult to 
motion correct, especially if background suppression pulses have been used to 
reduce physiological noise, owing to the suppression of static tissue signal which 
removes key spatial information required by motion correcting algorithms [86]. 
BOLD data acquired from the same imaging volume can be more easily motion 
corrected, with the resulting transformation matrix later applied to the ASL 
images.  
An inherent problem with combined acquisitions is that the optimal echo time 
(TE) for ASL and BOLD are not equal. While ASL requires a short TE for high 
SNR [98], an echo time close to the tissue T2
* is optimal for BOLD contrast [27]. 
Interleaved methods acquire CBF and BOLD data with separate excitations 
(pseudo-simultaneous), so that the TE is optimised for both acquisitions [8, 138, 
287], however temporal SNR is compromised. Other research groups have used 
single shot acquisitions and have selected an intermediate TE which provides 
some sensitivity to both perfusion (difference between label and control images) 
and BOLD (sum of label and control images) [183, 290, 319], this increases tSNR 
but reduces the signal contrast for both modalities.  
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The Double Acquisition Background Suppressed (DABS) scheme [320] provides 
a solution to the enforced trade-off between tSNR and TE, whilst overcoming 
challenges of increased physiological noise faced when using ASL at ultra-high 
field [321]. Both ASL and BOLD images are acquired within a single TR, each at 
an optimal TE, with BOLD images being acquired for both the label and control 
ASL images. Background suppression is achieved with two global adiabatic 
inversion pulses applied, prior to image acquisition, to minimise the effects of 
increased field inhomogeneity and physiological noise experienced at high field. 
The remainder of this chapter will introduce and evaluate a modified multiphase 
version of the DABS acquisition, which combines the advantages of multiphase 
ASL readout schemes with that of the simultaneous measurement of CBF and 
BOLD using DABS.  
 
Figure 6-2) Schematic of the standard DABS FAIR pulse sequence. Two 
EPI readouts are acquired in a single TR to collect both ASL (stack 1) and 
BOLD (stack 2) at optimal echo times. Background suppression (BS) 
pulses are applied prior to the ASL readout to minimise physiological noise 
in the ASL data. 
6.4 Look-Locker DABS readout scheme (LL_DABS) 
 
Here a simple modification of the LL-EPI FAIR sequence is presented, termed 
Look-Locker Double Acquisition with Background Suppression (LL_DABS), 
which allows for simultaneous acquisition of CBF and BOLD without the need to 
assume transit time. This has the potential to provide a more accurate 
quantification of the change in CBF on hypercapnia. As introduced in Chapter 4, 
BOLD weighting can be obtained from a standard LL-EPI readout scheme by 
increasing the flip angle of the last readout phase to a 90° pulse. However, the 
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magnitude of the measured transverse signal is limited by the available signal for 
recovery, the time between phases (TA). By increasing the time delay prior to the 
last readout phase, signal recovery is increased resulting in increased BOLD signal 
contrast as used in standard DABS (Figure 6-3). Due to the continued 
suppression of the control signal at time TA, the LL_DABS scheme has intrinsic 
background suppression for all (N-1) readout pulses, reaching a steady state signal 
as shown in (Figure 6-3B).  
 
Figure 6-3) A) Schematic of the modified LL-EPI FAIR (LL_DABS) pulse 
sequence. For N pulses, the time between the (N-1)th and Nth readout is 
increased to maximise BOLD sensitivity. B) Schematic of the resulting 
control signal magnetisation (TI/TA/FA = 1400/300/35°), the increased 
time between the (N-1)th and Nth readout is labelled as TA2. As TA2 
increases, the BOLD sensitivity increases. The echo time can be 
independently controlled for the N th readout compared to all (N-1) readout 
pulses. 
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The experimental results presented below compare the suitability of standard 
DABS and LL_DABS for measuring a hypercapnia-induced change in CBF and 
BOLD. The measured changes in CBF and BOLD are used to calculate the 
calibration constant (M-value) used in calibration of the BOLD signal. This is 
used to estimate the change in CMRO2 induced by motor activation for the 
LL_DABS sequence.  
6.4.1 Experimental Protocol 
 
This study was approved by the University of Nottingham Medical School Ethics 
Committee. Five subjects (aged 24 ± 0.4 years, all male) participated and gave 
prior, informed, written consent. MR scanning was performed using a Philips 
Achieva 7 T system with a head volume transmit coil and 32 channel SENSE 
receive coil, with foam padding used to reduce head motion. 
Prior to MRI measurement, the subject sat upright on the scanner bed while 
baseline metabolic values were estimated and targeted. A trial hypercapnic 
sequence was then run for the subjects who had not experienced hypercapnia 
before (n = 2). The trial sequence consisted of 1 minute of subject specific 
baseline, 1 minute of hypercapnia (PETCO2 = baseline + 8mmHg), followed by 1 
minute of baseline. The 2 subjects who took part in the trial sequence were asked 
if they were comfortable with the hypercapnic stimulus, with the option to 
discontinue if they felt they would not be able to tolerate it.   
The subject then lay supine in the scanner, with medical air administered until the 
respiratory challenge commenced. The respiratory challenge consisted of 3 
minutes of normocapnic baseline (subject-specific PETO2 and PETCO2), followed 
by 6 minutes of iso-oxic hypercapnia at the VXEMHFW·V UHVWLQJ3ETO2, (PETCO2 = 
baseline + 8mmHg), and then 3 minutes of normocapnic baseline (Figure 6-4). 
The total duration of the respiratory challenge was 12 minutes, including 
transitions (square-wave). All subjects performed this challenge twice, using the 
standard DABS and LL_DABS acquisitions. The sequences were pseudo-
randomised such that DABS data were acquired first in three subjects and 
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LL_DABS data first in the remaining two subjects. Subjects received medical air 
when not on a respiratory sequence.  
 
Figure 6-4) Targeted respiratory paradigm: 3 minutes of subject-specific 
baseline was followed by 6 minutes of  hypercapnia (baseline PETCO2 +8 
mmHg) and another 3 minutes of baseline. PETO2 targeted at subject-
specific baseline throughout. 
An initial functional localiser scan (GE-EPI, SENSE factor 2, TE/TR=25/3000 
ms, 2x2x3 mm3 resolution, FOV=192x1992x45 mm3) was acquired to obtain real-
time visualisation of  the motor cortex via IViewBOLD (Philips, Best, 
Netherlands). During the localiser, subjects were required to perform a 5 minute 
bilateral finger-tap task (30 s tap, 30 s rest).  At rest, a small white fixation cross on 
a black background was projected on a screen at the end of  the magnet bore, with 
WKHDFWLYHFRQGLWLRQFXHGE\DODUJHUHG´7$3µRQDEODFNEDFNJURXQG6XEMHFWV
wore prism glasses throughout in order to see the screen.  
The hypercapnic challenge was then performed and data acquired using either 
DABS or the LL_DABS scheme. A spatial resolution of 2 x 2 x 3 mm3, FOV of 
192 x 192 x 15 mm and SENSE acceleration factor 2 was used for both the 
DABS and LL_DABS sequences using a GE-EPI readout with 5 contiguous 
slices per TR. For both schemes pre- and post-saturation pulses were applied to 
the imaging plane around the labelling, and vascular crushing applied. The DABS 
FAIR sequence had the following imaging parameters: TR = 4000 ms, 5 
contiguous slices, selective and non-selective imaging slab widths of  48 mm and 
300 mm respectively, with a TE of 16 ms for ASL acquisition and TE of  25 ms 
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for the BOLD acquisition. Due to the interleaved label and control ASL 
acquisition, the effective TR for ASL was 8 s. Background suppression inversion 
pulses were applied at TBS1 = 402 ms and TBS2  = 1034 ms, with a post-label delay 
(TI) of 1400 ms used to account for a reduced transit time with hypercapnia. The 
total scan duration was 12 minutes to match the respiratory paradigm. LL_DABS 
acquisition parameters were TI/TA1/TA2/TR=200/300/1300/4000 ms, 9 
readout times per TR, and scan duration 12 minutes. For phases 1-8, FA = 35°, 
while for phase 9, FA = 90° and TE = 23 ms.  
Four of the five subjects completed an additional motor task; a bilateral fingertap 
(24 s on, 40 s off) was repeated for seven cycles. During the functional task, data 
were collected using the LL_DABS acquisition, with identical parameters to those 
described above. For volunteer comfort, RespirAct studies were limited to one 
hour. This time constraint prevented data acquisition with the DABS labelling 
scheme for the motor task. 
Base EPI images were acquired across the same imaging volume for the DABS 
and LL_DABS acquisition to allow estimation of  M0. Inversion recovery (IR) data 
ZHUH DFTXLUHG DFURVV 7,·V -2500ms) for T1 mapping, from which a GM 
PDVNZDVFUHDWHGXVLQJWKHWKUHVKROG71V 
6.5 Data Analysis 
 
6.5.2 Respiratory data 
 
Transition periods were discarded and end-tidal values averaged to estimate the 
mean PETCO2 and PETO2 values on normocapnia and hypercapnia. The raw end-
tidal PETCO2 trace was down-sampled in MATLAB to 0.125 Hz to match the 
effective TR of 8 s. The interpolated timecourses were created for both the DABS 
and LL_DABS acquisitions and formed the input model for the GLM analysis in 
FEAT (FSL, Oxford).  
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The pressure trace taken from the sample line in the face mask was down-sampled; 
to  1 Hz to assess potential changes in respiratory pressure, and 0.125 Hz to 
match the effective TR of the BOLD and ASL acquisitions.  It is possible that 
hypercapnia increases respiratory pressure in order to increase the rate of CO 2 
clearance from the blood. For this reason, respiratory pressure was estimated 
from the root mean square (RMS) amplitude of the pressure trace (P) using RMS 
 >¥ƓP)2]/n, where n is the number of measurements taken (e.g. for a 2 minute 
time period sampled at 1 Hz, n = 120), and P is positive or negative depending on 
inhalation or exhalation. The down-sampled pressure trace was used as a covariate 
of no interest in the GLM analysis.  
6.5.3    Pre-processing 
 
Double Acquisition with Background Suppressed FAIR (DABS FAIR) 
 
In DABS, the ASL and BOLD data are acquired in two sequential stacks 
following labelling, images from stack 1 are ASL-weighted, and images in stack 2 
are BOLD-weighted. Stack 1 of the label and control images are subtracted to 
produce a perfusion-weighted difference image at a single post-label delay (TI) 
with an effective temporal resolution of 8 seconds. Perfusion-weighted images 
were visually inspected for motion artefacts, as described above, and motion 
correction applied to the BOLD-weighted images (acquired in stack 2) using 
MCFLIRT (FSL, FMRIB, Oxford, UK) separately for label and control 
conditions. The resulting transformation matrix from the label and control 
correction was applied to the ASL-weighted images using the applyxfm4D 
command in FSL (FMRIB, Oxford, UK). After motion correction, the 
transformation parameters were correlated with the end-tidal CO2 trace to 
investigate whether there was increased motion under hypercapnia.  
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DABS FAIR with Look-Locker readout (LL_DABS FAIR) 
 
Label and control images were subtracted to produce a perfusion-weighted 
difference image for the first 8 phases, with an effective temporal resolution of 8 
seconds. Perfusion-weighted images were visually inspected for motion artefacts. 
0RWLRQ LQGXFHG ´ULQJLQJµZDV HYLGHQW in a number of dynamics in DOOVXEMHFWV·
timecourses (as illustrated in Figure 6-5) and so motion correction was applied in 
all cases using MCFLIRT (FSL, FMRIB, Oxford, UK). Since the Look-Locker 
multiphase perfusion label and control data are difficult to motion correct due to 
the lack of static signal, motion correction was applied to the BOLD-weighted 
data from the last phase (TI9) (control and label image corrected separately). The 
resulting transformation matrix from the label and control correction was applied 
to phases 1-8 using the applyxfm4D command in FSL (FMRIB, Oxford, UK) ² 
this assumes no movement between phases 1- 8. After motion correction, the 
transformation parameters were correlated with the end-tidal CO2 trace to 
investigate whether there was increased motion during hypercapnia (due to 
increased breathing frequency or patient discomfort which may be locked to the 
hypercapnic stimulus). Statistical analysis of the LL_DABS data was performed in 
the same manner for both data collected during hypercapnia and to the finger tap 
paradigm. As described in Section 4.5.3.2, the perfusion-weighted difference 
images from phases 4-6 (1100 ² 2000 ms) were averaged to form an average 
perfusion-weighted timecourse on which GLM analysis was performed.  
 
Figure 6-5) Example perfusion-weighted data from a single dynamic at TI 
= 1400 ms where subject motion has occurred leading to an artefactual ring. 
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Assessing the response to hypercapnic challenge: 
 
The perfusion-weighted and BOLD data from the hypercapnia challenge were 
spatially smoothed using a 5 mm FWHM Gaussian kernel. A temporal filter with 
720 s cut-off (normocapnic period plus hypercapnic period) was then applied. 
Maps of  statistical significance of  the perfusion-weighted data in response to 
hypercapnia were formed using a GLM analysis in FEAT (FSL, FMRIB). For 
LL_DABS, the perfusion-weighted image averaged across phases 4-6 (as described 
above) was used in the GLM analysis. The PETCO2 trace was used in the GLM 
analysis as the input model, with the down-sampled pressure trace used as a 
covariate of  no interest. Haemodynamic latency in response to hypercapnia was 
corrected globally by including a 24 s lag (3 dynamics) in the input model. The 
delay was determined by aligning the peak change in BOLD/perfusion-weighted 
signal between dynamics 20-30 (corresponding to step-change in PETCO2 at the 
onset of hypercapnia). A binary mask of  grey matter (GM) was created by 
applying a threshold to the T1 map where GM was identified by 1.7<T1<2.3 s. 
7KLVELQDU\PDVNZDVXVHGWRLGHQWLI\WKH¶*052,·IRUVXEVHTXHQWLQWerrogation 
of  global GM changes in CBF. 
Assessing the response to the motor task: 
 
As described above, the perfusion-weighted difference images from phases 4-6 
(1100 ² 2000 ms) of LL_DABS were averaged to form an average perfusion-
weighted timecourse on which GLM analysis could be performed. The LL_DABS 
BOLD and perfusion-weighted data from the motor task were spatially smoothed 
using a 5 mm FWHM Gaussian kernel. A temporal filter with 128 s cut-off was 
applied. Maps of  statistical significance of  the CBF response to the motor task 
were formed using GLM analysis in FEAT (FSL, FMRIB), using a boxcar model 
of  the times at which subjects were instructed to finger tap convolved with a 
canonical HRF. The resulting activation maps were converted to binary masks 
(where Z > 3 and p <0.05) in MATLAB IURPZKLFK D ¶0RWRU52,· FRXOGEH
formed. 
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6.5.4 CBF Quantification: 
 
The DABS and LL_DABS datasets were separated into active periods 
(fingertap/hypercapnia conditions) and baseline volumes (rest/normocapnia 
conditions). The hypercapnia data across the transition periods was discarded.  
LL_DABS data were DYHUDJHG DFURVV WKH YR[HOV IRUPLQJ WKH ¶*0 52,· DQG
¶0RWRU52,· to obtain a signal time-course across the 9 readout phases for each 
condition. The timecourses were normalised by the appropriate M0 of  GM within 
each ROI estimated from the base EPI images, where M0 is scaled under 
hypercapnia to account for a change in T2
*  [67] as described in Section 4.5.3.2. 
Using the kinetic model of  Francis et al. [99], the normalised time courses from 
WKH¶*052,·DQG¶0RWRU52,· ZHUHILWIRU&%)WUDQVLWWLPHƅDDQGH[FKDQJH
WLPHƤZKHUHWLVVXHDUULYDOWLPHFDQEHHVWLPDWHGIURPƅDƤ7KH71 of  blood 
at 7 T was assumed to be 2.2 s [186, 187] and the T1 of  tissue assumed to be 2.0 s 
(in agreement with the T1 map). Activation induced changes in CBF were then 
reported as a percentage change for each task.  
The perfusion-weighted DABS images were averaged across normocapnia and 
hypercapnia and then normalised by their respective M0 of  GM (accounting for a 
change in T2
* [67]), estimated from the DABS base EPI. The perfusion-weighted 
signal (ƅMIURPWKH¶*052,·ZDVFRQYHUWHGWR&%)XVLQJWKHJHQHUDOkinetic 
model of  Buxton et al. [98] (Equation 6-1), assuming full inversion efficiency, a 
capillary transit time (ƅt) of  1 s [322], T1 of  blood of  2.2 s [186, 187] and TI = 1.4 
s. 
BloodT
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6.5.5 BOLD quantification: 
 
As previously described, for LL_DABS, the label and control signal from the last 
phase (TI9) provides a BOLD-weighted data set. Stack 2 of the DABS acquisition 
is BOLD-weighted. Percentage change in BOLD signal was quantified (using 
MATLAB scripts) for motor and hypercapnia tasks in the ¶0RWRU ROI· and ¶GM 
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ROI· respectively. For comparison purposes, BOLD signal was also taken from 
the control signal at phase 8 (TI = 2300 ms) of the LL_DABS sequence. This is 
comparable to the standard method of multiphase ASL acquisition (e.g. QUASAR 
[101]) for which a final 90° readout flip angle is not typically used.  
6.5.6 Calibration of  the BOLD signal 
 
The relative change in CBF and BOLD in response to hypercapnia were used to 
calculate the M-value, the calibration constant, IRU WKH ¶*052,· DFFRUGLQJ WR
Equation 6-1 derived from Davis et al. [7]. M was calculated on an individual 
subject basis for both the DABS and LL_DABS schemes. Measurements made 
XQGHU K\SHUFDSQLD DUH GHQRWHG E\ WKH VXEVFULSW ¶+&· DQG QRUPRcapnia by the 
VXEVFULSW¶·+HUHDYDOXHRIơ DQGƢ DUHDVVXPHGLQWKHFDOLEUDWLRQVHH
Chapter 5). 
 
                                                               6-2                                          
 
The DABS and LL_DABS measurements of M  under hypercapnia were used to 
estimate the relative change in CMRO2  LQ WKH ¶0RWRU52,· LQ UHVSRQVH WR WKH
motor task (Equation 6-2), according to the Davis model [7] as introduced in 
Chapter 3.  
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All statistical analysis was performed using SPSS (SPSS 16, Chicago, IL, USA). 
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6.5.7 Assessing the optimal scheme (DABS vs. LL_DABS) 
 
To assess the optimal scheme for calibrated BOLD measures, the temporal SNR 
(tSNR) of the DABS and LL_DABS data was assessed for both the perfusion-
weighted and BOLD-weighted data. tSNR of the BOLD-weighted data from 
phase 8 of the LL_DABS data was also assessed. First, temporal mean and 
standard deviation images were created by taking the mean and standard deviation 
across the 4th dimension data set (MATLAB). A tSNR image was then obtained 
by dividing the temporal mean by temporal standard deviation. For the LL_DABS 
sequence, the tSNR of the perfusion-weighted image (average across phases 4-6 
for LL_DABS) was assessed. tSNR was compared for the respiratory paradigm, 
motor task and a 2 minute period of medical air whilst the subject was at rest. 
Contrast-to-noise ratio (CNR) was calculated for both the respiratory challenge 
and motor task by dividing the mean change in signal in response to 
hypercapnia/motor task (SHC/task ² SRest) by the standard deviation. This was 
calculated for the whole brain and GM ROI. All statistical analysis was performed 
using SPSS (SPSS 16, Chicago, IL, USA).  
6.6 Results 
6.6.8 Respiratory challenge: 
 
Average PETO2 and PETCO2 for baseline and hypercapnic stimuli  are shown in 
Table 6-1. There was no significant difference in the hypercapnic step used 
between each acquisition scheme (Wilcoxon Signed Rank Test).  Breathing 
frequency and inspiratory/expiratory pressure were constant across stimulus 
blocks (medical air, normocapnia and hypercapnia) as shown in Table 6-2, 
)ULHGPDQ·VRQH-way ANOVA).  
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 Normocapnia  Hypercapnia 
P
ET
O
2
  P
ET
CO
2
  P
ET
O
2
  P
ET
CO
2
  
DABS 112.6 ± 0.9  39.6 ± 0.4  114.7 ± 0.9  45.1 ± 0.4  
LL_DABS  112.3 ± 0.8  39.8 ± 0.4  114.8 ± 1.4  45.2 ± 0.6  
Table 6-1) End tidal pressures (mean ± SE) of O2 (PETO2) and CO2 (PETCO2) 
for baseline and hypercapnic periods of the respiratory challenge for the 
DABS and LL_DABS sequences. 
  Breathing Frequency 
(breaths per minute)  
Inspiratory/Expiratory 
amplitude (mmHg)  
DABS  Normocapnia 11.6 ± 2.0  7.7 ± 2.5 
Hypercapnia  12.5 ± 1.7  7.9 ± 2.6 
Medical Air 11.9 ± 2.2  7.4 ± 2.6 
LL_DABS  
 
Normocapnia 12.8 ± 2.1  5.7 ± 1.1 
Hypercapnia  11.8 ± 1.8  6.8 ± 1.5 
Medical Air  12.9 ± 2.1  5.2 ± 0.7 
Table 6-2) Breathing frequency and inspiratory/expiratory amplitude 
across medical air, normocapnia and hypercapnia for the DABS and 
LL_DABS sequences. 
6.6.9 Motion correction: 
 
There was no significant difference between the absolute and relative 
displacement as measured by MCFLIRT ()ULHGPDQ·V one-way ANOVA) for the 
hypercapnia challenges and motor task. Furthermore, there was no significant 
correlation between the motor paradigm and the motion parameters )ULHGPDQ·V
one-way ANOVA). However, all subjects showed significant correlation between 
at least one rotational/translational direction and the hypercapnic stimulus for 
both DABS (-0.50 < r2 < 0.56) and LL_DABS (-0.61 < r2 < 0.56) sequences. 
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Figure 6-6 shows an example trace from a representative subject taken from the 
final BOLD-weighted readout of the LL_DABS sequence during the hypercapnia 
challenge. Motion correction cropped regions from the top and/or bottom slice 
in some subjects and so for consistency these slices were removed in all cases.  
. 
Figure 6-6) Estimated translation (A) and rotation (B) transformations 
using MCFLIRT (FSL, FMRIB, Oxford, UK) for a representative subject 
receiving hypercapnia (black solid line) during the LL_DABS sequence. 
For this subject, translation was significantly correlated in both the x (R2 = 
0.25, p <0.01) and y direction (R2 = -0.43, p <0.01).  
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6.6.10 Haemodynamic response to hypercapnia 
 
The statistical CBF activation maps in response to hypercapnia showed significant 
grey matter activation in all subjects (Figure 6-7). However, given the known 
potent effect of hypercapnia on CBF, the maps for both DABS and LL_DABS 
do not appear to be as robust as expected for the given Z-statistic of 2.3. 
Nonetheless, the CBF activation appears to be more closely localised to GM for 
LL_DABS in comparison to DABS. Activation maps in response to hypercapnia 
were robust across all subjects for BOLD-weighted data from both DABS and 
LL_DABS.  
 
Figure 6-7) Statistical activation maps shown for a single representative 
subject created using GLM analysis in FEAT (FSL, FMRIB, Oxford, UK). 
Maps shown for CBF and BOLD as measured with DABS and LL_DABS. 
Colour bars represent minimum and maximum Z-statistic, where Z > 2.3 
and p <0.05. 
LL_DABS perfusion-weighted timecourses across the readout phases for 
normocapnia, hypercapnia and the fingertap task are shown in Figure 6-8 for 
individual subjects. The variability in shape between individual subjects is clearly 
evident, highlighting the potential error induced from a single post-label delay of 
1400 ms used in DABS. Results from the fitted kinetic model averaged across 
subjects are provided in Table 6-3. 
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  CBF (ml/min/100g)  Tissue Arrival Time (ms)  
DABS  Normocapnia 42 ± 5  --  
Hypercapnia  47 ± 6  --  
LL_DABS Normocapnia 49 ± 12  520 ± 67 
Hypercapnia  61 ± 9 442 ± 52 
Table 6-3) Absolute CBF (ml/min/100g), tLVVXHDUULYDOWLPHƅtissue, in ms) 
for normocapnia and hypercapnia as measured with LL_DABS and 
absolute CBF as measured with DABS. Results are averaged across 
subjects (mean ± SEM).  
 
Figure 6-8) LL_DABS timecourses across the first 8 phases for 
normocapnia (black), hypercapnia (red) and the fingertap task (grey). Data 
shown for individual subjects (A-E). Subject A did not perform a motor 
task. 
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A 7.7 ± 4.1 % increase in CBF per mmHg of CO2 was measured using LL_DABS. 
This is in contrast to a 2.9 ± 1.5 % increase in CBF per mmHg of CO2 measured 
with DABS. This difference in CBF per mmHg of CO2 between the two 
sequences (Figure 6-9) was significant (p = 0.043, Wilcoxon Signed Rank Test).  
 
Figure 6-9) Comparison of the measured change in CBF expressed 
as %/mmHg CO2 in response to hypercapnia as measured with DABS and 
LL_DABS. Data areaveraged across all subjects (± SEM). A significant 
increase is found for LL_DABS.  
There was no significant difference between DABS and LL_DABS in the 
hypercapnia induced BOLD signal change (Wilcoxon Signed Rank Test) (Figure 
6-10). The BOLD increase in response to hypercapnia was 0.55 ± 0.11 %/mmHg 
for DABS and 0.45 ± 0.14 %/mmHg for LL_DABS. The BOLD increase in 
response to hypercapnia as measured from phase 8 of the LL_DABS sequence 
(equivalent to QUASAR) was significantly less (-22 ± 8 %) than the measurement 
from phase 9 given above (p = 0.043, Wilcoxon Signed Rank Test) (Figure 6-10) . 
This can be explained by the significant reduction in both CNR (64.4 ± 9.0 %, p 
= 0.043, Wilcoxon Signed Rank Test) and tSNR (53.8 ± 1.3 %, p = 0.043, 
Wilcoxon Signed Rank Test) between phase 8 and 9 of the LL_DABS sequence. 
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Figure 6-10) Comparison of the measured change (%/mmHg CO2) in 
BOLD  in response to hypercapnia as measured with LL_DABS , DABS 
and phase 8 (TI = 2300 ms) of the LL_DABS sequence (equivalent to 
BOLD-weighting from a standard LL-EPI sequence without a final 90° 
readout). Data are averaged across all subjects (± SEM). 
6.6.11 Haemodynamic response to motor activation 
 
CBF and BOLD was simultaneously measured in response to a fingertap task 
using the LL_DABS sequence. Statistical activation maps from GLM analysis 
showed a robust CBF response in the primary motor cortex (Figure 6-11). 
Resting-state CBF increased from 40 ± 3 ml/min/100g to 61 ± 6 ml/min/100g 
LQ WKH ¶PRWRU 52,· WKUHVKROG DW = ! ), an average increase of 51 ± 7 %, 
averaged across subjects. This was supported by a decrease in tissue arrival time 
from 650 ± 89 ms to 346 ± 13 ms. A robust BOLD response was observed in the 
primary and supplementary motor cortex (Figure 6-11) with a measured increase 
of 2.6 ± 0.2 % DYHUDJHGDFURVVWKH¶0RWRU52,·. 
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Figure 6-11) Statistical activation maps from a fingertap measured with the 
LL_DABS scheme shown for a single representative subject created using 
GLM analysis in FEAT (FSL, FMRIB, Oxford, UK). Colour bars represent 
minimum and maximum Z-statistic, where Z > 2.3 and p <0.05.  
6.6.12 Calibration of the BOLD signal 
 
The hypercapnia induced changes in BOLD and CBF as measured with DABS 
resulted in an average M-value value of 88 ± 46 %. This was significantly higher 
and had a considerably larger variance than the M-value calculated using the 
LL_DABS scheme of 15 ± 7 % (p = 0.043, Wilcoxon Signed Rank Test). Using 
the measurement of the M-value from the LL_DABS scheme, the relative change 
in CMRO2 in response to the motor task was 14 ± 4 %. This was significantly 
lower than the relative change in CMRO2 using the M-value from the DABS 
s e quence (36 ± 11 %),  (p = 0.029,  Wilc oxon Si gned Ra nk Te st) .  
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Figure 6-12) Comparison of the measured calibration parameter M-value as 
measured with DABS and LL_DABS. Data areaveraged across all subjects 
(± SEM). 
6.6.13     Assessing the optimal scheme (DABS vs. LL_DABS) 
 
The CNR of the perfusion-weighted data for the LL_DABS scheme was 
significantly increased compared to DABS by 167 ± 41 % , averaged across 
subjects (p = 0.043, Wilcoxon Signed Rank Test). Whole-brain temporal SNR 
(tSNR) was compared across the first three minutes of LL_DABS acquisition for 
the respiratory challenge and motor task, in order to compare medical air with 
normocapnia. Three out of four showed an increase in whole-brain tSNR with 
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medical air in comparison to normocapnia, 30 ± 38 %, however this change was 
not significant (Wilcoxon Signed Rank Test). 
tSNR LQ WKH ¶*0 52,· was compared across the first three minutes of the 
respiratory challenge for the DABS and LL_DABS sequence. tSNR LQ WKH ¶*0
52,· was significantly increased in the ASL acquisition from the DABS sequence 
in comparison to LL_DABS (41.2 ± 8.7 %, p = 0.043, Wilcoxon Signed Rank 
Test). There was no significant difference in CNR or tSNR LQWKH¶*052,· of 
the BOLD acquisition between DABS and LL_DABS (Wilcoxon Signed Rank 
Test).  
6.7 Discussion 
 
Hypercapnia is a widely used tool when studying cerebral haemodynamics. As a 
known vasodilator, it is used to study cerebrovascular reactivity (CVR) and 
calibrate the BOLD response. The effect of hypercapnia on perfusion is most 
commonly measured using a single post-label delay time (TI) ASL scheme, due to 
the relative ease of perfusion quantification and ability to simultaneously acquire 
CBF and BOLD measurements. However, single phase ASL cannot provide a 
measurement oIWUDQVLWWLPHƅtissue), where transit time refers to the time taken for 
labelled blood to travel from the arterioles to the capillaries in the tissue bed. 
Furthermore, under high-flow conditions (such as hypercapnia), it is possible that 
methods such as QUIPSSII [309] may be unfeasible, and a significant proportion 
of labelled blood will have left the imaging plane before a readout pulse at a later 
TI, such that a simple activation-rest subtraction will be erroneous. Here a 
reasonably short TI of 1400 ms was used for the single phase acquisition, in order 
to minimise this error. However, from inspecting individual LL_DABS 
timecourses (as illustrated in Figure 6-8), it can be seen that the  difference in the 
perfusion-weighted signal between normoxia and hypercapnia peaked at 1100 ms 
in three out of five subjects. This highlights the individual variability in transit 
time in response to hypercapnia, making it difficult to accurately quantify the 
perfusion change with a single TI measure.  
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This chapter presented a modified LL-EPI FAIR sequence termed LL_DABS. 
The standard LL-EPI FAIR sequence was altered to include a 90° RF pulse 
applied at the final TI (TI9). The time between TI8 and TI9 was increased from 
300ms to 1300ms (maximum available time, given the chosen TA /TR/TE) to 
increase the time available for signal recovery to maximise the BOLD signal. 
There was no significant difference between LL_DABS and DABS in either 
BOLD tSNR or CNR, but a significant improvement in the tSNR and CNR of 
the BOLD signal was found for LL_DABS compared to the final readout pulse 
of the standard LL-EPI-FAIR scheme. CNR provides an indication of how easily 
task induced responses can be detected [323].  
Due to the multiple measurements taken in multiphase ASL, it is more sensitive 
than single phase methods to changes in perfusion, in particular to allow changes 
in transit time to be quantified. Whilst single phase ASL can be repeated across a 
UDQJHRI7,·V to form a multiphase data set, this is time-consuming. This study 
compared single phase and multiphase ASL sequences, using otherwise equivalent 
scan parameters. Both sequences (DABS and LL_DABS) measured a significant 
increase in CBF response to hypercapnia, which was further supported by a 
significant reduction in transit time as measured with LL_DABS. However, the 
measured change in CBF in response to hypercapnia was significantly greater for 
LL_DABS, than the DABS method, and CNR in the GM ROI of the perfusion-
weighted image was increased. 
These findings have important implications for hypercapnia calibrated BOLD. If 
the hypercapnia-induced perfusion change is underestimated relative to the 
BOLD change, it will lead to an over-estimation in the calibration constant M-
value, and likely lead to an over-estimation of the change in relative CMRO2 in 
response to a task. The LL_DABS measurements of M-value and change in 
relative CMRO2 are in close agreement with a recent 7 T study where an increase 
in relative CMRO2 of 13 % was reported in response to a fingertap, based on an 
M-value estimate of 15.5 % using hypercapnia calibration with multiphase ASL 
[308]. The results suggest that if single phase ASL is to be used to measure 
perfusion in calibrated BOLD, it would be beneficial to consider alternatives to 
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hypercapnia calibration such as hyperoxia [8] which does not cause a change in 
CBF.   
It can be assumed that the majority of grey matter will show a significant increase 
in CBF in response to hypercapnia. The GM activation was shown to be more 
robust for the LL_DABS acquisition, although for both acquisitions, the statistical 
activation maps of CBF response to hypercapnia were far less robust than for the 
BOLD maps. The CBF and BOLD activation maps were consistent for the motor 
task, suggesting that the problem is stimulus amplitude specific.  Furthermore, the 
onset of the hypercapnic stimulus had a significant effect on subject motion, with 
significant correlation between the PETCO2 trace and motion correction 
transformations observed.  
Using the DABS scheme it is possible to assess motion during the task. 
Hypercapnia was found to be associated with increased motion, and there are two 
plausible explanations for why. It could firstly be explained by subject discomfort. 
Hypercapnia is characterised by an acidic taste and has previously been shown 
that a 10mmHg step in PETCO2 could be detected with an 80 % success rate [324]. 
However, this study aimed to control for this factor in advance by using a slightly 
lower step of 8 mmHg (in comparison to previous studies carried out in this 
research group [130]). Furthermore, for subjects who had not experienced 
hypercapnia before, a trial sequence was carried out prior to going into the 
scanner. However, it remains likely that the onset of hypercapnia would still be 
detected by subjects in this study. Secondly, hypercapnia modulates the ventilatory 
response, as described in Section 6.2. Should hypercapnia increase the 
inspiratory/expiratory pressure, it may introduce increased head motion. Both 
breathing frequency and pressure were assessed between medical air, 
normocapnia and hypercapnia. No significant change was found in breathing 
frequency, and although paced breathing was not employed, subjects were asked 
to breathe regularly throughout. There was also no change in respiratory pressure 
across the three conditions. However, including the pressure trace as a confound 
in the GLM analysis increased the number of grey matter voxels showing 
statistically significant activation. Pressure was measured from the pressure trace 
via RespirActTM, which was primarily designed for end-tidal targeting rather than 
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physiological assessment. A secondary measure of respiratory pressure from 
respiratory bellows would be beneficial in future experiments.  
The findings from this study provide guidance for future research using a 
hypercapnic stimulus. Here, the potential to underestimate a change in perfusion 
with single phase ASL in response to hypercapnia have been highlighted. 
Variability in individual responses to hypercapnia have been observed, therefore it 
is difficult to simply correct for a change in transit time by reducing the post-label 
delay and using a single TI. It is important to characterise the shape of the ASL 
signal curve. The effect of hypercapnia on subject motion must not be 
underestimated. Motion artefacts could be potentially minimised in future work 
by modifying the respiratory paradigm to include a ramped transition, to allow the 
subject to acclimatise to the stimulus and minimise discomfort. Furthermore, 
paced breathing will prevent any potential changes in breathing frequency.  
6.8 Conclusion 
 
Using the LL_DABS sequence, it is possible to quantify both CBF and transit 
time in response to a task, whilst maintaining high BOLD sensitivity. This study 
demonstrates the importance of using multiphase ASL for perfusion 
quantification in high-flow environments, where single phase ASL may lead to a 
over-estimation of relative CMRO2. By removing the need to assume transit time 
in simultaneous CBF/BOLD acquisition, the quantitative nature of such 
acquisitions are improved and sensitivity to perfusion changes are increased. 
Simultaneous measurement of CBF and BOLD is important for calibration of the 
BOLD signal and investigating cerebrovascular reactivity. Furthermore, the high 
temporal SNR of the LL_DABS labelling scheme would enable further 
modulation of the BOLD signal, allowing simultaneous CBF, BOLD and CBV 
acquisition [135] in a combined hypercapnia and hyperoxia paradigm.  
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7 Conclusions 
 
This thesis has used respiratory challenges to investigate the BOLD response, 
with a view to gaining a more quantitative understanding of this phenomenon. 
Whilst years of research have been dedicated to understanding this endogenous 
fMRI signal contrast, a clear understanding remains to be found of how neuronal 
and vascular mechanisms contribute. This chapter summarises the findings 
presented in this thesis and looks to how they may help guide future work, with 
particular emphasis on calibration of the BOLD response. 
7.1 The effect of isocapnic hyperoxia on 
neurophysiology  
 
Calibration of the BOLD response provides the potential for BOLD to become a 
quantitative fMRI technique, which will be beneficial for the study of cerebral 
metabolism in ageing and disease.  As introduced in Chapter 4, calibration of the 
BOLD signal using hyperoxia is becoming increasingly popular. This work 
assessed some of the fundamental assumptions made in hyperoxia calibrated 
BOLD to determine the validity of the hyperoxia model [8]. An isocapnic 
hyperoxic stimulus was used throughout removing potential confounds caused by 
changes in CO2. Using Phase Contrast MRA (PC-MRA), a T1-independent 
method of assessing mean blood flow, it was shown that isocapnic hyperoxia had 
no significant effect on blood flow in the internal carotid arteries. Using a Look-
Locker sampling scheme with FAIR ASL, the effect of isocapnic hyperoxia on 
arterial cerebral blood volume was assessed. No significant change was found, 
together with the PC-MRA findings this suggests that isocapnic hyperoxia does 
not induce vasoconstriction. It is important to note that the assumption of 
constant cerebral blood flow and volume under hyperoxia is unlikely to hold if 
constant CO2 is not maintained (with a stimulus of 100% O2).  
The effect of isocapnic hyperoxia on resting-state neuronal oscillations as 
measured with MEG was investigated. A small reduction was observed in the 
occipital lobe, however the response was significantly smaller than the global 
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response to hypercapnia [130]. It is likely that the change in neuronal oscillations 
are coupled to a metabolic change,  and so these findings suggest that hyperoxia is 
an ideal alternative to hypercapnia in calibrated BOLD fMRI. Nonetheless, 
further research into the role of hyperoxia on neuronal oscillations is needed. It 
would be very interesting to investigate the potential role which hyperoxia may 
play on attention and cognitive function.  
The final part of Chapter 4 assessed the impact of isocapnic hyperoxia on 
functional hyperaemia; the change in cerebral blood flow evoked by a task. 
Having shown that isocapnic hyperoxia has no significant effect on cerebral 
vasculature, any measured changes in the evoked response between normoxic and 
hyperoxic conditions could be attributed to an increase in O 2. The change in CBF 
and BOLD were simultaneously assessed and the change in response to a motor 
task did not significantly differ between normoxic and hyperoxic conditions. 
Furthermore, there was no significant difference in baseline CBF between 
normoxia and hyperoxia, in agreement with the PC-MRA results. The findings are 
contrary to previous literature results which have reported a counter-intuitive 
increase in the functional hyperaemic response under non-isocapnic hyperoxia 
[228-230, 241]. However, it is likely that maintaining a constant CO2 across 
conditions may explain this difference. Future research is required into the 
mechanisms which regulate task evoked CBF.  
7.2 7KHGHSHQGHQFHRIƅ52* on oxygenation across 
field strength 
 
7KHSRZHUODZZKLFKUHODWHVWKHFKDQJHLQWUDQVYHUVHVLJQDOUHOD[DWLRQƅ52*) to a 
fractional change in blood oxygenation (1-Y) forms an integral part of calibrated 
BOLD fMRI. To date, the assumed values are generally taken from analytical and 
numerical simulations [139, 248, 249], although a small number of experimental 
measures have been made [9, 250-252]. Here, using an isocapnic hyperoxic 
stimulus, blood oxygenation was modulated whilst vascular responses were held 
constant. This allowed the relationship between ƅ52* and (1-Y) to be assessed in a 
quantitative manner. A sub-linear relationship was found across cortical grey 
matter, across all field strengths (1.5, 3 and 7 T), which could be well 
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approximated to a linear dependence at all field strengths. This is contrary to prior 
results, which suggest that the relationship is supralinear at 1.5 T and tend towards 
a linear dependence at 7 T. These differences can probably be explained by the 
contribution of both intravascular and extravascular signal to the measured grey 
matter signal in the present study, despite the removal of large vessels. 
Experimental measures were combined with in-vitro blood data [20], in order to 
assess the relative signal contributions across oxygenation and field strength. A 
rapid decrease in the intravascular signal with increased oxygenation, relative to 
extravascular signal, may explain the observed sub-linear dependence. In-vivo 
assessment of pure intra- and extravascular signal would help clarify this. 
Furthermore, the dynamic range of oxygenation was somewhat limited in this 
study (0.3-0.4) in comparison to the full theoretical range of 0-1. Including 
hypoxic data in future studies would increase the dynamic range and provide a 
better test replication of previous simulations [139, 248, 249]. 
7.3 The effect of hypercapnia on cerebral 
haemodynamics 
 
Due to its low cost and wide availability, hypercapnia remains a popular 
investigative tool in calibrated BOLD fMRI and cerebrovascular reactivity, despite 
its potential impact on CMRO2. In such studies, it is useful to make simultaneous 
measurements of CBF and BOLD, and this is generally done in combination with 
a single phase ASL sequence. Chapter 6 assessed the suitability of using a single 
phase sequence to measure CBF changes in a high-flow environment, such as 
under hypercapnia. A modified LL-EPI FAIR ASL sequence was presented 
(LLDABS), which increased the time before the final RF pulse to allow an 
increase in signal recovery time such that BOLD sensitivity was maximised for the 
chosen TR. The measured change in CBF was found to be significantly smaller 
when measured with single phase ASL using the DABS scheme as opposed to 
multiphase ASL. This can be explained by the observation that the transit time 
significantly decreased with hypercapnia. In addition, transit time was found to 
significantly decrease with hypercapnia, further supporting the use of multiphase 
ASL (LL_DABS) which does not rely on an assumed transit time. These findings 
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highlight the importance in choosing a suitable combined BOLD/ASL sequence 
for simultaneously measuring the BOLD and CBF response to hypercapnia. It is 
possible that single phase sequences may underestimate the perfusion change, 
which would lead to an underestimation of a relative change in CMRO 2 in the 
hypercapnia calibrated BOLD model. Furthermore, the improved BOLD 
sensitivity of the LLDABS sequence means it can be used to acquire simultaneous 
vCBV [135] in addition to BOLD and CBF, this will provide a useful method to 
assess cerebral haemodynamics in health and disease.  
7.4 Conclusion 
 
The ability to independently modulate O2 and CO2 provides a unique perturbation 
for investigating the mechanisms which underlie the BOLD response. 
Understanding these mechanisms is crucial to fMRI, which despite its popularity 
within the field of psychology and neuroscience, currently lacks the quantitative 
capability required in order for it to be a gold standard clinical imaging technique. 
The findings presented in this thesis aim to guide future research into the BOLD 
response, particularly calibrated BOLD fMRI, where the simultaneous acquisition 
of haemodynamic measurements will prove to be invaluable. 
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